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Abstract 
Large fluid shifts and oedema are features of burn injuries. Oedema hampers burn 
wound healing and is directly related to the size and depth of the burn. The degree of 
oedema in burns covers a broad spectrum: Minor burns cause localised or peripheral 
oedema, whilst major burns may result in a systemic inflammatory response which 
can be life threatening and necessitates formal fluid resuscitation. Acute burn fluid 
resuscitation is paramount in decreasing patient morbidity and mortality but can 
contribute to already large amounts of oedema.  There is currently no single 
clinically applicable, non-invasive and accurate outcome measure to titrate fluid 
volumes in acute burns or monitor the effect of treatments on oedema (in minor and 
major burns). Bioimpedance spectroscopy (BIS) has emerged as a possible solution 
to these challenges. It can measure body fluid compartments and thus fluid volume 
changes over time providing a sensitive non-invasive device to estimate resuscitation 
requirements and oedema change and is emerging as a measure of wound healing. 
This series of studies therefore aimed to 1) address the potential barriers to use of 
BIS in the burns population, 2) determine if BIS provides an accurate measure of 
whole body/systemic fluid volume change and 3) localised burn wound oedema 
changes, as applied across the spectrum of burn severity, and 4) determine if BIS can 
monitor wound healing in minor burns.  
The studies therefore investigated novel whole body and localised electrode positions 
in the presence of open and dressed wounds, using repeated measures over time in 
minor and major burns. 
The key novel findings arising from the research series include: 1) alternate electrode 
placements are interchangeable with standardised placement for the measurement of 
whole body resistance, extracellular and total body fluid volumes in specified 
dressing conditions. Therefore BIS can be utilised to monitor changes in fluid shifts 
when wounds preclude the manufacturer’s standard placement of electrodes in the 
presence of burn wounds, 2) BIS is a reliable method of monitoring fluid in any 
dressing condition and electrode position with no systematic bias indicated in both 
major and minor burns, 3) In both minor and major burns, BIS is a valid indicator of 
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net fluid shifts and oedema change, if dressing condition is adjusted for using the 
developed algorithms or calculator and 4) BIS resistance variables, R0 and Rinf, can 
be used to monitor wound healing in minor limb burns as an adjunct to standard 
practice.
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List And Definitions Of Key Terms  
Acticoat
 TM
  Ionic silver antimicrobial burn and wound dressing (Smith & 
Nephew) (1) 
Bioimpedance 
spectroscopy 
BIS A method used to assess body composition and allows for evaluation 
of specific body compartments and cell health such as fat free mass 
(FFM), inter-compartmental fluid volumes (extra and intra cellular 
fluid and total body fluid) and cell mass (2, 3). It uses a range of 
frequencies from 4-1000 kHz.  
Bioimpedance 
Analysis 
BIA Like BIS it is a method used to assess body composition and allows 
for evaluation of specific body compartments and cell health. It is 
either a single frequency or multi-frequency method. 
Body Cell Mass BCM Reflects the actively metabolizing cellular compartment. Indicated by 
ICF.  
Burn Service of 
Western 
Australia  
BSWA Includes Fiona Stanley Hospital (FSH) 
Extracellular 
fluid. 
ECF Fluid outside the cell consists of interstitial fluid (~13L) (dense 
connective tissue and bone), plasma (~3L) and transcellular fluid 
(~1L) (4). 
Fluid 
resuscitation 
 Intravenous ± oral fluid given in the first 24-48 hours of moderate to 
large burn injury to maintain intravascular volumes (5) 
Intracellular 
fluid 
ICF Fluid contained within the cell, has a high K
+
 content (95%) as well 
as Mg
+
, phosphates and protein (4) 
Lean Body Mass LBM  Body weight – fat mass 
Net Fluid Shift  The difference between the input and output of fluids over a specified 
timeframe 
Oedema  The fluid which traverses from the intravascular space into the 
extravascular space in response to tissue injury (6, 7). Otherwise 
known as swelling 
Phase angle PA A measure of cell membrane vitality and prognostic indicator of 
malnutrition and disease. Calculated as the arc tangent of Xc/R and 
expressed in degrees (8). 
Resistance at 
infinite 
frequency 
Rinf An index of TBF and used in the calculation of estimates of TBF (9). 
Resistance at 
zero frequency 
R0 An index of ECF and used in the calculation of estimates of ECF (9). 
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Resistance of 
intracellular 
fluid 
Ri An index of ICF and used in the calculation of estimates of ICF (9).  
Total body fluid TBF ECF + ICF. 56%-70% of the body consist of fluid, equivalent to 35-
45 L in an average sized human being (4) 
Total body 
surface area 
TBSA Expressed as a percentage 
 
References 
1. Guidelines for Use of Nanocrystalline Silver Dressing - Acticoat™. In: 
Department of Health WA, editor. Perth, Western Australia: Health Networks 
Branch, Department of Health, Western Australia; 2011. 
2. Kyle UG, Bosaeus I, De Lorenzo A, Deurenberg P, Elia M, Gome JM, et al. 
Bioelectrical Impedance Analysis-Part I: Review of Principles and Methods. Clinical 
Nutrition. 2004;23:1226-43. 
3. Mialich MS, Sicchieri JMF, Jordao Junior AA. Analysis of Body 
Composition- a Critical Review of the  Use of Bioelectrical Impedance Analysis. . 
International Journal of Clinical Nutrition. 2014;2(1):1-10. 
4. Boron W, Boulpaep E. Medical Physiology. 2 ed. Sciences EH, editor: 
Elsevie; 2008. 
5. Demling RH. The Burn Edema Process: Current Concepts. J Burn Care 
Rehabil. 2005;26:207-27. 
6. Edgar D, Fish JS, Gomez M, Wood FM. Local and Systemic Treatments for 
Acute Edema after Burn Injury: A Systematic Review of the Literature. J Burn Care 
Res. 2011;32:334-47. 
7. Kao CC, Garner WL. Acute Burns. Plast. Reconstr. Surg. 2000;105:2482-92. 
8. Lukaski H, Moore M. Bioelectrical Impedance Assessment of Wound 
Healing. Journal of Diabetes Science and Technology. 2012;6(1):209-12. 
9. Kyle U, Bosaues I, De Lorenzo A, Durenberg P, Elia M, Gomez JM, et al. 
Bioelectrical Impedance Analysis - Part Ii: Review of Principles and Methods. 
Clinical Nutrition. 2004a;23:1226-43. 
 
 
 18 
Acknowledgements 
I am using this opportunity to thank all those who have supported and assisted me in 
completing this thesis. Your advice and efforts over the past three years are greatly 
appreciated and I literally could not have done it without you. 
Firstly, Associate Professor Dale W. Edgar for giving me this research opportunity; 
his ongoing belief in me; and for being one of the few who “gets” me. Thanks D1. 
For editing prowess and assistance throughout the research journey I sincerely thank 
Dr Tiffany Grisbrook. 
Dr Will Gibson I thank you too for your expert advice and editing expertise.  
As a role model Professor Fiona Wood sets a high standard and it is funding through 
the Fiona Wood Foundation that made this research possible. 
Statistical analysis is quite a specialised field and the expertise of Michael Phillips 
was invaluable to me. He even made this challenging area a little easier to fathom. 
Raw data has to come from somewhere and so I must thank all the staff of the 
BSWA who help flag suitable patients for my studies and were ever so patient and 
flexible while I collected my measurements. 
Dale Edwick (D2), Paul Gittings and Ingrid Krueger with whom I work every week 
and who are also involved in research – thanks for the camaraderie. 
As you can see I was rarely alone as I travelled down the research path. My fellow 
physiotherapy colleagues who were flexible and worked with me throughout the data 
collection process (and may have had an open ear at times to my statistical 
nightmares). 
I reserve a special thanks for my family who were forever reinforcing their belief that 
I could do this and, in the beginning, for nudging me into taking on this opportunity. 
Thanks for the dinners and time to proof read some of my work and for your 
willingness to act as a ‘bumper board’ on the very odd occasion.  
 19 
I extend an especial vote of gratitude to the Indian Ocean. She has soothed and 
bathed me, washing away the stresses that came with writing this thesis and 
replenished my enthusiasm for the task. I could not have done without her.
 20 
Chapter 1 Introduction 
Burns are one of the most traumatic injuries a patient can sustain often having a 
lifelong impact on a person’s quality of function, both physically and mentally. Burn 
injury causes tissue damage, and a unique inflammatory response, which results in 
marked oedema. The inflammatory mediators released, such as prostaglandins, 
histamine and bradykinin, increase intravascular permeability and promote the 
passage of fluid into interstitial spaces causing local and systemic fluid shifts (1, 2). 
Excess oedema inhibits blood flow and reduces oxygen perfusion in vulnerable 
tissue, resulting in worsening of the burn wound (3). Immediate management and 
ongoing monitoring of oedema is therefore essential in limiting the severity of burn 
injury, especially in the first 48 – 72 hours (4). 
Optimising emergency treatment of burns is paramount to achieve the best possible 
outcome. Fluid resuscitation is an important aspect of acute burns management in 
burns greater than 15-20% total body surface area (TBSA) and may be thought of as 
the cornerstone of burns early management and patient survival (5). Despite this, 
there has been limited innovation or progress in interventions in the area over the last 
30 years (6). Initial fluid resuscitation volumes delivered are determined using 
formulas based on the patients weight and %TBSA (7, 8). Fluid volumes are 
monitored closely and titrated, most commonly, according to urine output (30 – 
50ml/hour) (9). Administering acute fluid resuscitation volumes as closely aligned to 
those initially calculated and closely monitoring urine output is essential in the 
prevention of burn shock and other complications such as abdominal and peripheral 
compartment syndromes, kidney failure, pulmonary oedema and peripheral tissue 
oedema (10). Fluid resuscitation in the first twenty four hours post burns remains a 
complex task as the patient must receive sufficient fluid to prevent hypovolemia and 
ensure adequate tissue perfusion and blood supply to vital organs but it will also 
accentuate the oedema process (1, 11, 12). Both peripheral and systemic oedema can 
contribute to burn wound complications and delay wound healing. It therefore needs 
to be optimally managed (10, 13). To optimally manage oedema a reliable and 
accurate measurement device is firstly required. 
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Current methods of oedema or fluid shift assessment in burns are either invasive, 
time consuming, require an open wound or are an indirect measure. Fluid 
resuscitation volumes in moderate to large burns are initially determined using 
accepted formulas as guidelines e.g. Parkland formula (14, 15) and are then titrated 
using most commonly, urine output and haemodynamic observations such as oxygen 
saturation and blood pressure. Other objective measures used to guide fluid volume 
titration are: pulmonary artery catheterisation and transpulmonary thermodilution 
(provide right heart diagnostic information to rapidly determine hemodynamic 
pressures, cardiac output, and mixed venous blood sampling) and base deficit and 
lactate (16, 17). These are all indirect (and invasive) methods of measuring fluid 
volumes and attempts to normalise cardiac output and haematocrit in the first 48 
hours of injury does not improve patient outcomes and may lead to over resuscitation 
(18). Fluid creep, the tendency to administer too much intravenous fluid is not 
uncommon (6). 
The widely accepted methods for clinical monitoring of peripheral oedema are 
circumferential limb measures (CLM) and water displacement volumetry (WDV) 
(19). These are both confounded when wounds are dressed; pose a potential infection 
risk and WDV can be cumbersome. Limited progress in identification of clinically 
applicable oedema measures has contributed to the lack of emergent interventions for 
more proactive oedema removal (20). Thus, to guide improvements in fluid 
resuscitation and oedema management in the burn population, a non-invasive, easy 
to use, accurate assessment of oedema is required. 
Bioimpedance spectroscopy (BIS) is a technique used to assess and monitor an 
individual’s body composition, such as inter-compartmental fluid volumes, fat free 
mass and cell health (21, 22). It is an instrument frequently utilised in healthy 
populations, lymphoedema and more recently in other clinical populations such as 
dialysis patients (23, 24). There are many studies investigating its use as a method of 
assessing and monitoring malnutrition, fluid shifts in the critically ill and after 
surgery and as a prognostic tool in cancer (25-28). Bioimpedance spectroscopy is 
gaining popularity as method of assessment in the aforementioned areas as it is 
practical, rapid and has demonstrated sensitivity and reliability (29, 30).  
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The bioimpedance spectroscopy instrument applies a small alternating current into 
the body over a range of frequencies (4-1000 kHz), via electrodes, providing 
instantaneous measures of resistance (R) and reactance (capacitive resistance (Xc)). 
Resistance is the opposition to flow of an electric current and capacitance is the delay 
in the passage of current through the cell membranes and tissue interfaces. The flow 
and path of the electrical current is frequency (Hz) dependent (Figure 1.1). 
Resistances at zero and infinite frequencies (considered ideal measurement 
frequencies) are estimated utilising the Cole-Cole plot embedded in the BIS 
software, due the constraints of using a direct or very high frequency alternating 
current in humans (31). The resistance at zero (R0) and infinite (Rinf) frequencies (32) 
are representative of extracellular fluid (ECF) and total body fluid (TBF) 
respectively. Resistance (Ri) of the intracellular fluid (ICF) is extrapolated using the 
other raw variable data. At low frequencies, the current cannot traverse the cell 
membrane and will only pass through the ECF, which surrounds the cells. At high 
frequencies (>50 kHz) the current will pass through the ECF and the cell membrane 
or intracellular compartment thus estimating TBF (33) (Figure 1.1). When these raw 
resistance variables are incorporated into predictive mixture theory equations (e.g. 
Hanai equation) embedded in the BIS software, fluid volumes (ECF, ICF, TBF) can 
be calculated (32). The raw resistance variables can also be utilised to monitor inter-
compartmental fluid volume changes as body fluid behaves as resistive components 
and resistance is inversely proportional to fluid volume and therefore oedema (34, 
35). Reactance is caused by the capacitance of the cell membrane and represents cell 
membrane mass and function. Another variable, phase angle (PA), is a measurement 
calculated from the relationship between R and Xc (36). It is a predictor of cell 
health, and has been shown to have potential in the ability to monitor wound healing 
and as a prognostic indicator of malnutrition and disease (30). 
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Figure 1.1: Current distribution in cell suspensions (37) 
Bioimpedance can measure fluid shifts at a whole body level, with electrodes placed 
on the hands and feet (38). Fluid volume change and cell health of limbs or wounds 
can be measured simply by placing the electrodes either side of the segment to be 
measured. This is termed segmental or localised bioimpedance. It brings the field of 
measurement closer to the site of interest and is more sensitive to fluid volume 
changes compared to whole body measures (35).  
To date there is limited literature investigating the use of bioimpedance in burns. 
Zdolsek (1998) found whole body bioimpedance analysis (BIA) was sensitive 
enough to determine the development of oedema (using TBF) and the effects of fluid 
resuscitation following burn injury (15-63% TBSA) (39). This was however a small 
and underpowered study (n=9). Another study by Miller et al (1999) found there was 
a significant positive correlation (r=0.958) between single frequency whole body 
BIA and the titrated water method of determining TBF in patients with severe burns 
(<23% TBSA range 23-65%). More recently, Edgar et al (2009) used whole body 
BIS to measure acute oedema shifts in human burn survivors in different dressing 
conditions (29). They concluded that BIS analysis is clinically applicable for the real 
time monitoring of whole body fluid shifts in patients with injuries less than 30% 
TBSA regardless of dressing conditions, but it was more reliable with no dressings 
than when dressings were in place. They did not however, explore the reason 
dressings affected the reliability of BIS variables. These researchers demonstrated 
BIS has the ability to monitor fluid changes in acute burns, however they did not 
confirm whether it is a valid measure of fluid shift to be able to clinically titrate fluid 
resuscitation volumes.  
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There are no studies in the literature, exploring BIS as a measure of localised limb 
oedema or wound healing in burn injured patients. However in muscle injuries, 
single frequency bioimpedance analysis (BIA) with localised electrode placement 
(sense and drive either side of the injury) was able to detect changes in oedema and 
cellular injury consistent with MRI imaging over time in the individual (41). In 
patients with wounds of varying aetiologies, localised single frequency 
bioimpedance variables R, Xc and PA were found to increase with re-
epithelialisation of a wound, with modest decreases after wound debridement and 
greater decreases with methicillin-resistant staphylococcus aureus (MRSA) infection 
of a wound (30). The rate of change in the raw variables signalled the presence of 
infection before detection with laboratory methods (30). Measuring local wound and 
peripheral oedema practically and with ease in a clinical setting will guide 
improvements in pro-active oedema management and thus aid wound healing. 
There are potential barriers to the use of BIS in burns such as open wounds and 
dressings. These may prevent the placement of standardised electrode positions and 
influence the BIS variable output. There is conflicting evidence regarding movement 
of standardised electrode positions and repeatability of BIS variables. The theory of 
equi-potentials, which are loci of points with the same electrical potential and 
perpendicular to the flow of the current, suggest movement of electrodes at points 
circumferentially will yield the same results as standard electrode placements (42). 
Movement proximally however, by one and two centimetres has been reported to 
change mean resistance values by 2% and 4% respectively, indicating BIS is a highly 
sensitive measure (43). Thus, the standardisation and accuracy of electrode 
placement is important to minimise BIS reproducibility errors between measures. 
Acute burn wounds, minor and major, will have a dressing in place at all times 
except at the time of dressing change. Further, commonly burn dressings are 
impregnated with silver ions or are water based (hydrocolloid). Considering 
resistance (opposition by a conductor; a type of material that allows the flow of 
electrical current in one or more directions) is proportional to the amount of fluid and 
ionic content of the fluid, it is not unrealistic to expect burn dressings may alter the 
BIS variable measures (resistance and calculated fluid volumes). Silver is a highly 
conductive material and will therefore likely decrease the measured BIS resistance. 
Hydrocolloid dressings will also be expected to affect the resistance measured due to 
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it being an ionic dressing. Edgar et al (2009), as previously mentioned, demonstrated 
BIS measurements were less sensitive in older dressings (>8 hours old) compared to 
when no dressings were in place (29). Moving forward, being able to utilise BIS 
when dressings are in place and/or when wounds prevent standardised electrode 
positioning would enhance the applicability of BIS clinically in burns and other 
clinical environments. 
1.1 Statement Of The Problem 
All burn injuries result in a cascade of inflammatory mediators and oedema. Oedema 
is detrimental to wound healing. However, minimal advance is observed in the 
interventions to control or reduce oedema volume in wounded tissue. The lack of 
advances may be attributed to a lack of accurate, clinically viable assessment of new 
methods. Whether it is a localised wound or systemic oedema there is no single non-
invasive, real time, bedside measure of monitoring oedema change. It is evident in 
both the literature and clinical setting that oedema can lead to conversion of an acute 
burn wound, limb and abdominal compartment syndromes and slow healing. These 
negative sequelae of oedema can significantly impact an individual’s physical 
function, scar quality, psychological recovery and even morbidity outcome. These 
adverse outcomes lead to increased medical costs, increased length of stay and an 
increased burden on the patient and family. There has been little advance in 1) the 
assessment and monitoring of burns resuscitation fluid monitoring and titration in the 
last forty years and 2) in the assessment and treatment of peripheral limb oedema. A 
major reason for this is due to the lack of user friendly, sensitive outcome measures. 
Bioimpedance spectroscopy is a method of oedema measurement and wound 
healing, which has merit in burns. It is worth investigating BIS in this challenging 
unique population where dressings and open wounds often hinder the use of the gold 
standard measures of oedema volume (WDV and CLM) (4, 19). 
1.1.1 Aims Of Study Series 
This research aims to assess whether BIS is a reliable and valid measure of fluid 
volume change, across the spectrum of burn severity. Secondly, it aims to address the 
barriers, such as wounds and dressings that may impede the use of BIS in this 
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environment. It will attempt to provide solutions to overcome these potential 
barriers, through investigation of i) novel electrode placements and ii) the effect of 
dressings on BIS variable outputs. Thirdly, the study aims to establish whether BIS 
can be used to monitor local wound healing. 
1.1.2 Significance Of Study Series 
This series of studies will aim to provide a solution for real time, practical 
assessment and monitoring of fluid volume change and wound healing in burn 
patients, providing solutions to real clinical problems and therefore help guide 
improved clinical care of the patient. 
The basis of this research is to provide a reliable and valid measure of oedema 
change so it can i) guide future intervention studies to progress proactive oedema 
management and ii) improve oedema assessment clinically to allow application and 
adjustment of the current best practice management strategies in the burn population. 
Thus significantly impacting patient outcome and recovery following a burn, as 
“every intervention from the point of injury influences the outcome after burn” (4).  
It is anticipated the findings of this research will be applicable to all staff responsible 
for the wound care in burn patients, from nursing and medical staff to allied health 
professionals. All of these team members will benefit from the findings of this 
research, as all members are involved in aspects of oedema control, prevention and 
wound healing management. The findings hope to drive clinician behavioural change 
with respect to positive changes in proactive oedema management and care, through 
the use of BIS in standard clinical practice. By delivering the outcomes of the study 
to burns clinicians and translating the use of BIS into clinical practice, it will re-
iterate and reinforce the importance of oedema management in the care of the burn 
patient. It also has the potential to reduce the cost to the health system. 
1.2 Thesis Outline 
The context for the study, the research problem and its significance are presented in 
the introduction and literature review and they communicate the steps taken to 
address the questions posed. This is followed by a series of studies exploring the 
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challenges to the use of BIS in burns and establishment of its methodological utility 
and concluding with a synthesis of the results and discussion. Both studies 
investigate the use of BIS in acute burns, across the spectrum of severity as major 
burns cause a systemic inflammatory response and minor a localised inflammatory 
response. Each class of burn also have their own, similar but unique, potential 
barriers to the use of BIS.  
The first study relates to the assessment of whole body fluid shifts, using BIS, in 
acute burns requiring fluid resuscitation. It is disclosed as two papers; (i) addresses 
the issue of wounds to the placement of BIS electrodes and (ii) presents the 
reliability and validity of BIS and factors that influence BIS variables. 
The second study is also presented as two papers. The first of these addresses the 
barriers to the application of BIS and the reliability and validity of novel localised 
BIS in the assessment of minor limb burn oedema. The second presents localised BIS 
as a method of monitoring wound healing. The thesis therefore consists of four 
separate inter-related papers.  
There are aspects of each of the studies that are similar due to the nature of the burn 
environment and the similar aims addressed across the burns spectrum. The 
references are presented at the end of each studies manuscript. A synthesis of the 
results and discussion concludes the thesis.  
This series of studies was conducted at Fiona Stanley Hospital (FSH), the tertiary 
hospital for the Burn Service of Western Australia (BSWA), a state-wide service. 
Understanding the current clinical practices and model of care of the service will 
provide context and insight to the research methodology for the study series. The 
BSWA utilises the modified Parkland formula to instigate initial intravenous fluid 
resuscitation (2 ml/kg/hr) in burns greater than 15% TBSA, or as deemed clinically 
necessary. Fluid volumes are monitored and titrated according to urine output (0.5 
ml/kg/hr) and haemodynamic monitoring. Limb oedema is most commonly assessed 
subjectively and with CLM. Oedema management is integral to clinical practice and 
a priority of all treatments. The BSWA employs a multi-disciplinary approach in 
ongoing oedema management practices. The most common oedema management 
principles applied are: education; elevation using positioning devices such as lower 
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limb wedge cushions and axilla arm boards; low stretch compression using - Coban 
3M
TM
 (Critical & Chronic Care Solutions, New South Wales, Australia) self 
adherent wrap, tubular-form (Sutherland Medical Pty.Ltd., Victoria, Australia) and 
oedema gloves; cardiovascular fitness exercise such as walking, exercise bike and 
arm ergometer; active range of motion to enhance lymph flow and strength/resisted 
exercise.  Wounds in the first 48 hours of injury are managed with an antimicrobial, 
silver impregnated dressing (Acticoat
TM
) as it has been shown to be effective against 
most common strains of wound pathogens; decreases pain levels; reduces infection 
rates; and is cost effective (44). Dressing choice after this period is dependent on the 
status of the wound as decided by the clinical specialist.  
1.2.1 Study One: Addressing The Barriers To Bioimpedance 
Spectroscopy In Major Burns: Alternate Electrode 
Placements 
The aim of this study was to:  
 Determine whether alternate electrode configurations for whole body and 
limb segmental BIS outputs were comparable to standardised electrode 
configurations in moderate to large size burns across different dressing 
conditions 
It was hypothesised that: 
 Whole body and limb segmental alternate electrode positions will provide 
comparable BIS variable output, raw and predicted, to standard electrode 
positions 
Conclusion: Whole body resistance variables and extracellular fluid can monitor 
changes in fluid shifts with alternate electrode placements where wounds preclude 
standardised placement in both an open wound and Acticoat
TM
 dressing. It was also 
apparent the Acticoat
TM
 dressing exaggerated the differences between the standard 
and alternate electrode positions but also between the open wound and Acticoat
TM 
dressing condition. 
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1.2.2 Study Two: An Objective Measure For The Assessment 
And Management Of Fluid Shifts In Acute Major Burns  
The aims of this study were to: 
 Examine the reliability of BIS with respect to dressing condition and 
electrode position.  
 Establish the effect of ActicoatTM dressings on BIS variable outputs   
 Determine the validity of whole body BIS in the presence of major burns 
 
It was hypothesised that: 
 BIS will be reliable in any dressing and electrode position 
 ActicoatTM dressings used in the first 48 hours of burn injury in the Burn 
Service of Western Australia (BSWA) will reduce BIS variable outputs  
 BIS raw resistance variables will decrease and predicted fluid volumes will 
increase with increasing fluid shift 
Conclusion: Whole body bioimpedance is a valid indicator of net fluid shifts, if 
dressing condition is adjusted for.  
1.2.3 Study Three: Bioimpedance Spectroscopy: A Technique 
To Monitor Interventions For Swelling In Minor Burns 
The aims of this study were to: 
 Examine the reliability and validity of the BIS technique for the measurement 
of localised burn wound oedema with respect to electrode position and 
dressing condition.  
It was hypothesised that: 
 Bioimpedance resistance variables, R0, Ri, Rinf will increase as limb volumes 
decrease. 
Conclusion: BIS is a sensitive, reliable and valid technique that may be used 
clinically to monitor localised changes in burn wound oedema. 
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1.2.4 Study Four: Monitoring Wound Healing In Minor Burns – 
A Novel Approach 
The aim of this study was to: 
 Determine whether the BIS technique is a valid measure of wound healing  
 
It was hypothesised that: 
 BIS resistance and phase angle will increase with burn wound healing  
Conclusion: BIS is a technique, which has the potential to monitor the wound healing 
process of a minor acute burn. 
1.2.5 Synthesis Of Results And Conclusions  
This final chapter draws the results of the individual studies together, providing an 
integrated discussion of the major findings, study limitations and future research and 
gives an encompassing conclusion of the entire research. 
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Chapter 2 Review Of The Literature 
This literature review provides an overview of oedema production after a burn 
injury, its potential impacts in the burn wound environment and why it is important 
to have a reliable and valid bedside oedema assessment tool. The pathophysiology of 
burn wound healing and oedema is firstly discussed. It then outlines factors 
contributing to burn severity and oedema volumes. Followed then by a discussion of 
current burn oedema or fluid monitoring outcome measures and their limitations. 
Bioimpedance spectroscopy is subsequently introduced. A brief overview of BIS 
properties and its potential uses in the burns environment is provided. 
2.1 Wound Healing 
Inflammation is the body’s normal response to injury. It is a complex process of 
vascular and cellular responses protecting the body against infection. Normal healing 
of an acute wound occurs in a timely and orderly sequential manner (1). Factors 
impacting the normal pathway to healing include injury severity, age, co-morbidities 
and ethnicity (2). The longer a wound takes to heal the greater the risk of infection 
and hypertrophic scarring. 
The ability for the skin to heal largely depends on the extent of the injury (2). Skin 
can be simply divided into three layers (Figure 2.1) (3). Understanding the structure 
of these three layers and the burn depth can provide invaluable information on 
expected wound healing times and necessary medical interventions.  
i. Epidermis: outer most superficial layer of skin. It is composed of epithelial 
tissue. The dermal epidermal junction, the interface between the epidermis 
and dermis, attach the two layers to each other and is a key to epithelial 
repair. The epidermis also influences the dermis with regards to structural 
remodelling, re-innervation and vascularisation (3). 
ii. Dermis: has two layers, the papillary and reticular layers. The upper, papillary 
layer, contains a thin arrangement of collagen fibres and the lower, reticular 
layer, is thicker and made of thick collagen fibres arranged parallel to the 
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surface of the skin. The dermis consists of oil and sweat glands and hair 
follicles. The types of tissue are: collagen, elastic tissue and reticular fibres. 
iii. Subcutaneous tissue: a layer of fat and connective tissue that houses larger 
blood vessels and nerves. This layer is important in the regulation of skin and 
body temperature.  
 
 
Figure 2.1: Cross section of burn depth and skin layers (reproduced 
with permission F. Wood) 
Superficial burns (involving epidermis and papillary dermis) will regenerate 
epithelium from sufficient unburned epithelial appendages, allowing spontaneous 
healing with minimal scarring. Deep partial and full thickness burns (deep dermis to 
subcutaneous tissue) are slow to heal with resultant unstable skin and hypertrophic 
scarring (4, 5).  
2.1.1 Factors Affecting Wound Healing  
Multiple factors can impair healing and they exist at a local wound and systemic 
level. The following are a common but not exhaustive list of patient factors affecting 
healing: 
 Pre-existing disease (e.g. peripheral vascular disease, diabetes) and increasing 
age. Both result in an altered inflammatory response compared to normal and 
are predisposing factors to oedema formation (6). 
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 Alcoholism, obesity and smoking increase the risk of vascular, heart and lung 
disease. These diseases commonly cause affect the structure and function of 
the vessels which can interfere with oxygen supply (2).  
 Ethnicity, pre-existing nutrition and stress also impact wound healing (2).  
 
Additionally, injury severity, presence of infection and oedema all contribute to the 
healing capacity of a wound (7).  
A burn injury results in a hypermetabolic response and increased catabolism of 
protein. In severe injuries the body can be catabolic during wound healing greater 
than 12 months after injury (8, 9). The body requires sufficient and generally extra 
nutrients to promote healing and sustain hypermetabolism. A high caloric and 
nutritious diet is therefore needed. Further detail here is beyond the scope of this 
project but it is necessary to understand factors influencing a healing wound. 
Burn injuries are highly susceptible to infections due to loss of skin integrity and 
reduced cell mediated immunity (10). The presence of infection will slow wound 
healing and leads to altered fluid dynamics and extravasation of oedema (6). Burn 
patients are susceptible to infection due to the removal of skin, the protective barrier; 
general immunosuppression; surgical intervention; prolonged hospital impatient stay; 
and the environment of injury (11). It is the main cause of mortality and morbidity 
for burn injured patients (10). Wound colonisation with microorganisms delay 
wound healing, increase graft loss and increase risk of systemic infection (1, 12). It is 
vital that wound management is optimum and infection control procedures (e.g. 
sterilisation and/or cleaning of equipment, hand hygiene) are adhered to (13). 
Burn wound dressings are therefore important and provide a variety of benefits. They 
protect the wound from further trauma or infection by providing a barrier to 
infection, provide comfort and pain relief, and promote healing (14). There are 
number of different dressings and choice is dependent on various factors: the extent 
of injury, stage of healing, amount of exudate, patients intact skin integrity, presence 
of infection, position of injury, surgical intervention. The BSWA protocol is to apply 
Acticoat
TM
 dressings to all burns for the first forty-eight hours of injury, then change 
as appropriate according to the wound condition. 
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2.2 Burn Wound Response  
Oedema, a natural inflammatory response to trauma, is a normal part of the healing 
process. This response however is exaggerated in a burn injury causing excessive 
tissue fluid deposition, both locally and systemically (15, 16). 
2.2.1 Zones Of Injury  
The burn wound is described in three zones of tissue injury (Figure 2.2). 1) The 
irreversible zone of necrosis – the extent of which is directly related to the 
temperature and duration of exposure and is irreversible due to coagulation of 
constituent proteins (16). 2) The zone of stasis - characterized by decreased tissue 
perfusion. In the first 48-72 hours it can be salvaged through timely and appropriate 
intervention. In this area, excess oedema can further decrease tissue perfusion 
converting salvageable to necrotic tissue, a process known as burn wound conversion 
(17). 3) The outermost zone of hyperaemia – an area of tissue with increased 
perfusion, which surrounds the zone of stasis. It is invariably oedematous 
recoverable tissue (17). Oedema, a natural response to trauma through inflammation, 
is a normal part of the healing process. However, excessive oedema can result in 
increased tissue losses, slow wound healing, exacerbate tissue scarring, limit 
function and at worst increase mortality (15, 18).  
2.2.2 Burn Wound Conversion 
Burn wound conversion is an important phenomenon in the treatment of thermal 
injury as burn wound depth may be a significant determinant of morbidity and 
mortality. It is also clinically significant because as the degree of burn advances it 
increases the likelihood of hypertrophic scarring, contractures, need for surgical 
excision and grafting, wound infection, sepsis and shock (19). 
Burn wound conversion is a term for the dynamic process resulting in increased 
tissue losses and wound deepening. It is caused by many factors both local and 
systemic such as excess oedema, changes in blood flow, excess inflammation and 
inflammatory mediators, infection and chronic medical illnesses (e.g. diabetes, 
vascular disease) (20). Excess oedema limits the exchange of vital nutrients 
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Figure 2.2: Diagrammatic representation of the zones of injury 
(reproduced with permission, D.Edgar) 
 
A
 
B
 
Figure 2.3: Demonstration of burn wound conversion in a scald injury. 
Mid dermal (A) to full thickness (B). 
(including oxygen), between the circulation and the damaged areas compromising 
vulnerable tissues (21). Conversion is commonly seen in the subacute phase (three-
five days) where burns initially assessed as superficial-mid dermal thickness progress 
to deep partial or full thickness burns (Figure 2.3). Thus, timely removal of oedema 
is paramount in limiting the risk of burn wound conversion. Also, as the TBSA of the 
burn increases so too does the risk of wound progression (17). Limiting the degree of 
both local and systemic oedema through optimal control of fluid resuscitation in 
major burns, elevation, movement, compression where appropriate and using 
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appropriate wound dressings, maintaining nutritional status and timely surgery can 
reduce the risk of burn wound depth.  
2.2.3 Burn Pathophysiology  
The pathophysiology of the microvascular changes post-burn is quite complex. It is 
known that when burnt the damaged tissues release chemical mediators, such as 
histamine, prostaglandins and oxidants (all cells altered from the burn injury are 
capable of releasing oxidants), which can damage the capillary membrane and 
increase capillary permeability (22). This allows leakage of fluids, plasma proteins 
and electrolytes from the intravascular space into the extravascular space (or tissues) 
causing immediate localised oedema, and in burns greater than 15-20% TBSA, 
systemic oedema (swelling in non-injured tissues and the lungs) (23). This is known 
as the ‘vascular leakage syndrome’ noted to last for ~24 hours after burn. The 
syndrome is life threatening and immediate medical attention is recommended as it 
can lead to burn shock, a unique phenomenon, which is a combination of 
distributive, hypovolemic and cardiogenic shock (22). Fluid resuscitation is 
necessary to maintain circulating blood volume and blood supply to vital organs, but 
it also contributes to oedema in the tissues, particularly during the ‘leaky blood 
vessel’ period.  
Unavoidable local oedema and large scale fluid shifts are caused by disruption of 
collagen cross linking destroying the integrity of the osmotic and hydrostatic 
pressure gradients (24). There is also worsening fluid regulation and systemic 
inflammatory responses due to cell membrane damage from the influx of 
inflammatory mediators exacerbating abnormal cell to cell permeability. 
These fluid shifts and resultant micro-thrombi in vessels can exacerbate 
hypoperfusion (or inhibition of blood flow) in vulnerable tissue, specifically in the 
zone of stasis and hyperaemia i.e. inadequate oxygen perfusion can increase the zone 
of necrosis thus worsening the burn wound (25). Limiting excess oedema is therefore 
important as it can reduce healing time via optimal blood flow and oxygen to the 
wound thus positively benefiting burn survivors. 
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2.3 Contributing Factors To Acute Burn Oedema 
Acute burn oedema formation and resolution is related to the severity of the injury 
including factors such as the depth and size of burn, immediate first aid management 
and fluid resuscitation. 
2.3.1 Burn Depth 
Burn depth is defined according to the layer of skin damaged i.e. epidermis, dermis, 
subcutaneous fat and can be divided into five categories of increasing depth: 
epidermal, superficial dermal, mid dermal, deep dermal and full thickness (Table 
2.1) (26).  
Burn depth affects the volume and location of oedema. Superficial and mid dermal 
burns have a greater local, immediate oedematous response than full thickness burns 
(22, 27). Excess ECF (oedema) can be persistent in deeper burns due to the disrupted 
integrity of capillaries and increased capillary leak. The capacity for oedema to be 
reabsorbed into the vascular system and be carried away by the lymphatics in a 
timely fashion as it is in normal wound healing, is therefore reduced (28).  
In partial thickness burns, oedema located mainly in the dermis, increases in the first 
few hours and then gradually reabsorbs over three-four days due to the preserved 
lymphatic system (17, 22). Oedema in deep or full thickness burns increases at a 
slower rate and over a longer period due to damaged dermal vascular and lymphatic 
channels with reports of peak levels at 18 hours after-injury (29). Twenty five 
percent of oedema in deep burns is still present at one week.  
In pigs inflicted with minor burns, Papp et al (2006) found superficial burns had 
increased water content of the whole dermis and subcutaneous fat at eight hours after 
burn; partial thickness burns had a greater water content in the whole dermis still at 
24 and 72 hours after burn; Full thickness burns presented with significantly less 
water content in the upper dermis at 24 hours and was associated with necrosis of the 
tissue layer (30). All burns had higher tissue water content in the subcutaneous fat 
compared to non burned areas. In sheep inflicted with burns, oedema was located in 
the surrounding dermis and subfascial tissue for all burn depths and in underlying 
adipose and muscle in full thickness burns of sheep (31). It has been demonstrated 
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the distribution and the rate of occurrence of oedema and the capacity of the body to 
reabsorb oedema is related to burn depth. It is just one component of burn injury 
supporting the importance of early oedema management and monitoring. 
Table 2.1: Burn depth characteristics. 
Depth Colour Blisters Capillary 
Refill 
Sensation Healing 
Epidermal Red No Present Present Yes (3-7 days) 
Superficial 
Dermal 
Pale pink Small Present Painful Yes (7-10 days 
with minimal 
dressings) 
Mid-dermal Dark pink Present Sluggish +/- Usually (should 
heal within 14 
days) 
Deep 
Dermal 
Blotchy 
red 
+/- Absent Absent No (generally 
needs surgical 
intervention) 
Full 
thickness 
White No Absent Absent No (generally 
needs surgical 
intervention) 
[Table adjusted from the Emergency management of Severe Burns course manual 
2013] (26).  
2.3.2 Total Body Surface Area 
Total body surface area influences the volume of oedema production due to 
increased tissue damage increasing the rate or volume of vascular permeability (22). 
Increasing TBSA is also associated with an increased risk of burn wound conversion 
and is an indication of overall burn severity (16, 17). Generally minor burns < 10-
15% TBSA result in localised burn wound oedema and major burns > 20-25% TBSA 
induce a systemic reaction with significant ‘vascular-leak’ or hyper-permeability of 
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the capillaries in the first 24-48 hours after surgery (32). Research has estimated that 
in large burns up to 50% of oedema volume is in non-burn areas (22). Total body 
surface area is one of the main considerations in the determining fluid resuscitation 
volumes in large burns and is determined most commonly using the ‘rule of nines’ 
(Figure 2.4). 
 
  
Figure 2.4: Rule of nines for estimation of burn severity in adults (33) 
2.3.3 Inhalation Injury  
As the size of the burn increases so does the risk of inhalation injury and it will occur 
in two-thirds of patients with greater than 70% TBSA burn injury (5). Upper airway 
oedema can occur rapidly in patients with smoke inhalation and a sizable burn. 
Intubation should not be delayed. Patients considered at risk of inhalation injury 
should be assessed and monitored with arterial blood gases, chest x-rays and pulse 
oximetry. If the equipment is available, monitoring of end tidal carbon dioxide using 
capnometry or capnography can provide useful respiratory status information. 
Fiberoptic laryngoscopy and bronchoscopy can assess the extent of airway injury 
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(34). These are indirect measures of oedema but contribute to the overall picture of 
injury severity. 
The scope of this thesis is investigation of whole body and localised limb wound 
oedema and not distinguishing airway oedema. However, it is known major burns are 
at risk of pulmonary oedema due to vascular leak in the initial stage of injury (16). 
After reviewing the literature, Saffle et al (2007) reported fluid resuscitation 
requirements of patients with an inhalation injury was greater than those patients 
without an inhalation injury (from 35% to 65% greater) (35). This was independent 
of the type of resuscitation fluid delivered. 
2.3.4 First Aid 
Recommended immediate first aid management is 20 minutes of cool running water 
(15° - 18°C), occurring up to three hours after the injury has occurred at the burn site 
whilst keeping the patient warm (36). It significantly lessens the impact of the injury 
through reducing scar and infection and the need for surgery (37).  
2.3.5 Fluid Resuscitation 
A major goal of the initial management of burn injuries is to replace ECF loss 
proportional to %TBSA of the burn. This is in the form of intravenous fluids in large 
burns. Optimal fluid resuscitation is important to: maintain the circulating blood 
volume; supply blood to vital organs; help prevent local impaired wound perfusion 
through maintenance of perfusion pressures to maximally oxygenate the injured and 
non-injured tissues; and systemically to restore intracellular and intravascular fluid 
volumes thus improving cellular respiration and increasing tissue perfusion (17, 20, 
22). 
Resuscitation itself is a source of fluid that leaks into the tissues and contributes to 
the oedema (38). It is therefore important to be as precise as possible, giving the 
minimal volumes of fluid required to achieve vital organ perfusion and limiting 
contribution to oedema. There are a number of formulas used to guide initial 
volumes of fluid required for adequate resuscitation in partial to full thickness burns 
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exceeding 15-20% TBSA (39-41) but the Parkland formula developed by Baxter and 
Shires’s over 40 years ago is most widely used (23, 24, 38).  
The Parkland formula calculates total fluid requirements using lactate ringer’s 
(crystalloid) solution in the first 24 hours from injury as 4mL/kg/%TBSA and the 
current Emergency Management of Severe Burns formula is 3-4mL/kg/%TBSA (42, 
43). The total volume is divided in half and half the fluid given intravenously over 
the first eight hours following the burn and the remaining volume over the next 16 
hours. In addition, two litres of background fluid is administered. For a 70 kg person, 
with a 20% TBSA burn, this can equate to a total of 6200 – 7600 ml of resuscitation 
fluid delivered in 24 hours. The host of formulas utilised in the literature are almost 
all based on weight and burn size and use various combinations of fluids. 
2.3.5.1 Fluid Creep 
It has been demonstrated in recent times that over-resuscitation or delivery of fluid 
volumes in excess of those predicted is a frequent occurrence, a phenomenon known 
as ‘fluid creep’ (43-45). It can negatively impact a patient’s outcome and contributes 
to the volume of oedema caused by the acute burn injury. The reasons for this fluid 
creep remain unclear. Saffle et al (2007) post review of the literature suggested 
clinicians are instinctively adopting a ‘more is better’ approach with less stringent 
adherence to guideline formulas as a decrease in mortality is being seen with 
aggressive fluid resuscitation (35). In 2000, Engrav et al conducted a survey of 28 
burn centres in the USA and found 58% of patients received greater than 
4ml/kg/%TBSA of fluid (46). 
The use of opioid drugs is another primary cause thought to contribute to this 
phenomenon. Opioids given in high doses for pain relief are known to cause 
hypovolemia, as they have significant effects on the cardiovascular system 
(contribute to vasodilation) thus increasing fluid requirements (46, 47). Current pain 
control interventions have improved and more opioids are given now than in the 
1970’s (24) contributing to the higher incidence of over resuscitation. In 2004 a 
study by Friedrich et al compared a group of patients treated at a Washington burn 
centre from 1975-1978 to a similar group of patients (%TBSA, sex, age) treated in 
2000 and found the latter group received significantly more fluid per %TBSA and 
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significantly more opioid agonists than the 1970’s group. They concluded that opioid 
dosage correlated positively with fluid requirements (48).  
Other proposed reasons behind ‘fluid creep’ have been identified and may include: 
patients with inhalation injuries, electrical burns, delayed resuscitation, other 
traumatic injuries, pre-existing disease and nutritional status and previous alcohol or 
drug abuse. These patients are most likely seen to require additional fluid to maintain 
end organ perfusion (24, 35, 49).  
Inexperienced clinicians may also contribute to increased resuscitation volumes by 
making substantial errors in estimating burn area and depth, which can result in 
significant under or over calculation of fluid requirements. Despite these known 
influences the accuracy of Parkland formula has not been challenged by these 
reports, rather it has emphasized the necessity of monitoring patients carefully and 
adjusting fluid infusions based on patients’ response (35, 44). It has proposed the 
need for valid and sensitive monitoring devices (22, 35).  
Fluid creep and its prevention are imperative due to the increase risk of adverse 
outcomes. Well documented side effects of over resuscitation are pulmonary 
oedema, acute respiratory distress syndrome, abdominal compartment syndrome, 
peripheral compartment syndromes, elevated intraocular pressure, increase gut 
permeability and burn wound conversion (24, 35, 50). It also hampers burn wound 
healing contributing to worsening scar formation and potentially decreased physical 
function. 
2.3.5.2 Resuscitation Fluid Choices 
Fluid resuscitation is fundamental in the management of acute major burns. The two 
most common fluids administered during the resuscitation period are either 
crystalloid or lactate ringer solution (23). However there is ongoing debate regarding 
the use of and timely delivery of colloid (protein based) solutions. 
Colloids are used to increase the intravascular osmolality and to stop the 
extravasation (leakage into the extracellular space) of the crystalloid or lactate ringer 
solution (23). There is conflicting evidence as to whether colloids decrease fluid 
volumes delivered in the initial resuscitation phase or add to already existing tissue 
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oedema. Goodwin et al (1983) and Jelenko et al (1978) supported the use of colloids 
suggesting they reduced fluid resuscitation volumes infused, however mortality and 
pulmonary complications were increased. There was also no significant reduction in 
systemic sepsis or need for escharotomy (15, 51, 52). Pham et al (2008) reviewed the 
literature and found several studies indicating colloids provide little clinical benefit 
to burn patients especially in the first 12 hours of resuscitation. Further its use has 
been shown to increase lung water content (pulmonary oedema) after the 
resuscitation phase even in the absence of an inhalation injury (51, 53).  
Further experimental investigation is required to determine the most appropriate fluid 
resuscitation regime in order to limit tissue and lung oedema and the negative impact 
to the patient. 
2.4 Impact Of Acute Oedema 
There are numerous factors contributing to the magnitude of oedema in burn 
patients, both directly related to the extent or severity of the injury and the medical, 
nursing and allied health interventions or lack thereof (dressings, fluid resuscitation, 
oedema management procedures). Burn wound oedema can alter wound severity 
through increasing the oxygen diffusion distance to the wound, forming a physical 
barrier to healing (54). Consequently increasing the risk of hypertrophic scarring 
with associated functional, psychological and aesthetic sequelae (55). In children, a 
wound taking greater than ten days to heal had an eight percent chance of 
hypertrophic scarring (7). Finlay et al (2017) demonstrated reduced burn scar quality 
in adults as the time to healing increased, with the effect being significantly greater 
within 21 days after injury (56). Oedema affects the outcome of the wound (size, 
depth, healing). It also affects an individual’s immediate physical function. Oedema 
can limit the range of motion of joints, cause pain with movement and mobilisation, 
increase the effort required to move and affect the cardio respiratory system if the 
lungs are involved. The changes in the composition of oedema in subacute or chronic 
states, may increase the resistance to movement (57). In addition, prolonged oedema 
has been associated with deposition of calcium in the tissues, fat in the muscles and 
peri muscular fascia thickening (58). To limit the negative impacts of oedema, time 
is of the essence and oedema management strategies should be instigated straight 
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away. Oedema assessment techniques are imperative to successful oedema reduction 
and prevention. 
2.4.1 Summary 
Many factors contribute to the degree and extent of oedema in this unique population 
and if it is not managed optimally the results can be devastating. Timely management 
of acute burn oedema can positively impact burn survivors’ bio-psycho-social 
outcomes. Reducing wound healing time will also decrease the cost to the health 
system through decrease hospital inpatient length of stay, decreased services as an 
outpatient, decrease surgery cost and decreased risk of infections. Thus to improve 
acute and long term management of oedema an appropriate clinical tool for 
measuring and monitoring fluid shifts will help guide best practice. 
2.5 Outcome Measures To Monitor Post Burn Oedema 
The literature presents several options or current practices for quantifying oedema in 
both major and minor burns but they are not without limitations. The most common 
measures of burn fluid shift or oedema change are discussed below and it is evident a 
true gold standard outcome measure for burn oedema is still a goal worth pursuing. 
2.5.1 Major Burns: Monitoring Of Resuscitation  
Burns >15-20% TBSA require fluid replacement therapy to maintain circulating 
blood volumes. Initial volumes are determined by formulas including TBSA and 
patient weight variables. The fluid volume has to then be titrated according to the 
individual’s response to therapy. 
Endpoints of resuscitation include primarily urine output, and secondarily 
haemodynamic parameters such as blood pressure and oxygen saturation (44).
  
Fluid 
is titrated based on maintaining a urine output of 30-50ml per hour (or 0.5-0.8 
ml/kg/hr). The accuracy and validity of these endpoints of fluid resuscitation as a 
measure of whole body perfusion and fluid balance have been questioned (29). Burn 
centres are allowing urine output to exceed accepted values, contributing to over 
resuscitation (22, 41). Cartotto and Zhou (2010) carried out a retrospective review of 
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196 patients at a single centre over eight years and found the mean urine output was 
1.2ml/kg/hr (SD 0.7) in the first 24 hours and 76% of patients received 
>4.3ml/kg/%TBSA of fluid (recommended 4ml/kg/%TBSA with Parkland formula) 
(41). Despite knowing the phenomenon of fluid creep, the burns centre did not adjust 
the resuscitation volumes to maintain urine output within the accepted range. Urine 
output has also been suggested to lag behind the actual events of hypoperfusion by 
up to two hours (21, 59).
 
Other options of endpoint fluid monitoring have been explored, but many of these 
are invasive and require expensive or specialist equipment (e.g. central venous 
catheters and pulmonary artery catheters) (45, 49, 60, 61). Burn patients requiring 
formal fluid resuscitation admitted to Fiona Stanley Hospital (FSH) may be treated 
on the burns unit and not the intensive care unit, so invasive monitoring such as 
Swan-Ganz (pulmonary artery) catheters are not available. 
An American Burns Association survey of burn centres showed rates of different 
objective measures used to guide fluid volume titration are: pulmonary artery 
catheterisation eight percent, transpulmonary thermodilution three percent (44). 
These provide right heart diagnostic information to rapidly determine hemodynamic 
pressures, cardiac output, and mixed venous blood sampling; base deficit seven 
percent and lactate five percent (indicative of respiratory or metabolic 
compensations), lithium indicator dilution five percent (cardiac output measure), and 
haematocrit one percent. These are all used as indirect measures of the body’s fluid 
volume, haemodynamic state or tissue perfusion.  
These recommendations may need to be treated with caution in the first 24 hours as 
attempts to normalise the values can lead to over resuscitation and compartment 
syndromes (44). Abnormal arterial lactate and base excess values have been shown 
to correlate with the magnitude of injury and their failure to correct over time 
predicts mortality but there are no prospective studies to support their use to guide 
fluid resuscitation (53). The pathophysiology of burn shock creates a persistent 
hypovolemic state that gradually subsides, attempts at rapidly clearing anaerobic by 
products with aggressive volume replacement (attempting to normalise blood lactate 
and haematocrit) may be unsuccessful and exacerbate oedema formation. 
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Holm et al (2004) completed the only well designed prospective randomised trial 
comparing burn shock therapy guided by invasive haemodynamic monitoring to 
restore preload and cardiac output with standard therapy according to Parkland’s 
formula (in the first 24 hours after burn) (60). In the pre-load driven intervention 
group intrathoracic blood volume or cardiac index (to within normal range) was 
unable to be achieved and they received 68% more fluid (above the predicted 
volumes) compared to the Parkland driven strategy. No association between 
increased fluid administration and more effective resuscitation was shown and the 
patients in the treatment group also showed much more pronounced subcutaneous 
oedema. This demonstrates attempts to normalise invasive haemodynamic properties 
may not lead to improved outcomes in the first 48 hours of major burns. It also has 
increase risks due do its invasive procedure and injection of contrast dye. Invasive 
procedures in acute burn care also increase the risk of septicaemia and wound 
infection (44).  
Patient’s weight can also be used to monitor changes in total body fluid although 
clinical validity is controversial (62). Reliable and valid body weight measurements 
are difficult to ascertain in the acute burns environment due to reduced patient 
mobility; resuscitation fluid retention and the added weight of burn dressings and 
wound ooze. All these factors introduce confounding and variability in the weight 
measurement and make interpretation of weight changes difficult.  
Current techniques to guide fluid therapy are blunt and do not measure volumes of 
the body fluid compartments, most importantly extracellular and intracellular fluid. 
These give an indication of the extent of oedema (primarily in the ECF) and 
reabsorption of fluid into the capillaries and/or cellular oedema (23). If the volume of 
ECF could be measured easily and regularly over time, then re-hydration volumes 
could be adjusted to maintain normal (13-17L or ~25% of total body water) or 
clinically acceptable values, in turn limiting oedema and potentially catastrophic side 
effects (63). 
2.5.2 Minor Burns: Localised Oedema Outcome Measures 
Burn oedema volume and location (e.g. lungs, limbs) relates to the spectrum of 
severity of burn. In minor burns, complex, formal fluid resuscitation is not required 
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and oedema is generally localised to the vicinity of the burn site. The ability to track 
changes in localised oedema volumes at the site of injury can provide information on 
the efficacy of oedema management and treatment (e.g. medical management, 
physiotherapy input) and thus help guide best practice. An understanding of effective 
interventions is determined through appropriate assessment. There are few sensitive 
and accurate measures of localised oedema that are easy and quick to perform, 
however they are not without limitations in the burn trauma environment.  
The ‘gold standard’ measures of peripheral oedema (limb volume change) include 
WVD and CLM (57). These can be difficult to perform with the nature of burn injury 
and can be logistically and mechanically challenging. For example, WVD may 
require large volumes of water to submerge a whole limb, depending on the location 
of burn and thus is not practical in large %TBSA burns. In addition, the vessel must 
be cleaned appropriately between subjects to prevent potential cross-infection. Limb 
circumference measures have limitations in the burn population due to dressings and 
open wounds. Infection prevention and management protocols of individual burn 
facilities, may prevent the use of CLM, otherwise require single use tape measures 
thus increasing patient contact consumables (64). In lymphoedema and hand therapy, 
however, CLM has been shown to have a significant correlation with WVD and thus 
can be used with confidence in detecting volume change (65, 66).  
Limb oedema can also be objectively measured using clinical assessment, magnetic 
resonance imaging (MRI), computed topography scans, near-infrared spectroscopy 
(NIR), perometry and ultrasound. However, they lack clinical utility and validation 
(18, 67). An easy to use, rapid outcome measure for more localised oedema will 
provide immediate feedback of the effectiveness of oedema and wound management 
interventions. 
2.5.3 Wound Healing Assessment 
Wound healing is a significant component in recovery from burn injury and it is also 
influenced by oedema change. Time to wound healing is directly related to the 
severity of scarring (56). Monitoring of healing is essential to ensure the most 
appropriate intervention to promote healing is carried out. This includes the choice of 
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dressing, surgical intervention, use of pharmaceutical agents (e.g. antibiotics), other 
indicated medical management (e.g. vascular optimisation), and oedema control. 
Current monitoring of wound healing assesses wound size, wound bed 
characteristics, type of tissue, colour and wound bed depth. Various methods 
including clinical assessment, photographs, visitrak wound area tracing, 
circumference measures, computer software packages such as digital planimetry and 
image J may be used in isolation or combination (68, 69). None of these methods 
provide cellular level information of the wound, have low sensitivity to changes or 
are expensive and require an undressed wound. 
Laser Doppler perfusion imaging (LDPI) is another method utilised to determine 
burn wound depth. It operates by scanning a burned area with laser light and the light 
frequency changes with the amount of perfusion of the tissues. A color-coded 
perfusion map is generated, which corresponds to varying burn depths. It is a highly 
valid and accurate (> 95%) measure of burn wound depth (70, 71). Wound infection, 
tissue curvature, topical substances and ambient light significantly affect the 
accuracy of LDPI, major limitations to its use in burns. (20). Other optical techniques 
such as optical coherence tomography, reflection-optical multispectral imaging and 
orthogonal polarization spectral imaging are non invasive, rapid methods of burn 
wound depth assessment (20). Their application and use are still in the research 
phase. Thermographic imagery is another emergent burn wound evaluation tool, 
however it is limited to use in temperature controlled rooms with a constant humidity 
(72). 
The literature transcribes, ‘no method of measurement is perfect’ and results need to 
be interpreted in conjunction with the clinical picture (69). An instrument that 
provides insights into the cell health and processes of healing over time would 
facilitate successful clinical decision making. 
2.5.4 Summary 
There is a lack of user friendly, valid, reliable and non-invasive outcome measures to 
determine real time fluid changes after an injury and during wound healing in an 
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acute setting. Bioimpedance spectroscopy (BIS) may be a solution. It is a tool 
capable of oedema assessment and emerging as an indicator of wound healing.  
2.6 Bioimpedance Spectroscopy 
There have been few studies investigating bioimpedance and measurement of inter-
compartmental fluid levels in major burns, and the current outcome measures of fluid 
management in this challenging population in the acute and subacute phase have 
questionable accuracy. Due to the rapid acute change and shift of fluid into tissues 
secondary to the body’s response to injury, the potential ability of BIS to provide 
‘real time’ measurements of volume change is promising. The first studies exploring 
bioimpedance as a method of oedema assessment in major burns was in the late 
nineties (73, 74). Bioimpedance analysis was determined to be a reliable and 
sensitive measure of TBF volumes. However, further investigation of BIA, as a 
method of monitoring fluid resuscitation, did not occur until ten years later (75). Was 
this potentially due to the difficulties in clinical application of BIA in the burns 
environment? The current literature explores the utility of BIS in a range of clinical 
areas, with novel concepts that may be applied in the burns patients. Following on, 
BIS and its potential application in the burns environment is described.  
2.6.1 Use And Significance Of Bioimpedance Spectroscopy In 
Burns 
Bioimpedance Spectroscopy is a method used commonly to assess body composition 
and allows for evaluation of specific body compartments and cell health such as fat 
free mass (FFM), inter-compartmental fluid volumes (ECF, ICF, TBF) and cell mass 
(76, 77). It is used commonly in the areas of nutrition and physical health and has 
gained popularity as a clinical tool in the last two decades. It is routinely used to 
monitor and assess lymphoedema (78, 79) and has also been used extensively in 
studies investigating fluid shifts in haemodialysis, as a prognostic tool in human 
immune-deficiency virus (HIV) and cancer, and as a screening tool for malnutrition 
in the elderly (80-82). The method has been validated in healthy and clinical 
populations against MRI and bromide and potassium dilution techniques, which are 
considered gold standard in the assessment of fluid compartment volumes and lean 
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body mass (LBM) (83-86). Bioimpedance spectroscopy is a popular tool for 
monitoring and assessing clinical changes as it is easy to use, processes information 
rapidly at the bedside, is relatively inexpensive and is portable (Figure 2.5) (87). It 
has demonstrated sensitivity, repeatability and high reliability of measures all 
deemed essential when investigating a new method of measurement (79). 
 
Figure 2.5: Impedimed SFB7 bioimpedance spectroscopy instrument 
(Impedimed Limited, Brisbane, Australia) 
Bioimpedance has demonstrated its application and usefulness as an assessment tool 
in fluid monitoring, wound healing and nutritional assessment in various clinical 
settings (88-91). Investigation into the possible uses of BIS in burns is therefore 
warranted. The burn wound journey can be arduous and long. The injury itself 
causes, whole body and local fluid shift alterations, increased metabolic rate and 
protein catabolism (affecting LBM) and open wounds (92). There is no real time, 
clinically available tool in the burns environment that objectively measure changes in 
wound healing, fluid distribution and LBM. The following provides an overview of 
BIS and discusses the possible applications and limitations of BIS in the burns 
populations.  
The term bioimpedance describes the response of a living organism to an externally 
applied alternating electrical current and is a measure of the opposition to the flow of 
that electrical current through the various tissues (93). It works on the principle that 
human tissues have different resistive and conductive properties. Electrically, a cell 
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can be represented as an “ion-rich conductive centre (cytoplasm) embedded in an 
ion-rich conductive medium (extracellular fluid), separated by a relatively non-
conductive barrier (cell membrane)”(94). Because the conductivity of the body is 
directly proportional to the amount of electrolyte-rich fluid that is present, BIS can 
be used to measure fluid components such as TBF and the condition of the tissue 
(85).   
There are a number of bioimpedance instruments on the market and they differ in the 
type of and array of electrodes used, range of frequencies applied and mathematical 
formulas (regression derived or biophysical curve fitted modelling) that are used to 
determine the body composition values (95, 96). They are single frequency, multiple-
frequency and spectroscopy devices. Irrespective of the device, bioimpedance works 
by applying electrodes to intact skin and then a small, painless alternating current 
across one or more frequencies is passed through the body. The current flows 
depending on the composition of the body. The resistance (opposition of flow to an 
alternating current) and capacitance (delay in the passage of current through the cell 
membranes and tissue interfaces) of the tissues and bodily fluids also vary with the 
frequency of the applied electrical current (76). This necessitates an understanding 
Ohm’s law which states that the flow of an electrical current (I) passing through two 
points of a conductor is equal to the voltage drop (V) divided by the electrical 
resistance (R) between these 2 points (97). 
I = V/R Or  R = V/I 
 
This is based on a direct current into a simple conductor. Generalisation of Ohm’s 
law to alternating current yields the concept of electrical impedance (Z). 
𝑍 =
𝑉
𝐼
 
At low frequencies (<30-50 kHz) the current passes through only the ionic 
environment surrounding or outside the cells and therefore is indicative of ECF. At 
high frequencies the current passes through the ionic extracellular environment, the 
cell membranes and intracellular environment and is indicative of TBF. Intracellular 
fluid can be determined by subtracting ECF from TBF and is also reflective of body 
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cell mass (BCM) (89). The components of the individual fluid compartments are as 
follows (Figure 2.6). ECF (13-17L): Fluid outside the cell consists of interstitial fluid 
(~13L) (dense connective tissue and bone), plasma (~3L) and transcellular fluid 
(~1L). It has a high electrolyte content of which 90% is Na
+
, then Cl
-
 and HCO3 and 
traces of others. It will expand in conditions of hyper-hydration and decrease in 
hypo-hydration states; ICF (21-25L): Fluid contained within the cell, has a high K
+
 
content (95%) as well as Mg
+
, phosphates and protein; TBF = ECF + ICF. 56%-70% 
of the body consist of fluid, equivalent to 35-45L (97, 98).  
 
Total body Fluid 35 – 45 L 
Intracellular fluid Volume = 21 – 25 L 
(K+          Mg+        phosphates         protein) 
Extracellular Fluid Volume = 13-17 L 
(Na+           Cl-      HCO3) 
Interstitial fluid 
~ 13 L 
Transcellular 
fluid ~1 L+ 
Plasma ~ 3 L 
Figure 2.6: Body fluid compartments 
The raw bioimpedance variables of resistance (R), reactance (Xc) and phase angle 
(PA) provide information about tissue hydration and integrity. Resistance is 
reflective of the body’s water compartments and is inversely proportional to fluid 
volume and therefore oedema i.e. the greater the fluid the lower the R (85, 89). 
Reactance indicates cell mass and function. Phase angle is the arc tangent of the ratio 
Xc/R (99) and is a result of the capacitance (a factor in determining Xc), due to the 
structure of the cell membrane. Capacitance causes the current to lag behind the 
voltage creating a phase shift (100, 101). If tissue health (integrity of the cytoplasm, 
cell membrane and/or cellular fluid) is disturbed in any way (e.g. inflammation, 
disease) the electrical properties of those tissues are altered, therefore directly 
affecting PA (100). Tissue or cell damage results in a loss of cell membrane 
structure, which allows ions and the BIS current to pass through the cell. Damaged 
cells therefore behave more like a resistor than a capacitor.  Phase angle therefore 
relates to the health of the cell/s (a lower PA is indicative of poorer health) (89). 
C
ell m
em
b
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These raw variables can either be interpreted alone or are used to calculate the fluid 
volumes through empirical predictive equations (76, 102).  
The different bioimpedance devices use different prediction equations but the 
impedimed SFB7 BIS instrument, uses a model which has been reported as being the 
superior model under conditions in which body water compartmentalisation is altered 
from normal state (103, 104). It also does not require the use of population specific 
prediction equations like single frequency bioimpedance analysis (BIA) does (105). 
The raw impedimed SFB7 BIS resistance values indicative of ECF, ICF and TBF are 
obtained on the basis of the Cole-Cole model and from here on BIS refers to 
measures obtained from this model (106). For further insight into the different 
models refer to Kyle et al (2004) and Mulasai et al (2014) (76, 107). Bioimpedance 
spectroscopy and multi-frequency BIA feed seven or more (4-1000kHz) and two or 
more frequencies (4-100khz) respectively into the tissue allowing for measurement 
of ECF, ICF and TBF (108). At low frequencies the current can penetrate the ECF 
only, due to the high capacitance of the cell membrane and at high frequencies it 
passes through both the ECF and ICF measuring TBF. The ICF is then determined 
by subtracting ECF from TBF. Single frequency BIA feeds one current, most 
commonly 50 kHz, which penetrates both the ECF and ICF (102). It is therefore 
more suitable for TBF and fat free mass (FFM) estimates only (107, 109).  
Body composition analysis can be performed via whole body or segmental BIS, 
differing in the placement of electrodes. Whole body BIS involves four electrodes 
(two current sensing and two current drives), which are placed on intact skin in a 
standard tetrapolar configuration on the dorsal surface of the hand and feet (104). It 
is standardised and has been widely used in assessment of physiological changes at a 
whole body level in normal and specific clinical populations (Figure 2.7) (83, 110). 
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Figure 2.7: Bioimpedance spectroscopy: whole body electrode 
positions 
Segmental BIA measures arm, leg or trunk segments and requires drive electrodes to 
be placed on the dorsum of the ipsilateral hand and foot (as per whole body BIS) and 
sense electrodes placed on either the 1) the dorsum of the feet at the talo-crural joint 
or 2) the dorsum of the hands at the radio-ulnar joint, depending on which segment is 
being measured (76). To produce interpretable data, this method relies on theory of 
equi-potentials, which are loci of points with the same potential and are 
perpendicular to the flow of current (111).For further explanation please refer to 
Cornish et al (1999) (112). Segmental BIS is described as being insensitive to 
oedema of the contra-lateral limb (113). It has been used in the assessment of 
unilateral lymphoedema to generate ECW/ICW ratios, using the unaffected arm as a 
control (114).  
Localised BIS is a relatively new concept and involves the electrodes being placed 
close to the site of injury (e.g. pressure sore, muscle tear, fracture site), zoning in on 
the field of assessment (87, 115, 116). Electrode positions have not been 
standardised, i.e. sense electrodes are placed as close to the injury as possible with 
the drive electrode remaining in the standard positions (hand and feet), or moved 
alongside the sense electrodes, or either side of a sub-limb segment e.g. calf (Figure 
2.8) (117). When the distance between the sense electrodes is reduced the sensitivity 
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close to the electrodes increases but the measurement depth is reduced (118). In 
muscle injuries, single frequency BIA with localised novel electrode placement 
(sense and drive either side of the injury) was able to detect changes in oedema and 
cellular injury consistent with MRI imaging over time in the individual (115). Other 
BIS studies assessing single limb oedema use segmental or localised electrode 
placement as whole body electrode placement has been shown to be insensitive to 
decreases in volumetric measures such as during the treatment of lymphedema (113, 
119). The reason for this is suggested to be due to the electric current path through 
soft tissues being largely determined by body geometry and the relative contribution 
of body segments to the whole body BIS measures. 
Impedance measurements of a sublimb (localised) segment, the calf, have become 
the method of choice to monitor fluid status during dialysis and are more sensitive 
and precise than whole body or limb measurements (95, 117).  
 
Figure 2.8: Localised (sense) electrode placement either side of a 
wound 
In the burn environment, the choice of electrode placements would depend on the 
desired assessment, such as whole body fluid shifts or local wound oedema. The 
standardised electrode positions may pose a barrier to clinical use in burn injured 
patients. This will be discussed in more detail later. 
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2.6.2 Application Of Bioimpedance Spectroscopy To Clinical 
Practice In Burns  
2.6.2.1 Monitoring And Assessing Fluid Shifts  
In a major burn, fluid resuscitation is instigated to maintain circulating blood 
volume, prevent hypovolemia and ensure adequate tissue perfusion and blood supply 
to vital organs (22, 40, 120). Fluid volumes resuscitated need to be monitored closely 
and administered as close to predicted as possible to prevent burn shock, renal 
failure, compartment syndromes, burn wound conversion, respiratory compromise 
and even death (29). Too much fluid will add to the already significant oedema 
volume.  
Currently fluid resuscitation volumes in major acute burns are initially determined 
using formulas as guidelines and then titrated primarily according to hourly urine 
output (38). Urine output is a quasi- measure of fluid shift and is not in real time. 
Other observations utilised as indirect measures of fluid management and titration 
are blood serum levels, standard nursing observations (blood pressure, tissue 
oxygenation) and measurement of cardiac output with pulmonary artery catheters 
(44, 45, 49, 60). Some of these are invasive and attempts to normalise bloods and 
cardiac output in first 24-48hrs often leads to increased fluid volumes delivered, thus 
increased oedema, but not improved patient outcomes (60). Where invasive 
monitoring is not available, the clinician’s ability to respond quickly is compromised 
by the insensitive measures available.  
Only a few studies have utilised BIA in the assessment of fluid shifts in burns 
patients (73-75). It has however, been investigated in goal directed therapy to guide 
intraoperative fluid administration in surgical and intensive care unit patients with 
promising results (89, 121). Both Ernstbrunner et al (2014) and Malbrain et al (2014) 
believe BIS can help guide fluid resuscitation but suggest more research is needed in 
the critically ill population (89, 122). Ernstbrunner et al (2014) assessed volume 
status in patient’s before and after surgery using BIS and believe it could become a 
useful guide to intraoperative fluid therapy (122). They found ECF (p<0.05) 
increased significantly from before to after surgery with administration of 
intraoperative fluid (mean 1.9L) with no significant change in ICF (p=0.15). In 
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contrast, Plank et al (1998) found BIS underestimated absolute volumes of ECF 
when compared to dilution techniques in the critically ill from day 0 to 10. However, 
the ECF change from day 0 to 10 was not significantly different between BIS and the 
dilution method (123). 
A study by Slotwenski et al (2013) of critically ill patients found those with sepsis 
had significantly higher impedance (566 ± 98.66 ohms, P=0.0003) than those with 
severe sepsis (423.86 ± 149.7 ohms), and a lower % ECF (45.95± 2.97% vs. 49.2 ± 
6.11% P=0.026) (124). Summarising, those with increasing sepsis severity had 
decreasing impedance and a greater percentage of ECF. This may be explained by 
damage of the cell membrane and loss of cell wall integrity in the critically ill (89).  
Assessment and monitoring of dry weight (targeted optimal body weight of the 
patient, achieved through the removal of excess water) in dialysis is important and 
BIS can provide real time continuous measurements of compartmental fluid volume 
changes and calculate over-hydration within 1-2 L (considered a clinically 
appropriate range) (125). Others have found development of their own bioimpedance 
algorithms improves accuracy of fluid volume changes in dialysis patients (90). 
Raimann et al (2013) recently compared single frequency BIA and BIS to direct 
estimation methods (DEMs) (i.e. deuteriumoxide-dilution, bromide-dilution and total 
potassium) in haemodialysis patients (126). They found BIS ECF was closer to DEM 
ECF than single frequency BIA based on root mean squared error analysis. Both BIS 
and single frequency BIA were equally precise in determining ICF and TBF, when 
compared to DEMs. 
Close monitoring of net fluid shifts in large burns is essential, especially in the first 
24-48 hours, when a complex inflammatory process is in place and fluid shifts are 
great with ebbs and flows. Using BIS to ensure adequate intravascular blood volume 
may be achieved through titrating fluid volumes to achieve a stable and ‘normal 
range’ ICF volume. Once the target ICF is reached and maintained the resuscitation 
fluid volumes may be titrated with the aim of reducing ECF volumes. This is one 
potential way BIS may be utilised for, real time monitoring to optimise fluid 
resuscitation and therefore improve patient outcomes.  
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2.6.2.2 Monitoring Peripheral Oedema  
As well as fluid shifts in large burns, monitoring smaller fluid shifts, or oedema, in 
minor burns is just as important. The standard measures of peripheral oedema 
include clinical assessment, water displacement volumetry (WDV) and 
circumference limb measures (CLM). These can be difficult to perform with the 
nature of burn injury and can be logistically and mechanically challenging. In a proof 
of concept study, Edgar et al (2013) demonstrated BIS is a sensitive measure of 
small changes in fluid locally and thus ideal for monitoring and determining best 
practice for oedema management (75). Bioimpedance spectroscopy is used routinely 
to monitor and assess lymphoedema (78, 127, 128). Multiple frequency BIA was 
100% sensitive in detecting limb volume changes as compared to CLM in upper limb 
lymphoedema (81) and it is now being considered as gold standard of measurement 
in lymphoedema (97). 
Segmental BIS was able to detect changes in oedema post-traumatic ankle fracture 
with a strong inverse linear relationship between impedance at 5kHz (representative 
of ECF) and WDV (r=-0.92) (67). Localised electrode placement BIS was also able 
to detect changes in oedema and cellular injury consistent with MRI imaging over 
time after muscle injury (115). Pichonnaz et al (2015) propose the raw BIS variable 
R0 had greater diagnostic sensitivity and responsive, and is a valid method for 
measuring oedema post total knee replacement, as compared to CLM and volume 
measures (129). 
An accurate and sensitive assessment technique of oedema can guide best practice in 
the treatment of oedema, thus contributing to optimum healing conditions in most 
injuries. Bioimpedance spectroscopy has been identified as a method of oedema 
assessment that has merit after burns (75). 
2.6.2.3 Wound Assessment And Monitoring 
Optimal management of the acute burn wound aims to: cool the wound immediately 
for 20 minutes; reduce oedema in the first three to four days; and prevent burn 
wound conversion in order to aid in reduced healing times (4, 17). This is important 
because the severity of scarring is directly related to time to healing (25). Current 
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wound assessment techniques can be time consuming, require specialist equipment, 
software or clinicians and many do not provide outcomes that are indicative of the 
wound at a cellular level. The most common techniques are photographs, laser 
Doppler and wound area measures, all reliant on a degree of clinician experience and 
subjectivity. Objective assessment of wound healing is essential to evaluate 
nutritional and therapeutic interventions and detect complications. Bioimpedance 
analysis is an emergent concept in the assessment of wound healing but shows 
promising results. 
Lukaski et al (2012) discovered in several case studies in wounds of varying 
aetiologies, localised single frequency raw bioimpedance variables, resistance (R), 
reactance (Xc) and phase angle (PA) increased with re- epithelialisation of the 
wound and could detect the presence of infection prior to laboratory methods (130). 
This is supported by Moore et al (2011) who found PA measurements mirrored the 
health of the wound and provided an accurate tool for assessing the regional tissue 
health, in diabetic, surgical, neurotrophic, venous, traumatic and infectious chronic 
wounds (88).  
Wagner et al (1996) found localised BIA (frequency 50kHz) was able to predict 
patients at risk of pressure ulcers (116). Phase sensitive measures were taken and 
patients at risk had significantly decreased Xc, R and PA values suggesting 
malnutrition, ECF accumulation and decreased cellular vitality. In rats, local BIA 
was found to be a highly reliable measure with low within subject variability and 
high retest reliability for describing cellular changes that occur during and signal 
complications to wound healing. In these rats, tissue health was highly correlated 
with impedance (94). Rats were subject to a one and three hour ischaemic injury with 
weighted magnets and fluorescence angiography was utilized to image real-time 
blood flow in the tissue. Wounded areas showed a decrease in impedance magnitude 
and PA closer to zero, suggesting BIS could identify tissue damage that is not 
visible. Swisher et al (2015) reported that many researchers are actively exploring 
this area, with a number of clinical trials underway and impedance-based wound 
monitoring devices have been patented (94). 
Bioimpedance assessment decreases the degree of subjective error in wound 
assessment and may allow for earlier detection of infections and more timely 
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treatment as opposed to waiting for clinical signs and laboratory tests in the burn 
population. The ability to track wound healing with an instrument, which is 
indicative of wound changes at a cellular level could positively affect treatment 
choices. Major burns patients are a high risk for pressure injuries, especially in the 
intensive care setting. Regular assessment of at risk areas such as the heels and the 
sacrum with BIS could lead to earlier pressure care intervention, such as more 
frequent patient turns, thus minimising the impact on patient care and morbidity. In 
the series of the following studies, one explores the novel concept of wound 
assessment in minor limb burns. 
2.6.2.4 Assessment Of Nourishment And Health 
It is known that a burn injury causes an increase in metabolic rate and catabolism of 
protein, hence the need for increased nutritional and energy requirements (8). This 
response is characterised by decreases in lean body and total body mass, liver 
dysfunction, proteolysis and insulin resistance amongst other things (131). Newsome 
et al (1973) stated severely burned patients in the acute setting can lose up to 25% 
total body mass (132), as skeletal muscle is a major source of fuel for the burned 
patient (133). Accurate assessment of cellular level body components such as body 
cell mass (BCM which is equivalent to ICF) and fluid compartment volumes can 
indicate malnourishment and cell health. Malnutrition has been associated with 
increased infections, longer length of hospital stay and higher mortality (134-136). 
Therefore optimising nutrition is essential to promote and provide best conditions for 
wound healing, help prevent infection and limit functional decline (137). Measuring 
BCM can provide an estimate of protein balance and an aspect of metabolic 
improvement (138). Protein is the main component of muscle mass and protein is 
directly related to ICF. Therefore, an improvement in BCM or ICF may indicate the 
effectiveness of nutritional support (139, 140).  
Initial nutritional support assessment of burns patients includes consideration of 
resting energy expenditure, burn depth, %TBSA, time post burn, pre-existing 
nutrition and their level of activity. These factors are then incorporated into 
equations such as the Toronto formula and modified Harris-Benedict equation to 
determine the caloric requirements (141). These assessments are used in the BSWA. 
Ongoing monitoring and assessment are required to adjust nutritional support as 
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necessary. Other methods of nutrition and LBM assessment may include: 
questionnaires (e.g. Subjective global assessment) however these can be time 
consuming and tedious for the patient to complete and clinician to assess, 
biochemical indicators such as serum albumin, total lymphocyte count and serum 
pre-albumin but there have been recent objections raised against these as they are 
influenced by acute inflammation (142, 143). Computerised tomography (CT) and 
MRI can also assess LBM but these are costly, time consuming, not always readily 
available and may not be appropriate for acute burns patients, particularly the 
critically ill. Ongoing monitoring of nutritional status is by body weight, aiming for a 
stable positive change. Factors such as maintenance fluids, fluid shifts associated 
with infection and hypoproteinemia however can mask LBM losses as fluid can 
increase their weight (131). 
Bioimpedance spectroscopy has the ability to assess components of nutrition with 
variables BCM and PA. Phase angle indicates cell viability and health. 
Bioimpedance analysis, using a predictive regression equation, has been shown to 
provide valid estimates of skeletal muscle mass (SMM) (r
2
 = 0.86, SEE 9%), across 
multiple ethnicities, when compared to SMM determined by MRI (85). In disease 
such as HIV and cancer, a loss of ICF (reflecting BCM) is frequently accompanied 
by an increase in ECF. This can cause body weight to remain constant or increase, 
masking malnutrition (144), indicating BIS may be useful in the assessment and 
monitoring of burn patient caloric intake or nutrition.  
In studies particularly in the elderly a lower PA is associated with malnourishment 
and has been found to be a determinant of those nutritionally at risk in hospital (137). 
Zdolsek et al. (1998) proposed that PA was able to detect the effects of a burn and 
sepsis in cellular membranes, because it significantly decreased in the post-burn 
period, with the lowest values being found in two patients who died (74). This was 
however a small sample (n=10). In critically ill patients in intensive care units, Lee et 
al (2015) found a PA <4.1 (+-1.1, P=0.01) degrees indicates negative nutritional 
issues (145). In another study, lung cancer patients with a PA <4.5 degrees had 
significantly (P=0.01) shorter survival rates (median 3.7 months) compared to those 
with PA >4.5 degrees (median 12.1 months) (146). The PA of healthy white 
populations has been reported as >7 degrees for males and >6 degrees for females 
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(101, 147). Others state the average range of PA for healthy humans is 5-9 degrees 
(148). Multiple frequency BIA was used to assess Xc and PA in response to re-
feeding treatments for anorexia nervosa patients (n=21) (149). Reactance and PA 
improved significantly in patients who were receiving the treatment and these values 
no longer differed from age matched healthy females at 15 weeks, even though their 
body mass index remained significantly lower than the controls. This suggests cell 
health can improve without an increase body weight. However, this was a small 
sample size. 
In burns it is essential patients have optimal feeding to promote and provide best 
conditions for wound healing, help prevent infection and limit functional decline 
(137). It is difficult to determine an individual’s nutritional needs and absorption of 
their dietary intake, especially in major burns, due to other medical issues. 
Assessment of BIS variables could theoretically guide nutritional support 
prescription and aid in optimising their management (150). Investigation of 
nutritional assessment in burns is out of the scope of this study but is an area worth 
pursuing in future research. 
2.6.2.5 Assessment And Monitoring Of Body Composition  
Part of the standard care of patients with a burn injury is exercise to maintain 
movement, function and strength. It is essential to patient recovery, for optimal 
outcomes, in both the acute and long term rehabilitation phase (151). There is limited 
literature in acute burns, assessing the impact of exercise on the individual’s rate of 
protein catabolism and lean body mass (LBM), especially in the acute care phase.  
A burn injury causes an increase in metabolic rate and catabolism of protein. This 
response may last up to or greater than 12 months after injury (152, 153). The loss of 
protein leads to a loss of LBM and muscle wasting and therefore strength. The lean 
tissue compartment (BCM) is vitally important in the body’s ability to respond to 
acute and chronic illness. A decline in BCM is associated with a decrease in strength, 
functional decline, and immune function, as seen in HIV patients for example (144, 
154, 155). The addition of exercise will enhance an individual’s energy requirements 
but is essential in building or maintaining lean muscle mass. It is however unknown 
whether a resistance and strength building exercise program in the acute burn phase 
 65 
is beneficial or detrimental to the healing process. Also for a patient to be able to 
participate fully in physical rehabilitation they need enough caloric energy to do so. 
Bioimpedance spectroscopy provides an opportunity to objectively measure the 
effects of exercise on LBM and more specifically BCM.  
Current and traditional methods of monitoring the effects of exercise training on 
muscle and LBM are, anthropometric measures (girths and skin folds), muscle 
strength (by e.g. dynamometry), dual X-ray absorptiometry, MRI and CT. Only MRI 
and CT can provide muscle anatomical and physiological cross sectional area but 
these aren’t always readily available for use and are expensive (91). Dual X-ray 
absorptiometry is not real time and involves the injection of tracer dyes; skin folds 
are challenging, if not invalid, with open wounds or scarred tissue; and muscle 
strength dynamometry is a valid measure, but may at times be limited due to pain 
with open wounds in the acute burn environment. 
Bioimpedance spectroscopy has been used to assess both body composition and the 
effects of exercise training on body composition in healthy and clinical populations 
in numerous studies (110, 156, 157). Weber-Lang  (2009) showed improved BCM 
over time when comparing two different exercise training types in end stage lung 
disease (158). Intracellular fluid and SMM, assessed by BIA, increased significantly 
(P = <0.05) in both men (8.2% and 4.2% respectively) and women (11% and 3.9% 
respectively) after 16 weeks of resistance training (159). A significant correlation 
(Pearson r= 0.66-0.8, 95% CI, p<0.01) was found between upper extremity strength 
and SMM measured by segmental BIA in healthy individuals (91). Burn injured 
patients more than 2 years after injury, after a 12 week interval training program, 
displayed the same training effects, in strength measured by dynamometry and LBM 
measured by DEXA, as healthy matched controls (160). Immediate assessment of 
LBM by BIA would be far more convenient and would have less impact on patient’s 
time than methods such as dual X-ray absorptiometry and MRI’s. 
Bioimpedance spectroscopy may provide an additional and complementary outcome 
measure for measuring the training effect of muscle. Some traditional anthropometric 
measures such as skin fold and girth measurements may not be suitable in large 
burns due to open wounds, extensive scarring, oedema and the loss of skin elasticity. 
Monitoring training effects of LBM and BCM with bioimpedance can be frequent 
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and easily achieved. It may therefore help guide best practice for exercise training. 
Additionally it may help determine how exercise affects BCM and therefore its 
potential impacts on nutrition and wound healing. The scope of this study however, 
does not include exploration of BIS in monitoring exercise training. It is important to 
understand though, the possible applications of BIS in the burns environment and 
how valuable it may be.  
2.6.3 Limitations Of The BIS Technique And Its Use In Burns 
The bioimpedance technique recommends the use of standardised electrode 
placement, correct positioning and preparation of the patient. Acute burn injuries will 
often preclude the use of standardised whole body and segmental electrode 
placements, due to a high percentage of injuries, hence open wounds, to certain areas 
on the hands and feet. Alternate placements need to be considered, deciphered and 
interpreted in this population. Stahn et al (2008) and Grisbrook et al (2015) report 
alternate electrode positions used on the upper limb are valid substitute however 
further research is needed for valid alternate positions on the lower limb (160, 161). 
The effect of mature scar tissue and the skin area of non standard electrode positions 
on tissue impedance and skin resistivity is also unknown. It has been shown that 
impedance is affected by the thickness of the stratum corneum of glabrous skin 
(162), which likely indicates there will be impedance differences in scar tissue. 
Acute burns require dressings to assist wound healing and protect against infection. 
Common dressings used are nanocrystalline silver impregnated (a conductive 
material) and hydrocolloid (water based) dressings. Both of these dressings have the 
potential to alter the BIS variable measures as the technology is based on the 
conduction of a small alternating electrical current delivered through the body and is 
directly related to the ionic fluid in the field of measure. Grisbrook et al (2016) found 
Acticoat
TM
, a silver dressing, significantly affected BIS fluid volumes (ECF, ICF and 
TBF, p<0.01) compared to no dressing in burns patients with a median total body 
surface area (TBSA) of 15% (163). However they did not include fluid resuscitation 
in their analysis. To account for the Acticoat
TM 
they developed an algorithm to adjust 
BIS variables for clinical interpretation. As previously mentioned, Edgar et al (2009) 
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determined whole body BIS was more sensitive and reliable in new dressings (<8 
hour after application) compared to old dressings (>8 hours after application) (75). 
Further understanding of the effect of various dressings on BIS variable outputs, 
across the spectrum of burns severity and phases of healing is required to enhance its 
clinical utility in this environment. 
2.7 Summary  
There is currently no single use, rapid measure of fluid volume change in the burns 
environment that can be utilised with dressings in place. Bioimpedance spectroscopy 
is a promising and novel measure of fluid shifts, wound healing, nutrition and 
training effects in burns and is worth the further investigation given in this particular 
research. The current research explores whether BIS is a reliable and valid tool in the 
assessment of fluid change and wound healing across the spectrum of acute burns, 
and addresses potential barriers to the use of BIS in this population. Bedside, user- 
friendly outcome measures of oedema will aid in management and limitation of the 
negative sequelae of burn injuries. 
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Foreword 
The first two studies in this thesis investigate the use of BIS in acute major burns. 
They address the potential barriers to its use and the reliability and validity of BIS as 
a measure of fluid shift. The following study firstly investigates potential barriers to 
the use of BIS in acute major burns. Major acute burns, admitted to the BSWA, have 
Acticoat
TM
 (silver dressings) insitu and often have wounds at the site of BIS 
standardised electrode placement rendering BIS unusable in this environment. 
Alternative electrode positions have been investigated in healthy populations, but not 
in the burns environment. Therefore, prior to determining BIS reliability and validity 
in major burns and to enhance its clinical utility we investigated whether BIS 
alternate electrode positions were a comparable alternative to standardised positions, 
across different dressing conditions, in acute major burns.
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3.1 Introduction 
Bioimpedance spectroscopy (BIS) is a method of body composition analysis, which 
allows the immediate assessment of the inter-compartmental fluid volumes such as 
ECF, intracellular fluid (ICF) and total body fluid (TBF) and measures of cell health 
and function (1). By applying a small alternating current via electrodes placed on 
intact skin across a number of different frequencies, BIS measures the body’s 1) 
resistance (opposition by a conductor) and 2) reactance (opposition by a capacitor) to 
the flow of an electrical current (2, 3). The frequency of the alternating current 
determines whether it can penetrate the cell membrane and at low frequencies it 
cannot (1). The BIS instrument uses a Cole-Cole (4) model to generate Cole model 
terms including, resistance at zero frequency (R0) and at infinite frequency (Rinf), 
which are representative of ECF and TBF respectively and Ri (associated with 
intracellular fluid) (5). Fluid volumes (litres) are determined by applying the Cole 
model terms to predictive mixture theory equations incorporated into the BIS 
instrument (6). 
The ability of BIS to measure real time fluid shifts non-invasively has led to numerous 
studies investigating its evaluation in different clinical conditions with a small number 
being conducted in the burns environment (7-10). In minor burns BIS is reliable and 
able to measure the direction of oedema change using localised electrode placement in 
any dressing condition (11). Grisbrook et al (2016) also showed whole body BIS can 
measure resistance and fluid parameters in burns with a median TBSA of 15% in the 
presence of Acticoat
TM
 (Smith & Nephew, Australia) dressings, if the BIS variables 
are adjusted for using their provided Acticoat
TM
 BIS algorithm (12).  
There are numerous challenges in the assessment of fluid shifts in patients with burns, 
including (but not limited to) open wounds, dressings, reduced mobility plus ‘the need 
to monitor small whole body fluid shifts on the background of large fluid resuscitative 
volumes(10). On average, 23% of burn injuries in the State Burns Service of Western 
Australia have either their hands or feet involved, thus preventing the standardised 
positioning of electrodes (13). Tetrapolar electrode placement for whole body and 
limb segmental BIS measures requires one current and one sense electrode 5cm apart 
to be placed on the dorsum of both the hands and feet on intact skin (14). Cornish et al 
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1999 suggests, based on the theory of equi-potentials (loci of points with the same 
potential and are perpendicular to the flow of current), movement of electrodes 
anterior, posterior or laterally will yield the same results as standard electrode 
placements (15). Whether this is practically valid is yet unknown. However, others 
have reported movement of electrodes proximally by 1cm and 2 cm can result in a 
change of mean resistance values by 2% and 4% respectively (16).  
Dressings also need to be considered when using BIS. Moderate to large burns 
patients have an Acticoat
TM
 dressing insitu in the first 48 hours of burn care, the 
standard dressing used in the Burns Service of Western Australia. The dressings are in 
place at all times except when they are having a dressing change and shower. Thus, it 
is necessary to understand if standard and alternate electrode positions are comparable 
with dressings insitu. 
The aims of this study were therefore to determine whether alternate electrode 
configurations for whole body and limb segmental BIS outputs are comparable to 
standardised electrode configurations in moderate to large size burns across different 
dressing conditions. 
3.2 Methods 
3.2.1 Participants 
A longitudinal, prospective, single service study was conducted between December 
2014 and February 2016. Patients admitted with an acute burn requiring formal fluid 
resuscitation were recruited to the study within 48 hours of injury, providing they 
were over eighteen years old and were able to provide written consent. They were 
excluded if they had hand and/or feet burns preventing placement of electrodes. 
Manufacturer’s contraindications also excluded pregnant or breast-feeding patients, 
patients with surgical implants, cardiac pacemakers and/or on electronic life support 
devices. 
Patients were initially recruited from the inpatient Burns Unit at Royal Perth Hospital 
(RPH) and then at Fiona Stanley Hospital (FSH) after the move of the Western 
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Australian state Burn Service to the new facility. There was no change to the study 
protocol, patient population or equipment used in the study.  
3.2.2 Equipment 
The ImpediMed SFB7 (ImpediMed, Brisbane, Queensland, Australia) was used to 
collect whole body and segmental BIS measures. 
The equipment applies 256 discrete current frequencies (4-1000 Hz) to interpret each 
measurement. BIS computes raw variables (resistance, reactance) and derived fluid 
distribution values such as whole body ECF, ICF, and TBF using manufacturer’s 
algorithms. Extra and intracellular fluids behave as resistive ® components and R is 
inversely proportional to fluid volume and therefore swelling (ECF) (5, 17).  
Readily available ECG electrodes (Kendall CA610 diagnostic tab electrodes -
reference code 31447793, Covidien, Mansfield, MA, USA) were utilised. 
3.2.3 Data Collection  
Bioimpedance triplicate measures, with one second intervals between each measure, 
were taken in two dressing conditions 1) no dressing or an open wound, and 2) new 
Acticoat
TM
 dressing. BIS measures were taken within 5 minutes of the dressing being 
applied. The time between the open wound and new Acticoat
TM
 dressing was recorded 
as this was unable to be standardised. The patient’s weight and height, measured prior 
to the electrode placement, age and gender were input into the Impedimed instrument. 
All BIS measures were taken with the patient lying supine. Electrodes were placed 
over cleaned, intact skin in standard and alternate electrode whole body and limb 
segmental configurations unless precluded by wounds. If precluded by wounds that 
particular electrode configuration was not utilised. Due to the nature and presentation 
of moderate to large burns not all participants were able to have all electrode 
configurations assessed. Where feasible the measures were taken on the right side of 
the body unless precluded by wounds, then the left side was utilised. Electrodes 
remained in place between triplicate measures of each dressing condition. The 
researcher was blinded to the BIS measurements as only a file name was viewed and 
recorded.  
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3.2.4 Electrode Configurations 
Standardised whole body and upper and lower limb segmental tetrapolar electrode 
placements were utilised as well as an alternative placement for each. Alternate 
electrode placements were used as burn wounds often preclude the placement in 
standardised positions and were determined based on the theory of equi-potentials (see 
Cornish et al (1999) for further explanation of equipotential points)(15). The different 
electrode configurations and actual placements were as follows (see Figure 3.1): 
1) WBS: whole body standard tetrapolar placement   
2) WBA: whole body alternate tetrapolar placement.  Hand electrodes were placed on 
the volar surface of the hand and wrist, reflecting the standardised positions at the 
head of the third metacarpal and at the distal radio-ulnar joint. The foot electrodes 
were placed on the sole of the foot at the third metatarsophalangeal joint and anterior 
to the lateral aspect of the Achilles heel in line with the standard position. 
3) ULS: upper limb standard tetrapolar placement. The right hand electrodes are as 
per the whole body standard tetrapolar placement, at the head of the third metacarpal 
and at the distal radio-ulnar joint on the dorsal surface. The left hand electrode was 
placed on the dorsal aspect of the distal radio-ulnar joint. The foot electrode was 
placed at the third metatarsophalangeal joint on the dorsal surface. As per Cornish, 
Jacobs et al.’s (1999) protocol (18). 
4) ULA: upper limb alternate tetrapolar placement. The right side hand electrode 
placement was as per whole body alternate and the foot and left hand electrode 
placement remained in the standard position. 
5) LLS: lower limb standard tetrapolar placement. The right hand electrode was 
placed at the head of the third metacarpal dorsally. The right foot electrode 
placements were at the third metatarsophalangeal joint and talocrural joint on the 
dorsal surface. The left foot electrode was placed at the dorsal talocrural joint. As per 
Cornish, Jacobs et al.’s (1999) protocol(15) 
6) LLA: lower limb alternate tetrapolar placement.  The right side foot electrode 
placement was as per whole body alternate and the left foot and hand electrode 
placement remained in the standard position.  
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Figure 3.1: Electrode placement sites used for whole body, upper limb 
and lower limb BIS. 
3.2.5 Ethics 
This study was approved by the RPH Human Research Ethics Committee (EC 
2011/028), and FSH (2014 106) Research Governance Committee and The University 
of Notre Dame, Australia Human Research Ethics Committee (014139F). 
3.2.6 Statistical Analysis 
All results were analysed using Stata statistical software, release 14 (StataCorp LP 
2014, College Station, TX). Descriptive analyses were performed and are reported 
using the means and standard deviations (SD).  
All BIS triplicate measures were used in the analysis. Multi-level mixed effects 
(MLME) linear regression was therefore utilised to determine whether electrode 
placement significantly affected the BIS variables. Whole body measurements had a 
separate model fitted for each of the raw variables R0, Ri, Rinf and calculated values 
(ECF, ICF, TBF). Segmental measures only had models fitted for each of the raw 
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variables, as the BIS algorithm is not applicable for segmental volume calculations. 
The MLME accounts for confounding variables thus limiting bias and it assumes that 
each variable in the regression is approximately normally distributed. To determine 
whether the whole body, upper and lower limb alternate electrode positions, in each 
dressing condition, were a valid measure of BIS variables a χ2 post-estimation test was 
performed. It is a comparison of the difference of means as estimated by the 
regression coefficients determined by MLME linear regression. Results are reported 
as χ2 statistic and a p-value of <0.05 was deemed significant for all analysis. The 
percentage difference between the alternate and standard electrode position was also 
calculated, in each dressing condition, whereby each BIS variable from the alternate 
electrode positions were expressed as a percentage change of the value obtained from 
the standard site. This assists with clinical application and meaning of the estimated 
BIS values. A percentage difference of greater than five percent was deemed clinically 
significant. There appears to be little consensus on an acceptable level of error in fluid 
assessment and monitoring clinically. Earthmann et al (2007) suggests a five percent 
error is tolerable (19).   
3.3 Results 
In line with the planned study timeframe and university milestones, the patient 
recruitment period was between December 2014 and February 2016. Twenty one 
patients were recruited on average 25 (SD = 11) hours post burn injury. There were 
two patients with burns < 15% TBSA who were fluid resuscitated were burnt while 
intoxicated and were considered clinically dehydrated. The final number of patients 
included in each electrode placement was: WBS (n=21), WBA (n=18), ULS (n=14), 
ULA (n=14), LLS (n=15), LLA (n=14). Other patient data is presented in Table 1.  
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Table 3.1: Patient data. Presented as means (standard deviations) ± 
range 
%TBSA Age (years) Height (cm) Weight (kg) Time between open 
wound & new dressing 
(minutes) 
24 (13) 
range 12-80 
36 (13) 
range 18-63 
172.2 (38.4) 77.4 (16.3) 66. 7 (31) 
 
The means and confidence intervals for each of the BIS variables by electrode 
placement and dressing condition and the percentage difference between the alternate 
and standard electrode positions are presented in Table 3.1. The percentage difference 
between the alternate and standard electrode positions show a large variation across 
the variables (Table 3.2). 
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Table 3.2: Estimated BIS variable values for each electrode placement 
and dressing condition. Values presented as means (95% 
confidence intervals). 
 
BIS 
Variable 
Dressing 
Condition 
Electrode Placement 
WBS  WBA  ULS  ULA  LLS  LLA  
R0  
(ohms) 
Open 
 
498.77 
(467.17-
530.37)    
483.97 
(451.79-    
516.15) 
230.96 
(196.89-    
265.03 
231.79 
(197.71-    
265.86) 
268.77 
(235.22-    
302.33) 
254.69 
(220.61-    
288.77) 
 %difference  -2.97*  0.36*  -5.3 
 ActicoatTM 351.94 
(295.56-    
408.32)  
338.58 
(281.33-    
395.83)    
197.32 
(134.23-    
260.40)    
164.18 
(103.24-    
225.12) 
205.01 
(145.75-    
264.27) 
194.18 
(134.14-    
254.21)    
 %difference  -3.80*  -16.79  -5.30 
Ri 
(ohms) 
Open 
 
1412.47 
(1225.51-    
1599.42) 
1353.01 
(1164.26-    
1541.76 
660.29 
(465.29-    
855.29) 
644.85 
(449.83-    
839.87 
791.23 
(597.91-    
984.55) 
722.00 
(526.99-    
917.05) 
 %difference  -4.21*  -2.34*  -8.75 
 ActicoatTM 715.75 
(505.83-   
925.68)  
679.88 
(468.59-    
891.17)    
439.66 
(218.64-    
660.68) 
355.05 
(137.63-    
572.46) 
497.52 
(282.90-    
712.14) 
425.37 
(209.46-    
641.28) 
 %difference  -5.02  -19.25  -14.51 
Rinf 
(ohms) 
Open 
 
361.89 
(337.57-    
386.20) 
348.61 
(324.02-    
373.20) 
164.81 
(139.28-    
190.35) 
161.28 
(135.74-    
186.81) 
196.77 
(171.49-    
222.05) 
183.76 
(158.22-    
209.29) 
 %difference  -4.67*  -2.15*  -6.62 
 ActicoatTM 226.58 
(183.50-     
269.67) 
216.81 
(173.16-    
260.46) 
128.06 
(80.55-    
175.57)    
102.0139 
(55.92-    
148.10)    
135.01 
(90.03-    
179.99)    
122.57 
(77.08-    
168.07) 
 %difference  -4.32*  -20.34  -6.62 
ECF (L) Open 20.76 
(17.56-    
23.97) 
21.05 
(17.80-    
24.29) 
- - - - 
 %difference  1.40*     
 ActicoatTM 34.77 
(14.00-    
55.54)    
35.54 
(13.83-    
57.25)     
- - - - 
 %difference  2.21*     
ICF (L) Open  25.26 
(21.62-    
28.91) 
26.71 
(23.03-    
30.40) 
- - - - 
 %difference  5.74     
 ActicoatTM 48.47 
(27.74-    
69.21)    
51.32 
(29.83-     
72.82)      
- - - - 
 %difference  5.88     
TBF (L) Open 46.03 
(39.67-    
52.38) 
47.77 
(41.36-    
54.19) 
- - - - 
 %difference  3.78*     
 ActicoatTM 83.16 
(43.11-
123.20)     
86.66 
(44.96-  
128.37   
- - - - 
 %difference  4.21*     
 
R0 = resistance at zero frequency, Ri = intracellular resistance, Rinf =resistance at infinite frequency, ECF = extracellular fluid, ICF = 
intracellular fluid, TBF = total body fluid, open = open wound, ActicoatTM = ActicoatTM and betadine compress dressing. % 
difference = % difference between alternate and standard electrode positions. * <5% in % difference. Electrode positions: WBS - 
whole body standard, WBA – whole body alternate, ULS - upper limb standard, ULA - upper limb alternate, LLS – lower limb 
standard, LLA – lower limb alternate. 
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The results of the post-estimation test analysis, χ2, are shown in Table 3.3. The results 
show there is no statistically significant differences in the means of the BIS variables 
when comparing the standard and alternate electrode placements for the whole body, 
upper limb or lower limb segments (p = 0.097-0.96). This is true for any dressing 
condition. 
 
Table 3.3: Difference in means comparison of standard and alternate 
electrode placement, in different dressing conditions for 
each of the BIS variables. Data presented as χ2 (p-value).   
Electrode 
placement 
Dressing 
Condition 
R0 (ohms) Ri (ohms) Rinf (ohms) ECF (L) ICF (L) TBF (L) 
Whole Body Open  
ActicoatTM 
1.28 (0.258) 
0.40 (0.526) 
1.10 (0.295) 
0.49 (0.484)  0.49 (0.484) 
2.76 (0.097)    
0.44 (0.511) 
0.06 (0.804)   
0.004 (0.95) 
1.59 (0.208)    
0.06 (0.810) 
0.88 (0.346)     
0.02 (0.885) 
Upper Limb Open  
ActicoatTM 
0.00 (0.96) 
1.61 (0.20) 
0.06 (0.81) 
1.79 (0.18) 
0.15 (0.699) 
2.00 (0.16) 
- - - 
Lower Limb Open  
ActicoatTM 
0.91 (0.34) 
0.21 (0.65) 
1.18 (0.28) 
1.58 (0.21) 
2.10 (0.15) 
0.55 (0.46) 
- - - 
 
 
Table 3.4: BIS measures in standard and alternate electrode 
placements in the healthy population. 
BIS 
Variable 
Electrode Placement 
 WBS WBA ULS ULA LLS LLA 
R0 (ohms) 619.32 697.33 314.2 313.14 275.05 265.53 
Ri (ohms) 1458.41 1388.82 797.35 816.89 656.60 587.72 
Rinf (ohms) 428.19 416.61 220.68 221.43 191.62 180.55 
ECF (L) 17.45 17.69     
ICF (L) 24.27 24.84     
TBF (L) 41.72 42.53     
R0 = resistance at zero frequency, Ri = intracellular resistance, Rinf =resistance at infinite frequency, ECF 
= extracellular fluid, ICF = intracellular fluid, TBF = total body fluid. Electrode positions: WBS - 
whole body standard, WBA – whole body alternate, ULS - upper limb standard, ULA - upper limb 
alternate, LLS – lower limb standard, LLA – lower limb alternate. 
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3.4 Discussion 
The results of this study demonstrate alternate whole body electrode placements 
(WBA) measure all resistances and generate ECF and TBF BIS variables comparable 
to whole body standardised placements (WBS) in burns greater than 12% TBSA 
within dressing conditions. Upper limb alternate segmental electrode placement also 
provides comparable BIS variable outputs with an open wound but not with an 
Acticoat
TM
 dressing.  
Even though no statistical significant difference was found between standard and 
alternate electrode placements for all BIS variables, suggesting they are not different, 
consideration needs to be given to i) the percentage change between the two 
conditions and ii) the difference between the measured resistances and fluid volumes 
to determine clinically, if these differences are important. Each of these values needs 
to be considered in conjunction with one another, as there is the potential for volume 
over or understatement of up to 3.50L for TBF. A five percent difference was 
considered a clinically appropriate range for resistance and fluid volumes in the burns 
resuscitation environment. This could be in the order of ±1.25 L in an individual with 
25 L of ICF, for example. This level was determined after considering the available 
literature and the need for maintenance of the intravascular volume with limited 
expansion of the extracellular volume in the burn resuscitation period. A volume 
change greater than 200 ml or a bioimpedance resistance ratio percentage change of 
greater than 10% is a suggested cut-off to identify secondary upper limb 
lymphoedema (20). In surgical gynaecological patients postoperative fluid overload 
was defined as being greater than 15% change in extracellular fluid (ECF) volume 
(determined by bioimpedance) from peri operative volumes (21). 
Whole body electrode placements have a percentage change from WBS to WBA 
electrode placement for all BIS variables, except ICF, less than 5.02% in both 
dressing conditions. For R0 and ECF (representative of oedema) the percentage 
difference between WBS and WBA electrode placement is ≤ 2.97% with an open 
wound and ≤ 3.80% with an ActicoatTM dressing. These percentage differences are 
consistent with typical daily biological, intra-individual, within session variations, 
with multifrequency BIS, which ranges from 0.3-3% (as per manufacturers 
specifications) and up to 4% as reported by Kushner et al (22). Recently Pichonnaz et 
 88 
al (2015) reported variations in some BIS variables below 5.6 %, may be considered 
measurement error (23). The actual estimated difference in R0 and ECF between WBS 
and WBA electrode placements was -14.48 ohms and 245 ml in an open wound and -
13.36 ohms and 770 ml in the Acticoat
TM
 dressing condition. Clinically, these may be 
considered acceptable changes in the acute burns resuscitation environment where 
rapid fluid shifts are occurring on the background of large resuscitation volumes e.g 
13 354 ml (± 7386 ml) over 24 hours (24). This is in the realm of 500 ml of 
resuscitation fluid per hour. In gynaecological surgical cases an administered 
preoperative IV fluid volume of 1.9 L over 154 minutes resulted in an increase in ECF 
of 0.8 L (± 0.8 L), TBF of 1 L (± 1.4 L) and a stable ICF as measured by BIS (21). For 
TBF the volume difference between WBS and WBA were 1.74 L and 3.50 L for an 
open wound (no dressing) and Acticoat
TM
 dressing condition respectively. These 
values are less than a five percent difference, however a change from 1.74 L to 3.50 L 
between standard and alternate electrode placement in the Acticoat
TM
 condition is too 
large to be acceptable, potentially causing a patient to be under-resuscitated if 
alternate electrode positions were used. This suggests alternate electrode positions 
cannot be relied upon in the Acticoat
TM
 condition to monitor TBF volumes. In 
contrast, Rinf the equivalent raw variable of TBF, mean difference is 13.28 ohms in an 
open wound and 9.77 ohms in an Acticoat
TM
 dressing. These are considered 
acceptable when the mean Rinf is 348-361 ohms and 216-226 ohms in the respective 
dressing conditions. 
Although there was no statistically significant difference between whole body 
standard and alternate electrode placement for ICF the percentage difference was 
5.74% and 5.88%, with the greatest change in the Acticoat
TM
 dressing condition. This 
is above the normal biological variation range, accepted 5 percent error and in the 
order of 1.45 L and 2.85 L difference in volume between WBS and WBA for the open 
wound and Acticoat
TM
 dressing condition respectively. This variation is considered 
too great to be used clinically, as it could lead to under or over resuscitation of a 
patient. Yet the corresponding resistance (Ri) percentage difference was 57.66 ohms 
and 34.51 ohms respectively. These values are less than 5.02% difference and also 
considered insignificant on the background of whole body Ri values of 1350-1412 
ohms (open wound) and 680-715 ohms (Acticoat
TM)
. The WBA electrode placement 
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was the same utilised in Grisbrook et al’s (2015) study (25). However, they found all 
BIS fluid volumes to be significantly overestimated in healthy individuals.  
Whole body alternate electrode positions are comparable to that of the standard 
positioning for measuring BIS resistance variables, ECF and TBF (within the 
specified dressing conditions) but not ICF. Clinically, whole body BIS resistance 
values can be used to monitor changes in inter-compartmental fluid volumes and this 
is supported in the literature. Ward et al (2006) reported raw resistance values could 
be used as a surrogate index of volume due to their inverse relationship (26). It has 
also been suggested in the literature that raw BIS data may prove to be more clinically 
useful as it removes the need for predictive equations (27). Further support for the use 
of whole body BIS in daily monitoring of fluid volumes is the comparison of our BIS 
measures to normative values (Figure 3.4) (25). This study utilised the same alternate 
electrode placement as Grisbrook et al (2015). Considering the average time post burn 
was 25 hours, with a potential fluid resuscitation volume of up to ~ four litres over 
this period the results of the BIS measures seem reasonable. i.e the difference in 
standard BIS fluid volume measures between burns and healthy populations are ECF 
3.31 L, ICF 0.99 L, TBF 4.31 L (Table 3.4). The validity of BIS in its ability to 
measure fluid inter-compartmental volumes in major burns however is yet to be 
determined. Future research should therefore explore this. 
In the upper limb electrode positions however, there were large percentage differences 
(range 16.79-20.34%) in the Acticoat
TM
 dressing condition compared to an open 
wound (range 0.36-2.34%). There was however no statistical significance difference 
found between ULS and ULA electrode placements in χ2 test (p = 0.16-0.2) of the 
mean BIS values for each dressing condition. Upper limb alternate electrode 
placement can be utilised if wounds preclude the use of standard placements in the 
open wound as they give comparable measures. However, the large mean percentage 
change between ULS and ULA with Acticoat
TM
 insitu does not support the use of 
ULA in this dressing condition. Grisbrook et al (2015) found placement of electrodes 
on the ventral surface of the hand and wrist for upper limb segmental measures were 
valid alternatives to the standard placement in the healthy population (no dressings 
insitu) (25). 
No statistically significant differences were found between the LLS and LLA 
electrode placements, but they too also had higher than accepted intra-individual 
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biological variations in their mean percentage differences of the resistance variables 
(range 5.3 – 14.56%). Resistance at zero frequency had the lowest values (5.30% for 
both an open wound and Acticoat
TM
 dressing) with Ri having the greatest values. Such 
large percentage differences render LLA electrode placement unsuitable to be used if 
wounds preclude the placement of standardised lower limb electrode placements. This 
again, is consistent with the findings of Grisbrook et al (2015) in terms of potential 
clinical utility, although they found a statistical difference between LLS and LLA 
electrode placements (25). Limb segmental BIS measures provide only raw resistance 
variables, as they require a separate algorithm to calculate fluid volumes. The 
segmental measures were included in this research to determine whether they are a 
potential alternative to whole body BIS but further research is required for clinically 
meaningful application. 
A statistical significant difference was not found between any of the standard and 
alternate electrode placements however the percentage difference was deemed 
clinically significant for the aforementioned whole body fluid variables ICF, TBF and 
all lower limb resistances with and without Acticoat
TM
, and all upper limb resistances 
with Acticoat
TM
. This could be explained by the potential risk of type two error in the 
study due to the relative small sample size in each electrode placement group (n=14-
18) i.e. failing to reject the null hypothesis that there is a difference between standard 
and alternate electrode placement. Another possible reason for the larger differences 
in the BIS variables, between standard and alternate positions in the Acticoat
TM
 
dressing condition, is the age of the electrodes. The electrodes were kept in place 
between the open and new dressing condition to reduce the risk of electrode mismatch 
placement measurement error, which can be in the order of 4% (14). However, the 
electrochemical properties of the electrodes change with time (28) and resistivity 
decreases with moisture thus decreasing the resistance, however the magnitude of 
influence is unknown (29, 30). Burns patients stress levels and skin temperature will 
often increase during a dressing change and with dressings in place. The palms and 
soles of the feet (location of alternate electrode positions) have the highest density of 
sweat glands in the body (31). Therefore the resistance measured in the alternate 
electrode placements, especially of the hand, may be further decreased, increasing the 
percentage difference between BIS resistance values in the Acticoat
TM
 dressing 
compared to the open wound.  
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3.4.1 Future Research 
To make progress in the field new alternative electrode placements need to be 
investigated to ascertain whether they are comparable to standardised placement for 
all BIS variable outputs. It is evident the Acticoat
TM
 exaggerates the differences 
between the standard and alternate electrode positions but also between the open 
wound and Acticoat
TM 
dressing condition. Future studies should therefore examine 
alternate electrode placements in the Acticoat
TM
 condition. An Acticoat
TM
 BIS 
calculator to adjust for the Acticoat
TM
 effect in moderate to large burns (unpublished 
data) is currently being developed. To further enhance the clinical applicability of BIS 
in burns, studies investigating alternate electrode placements in other dressing 
conditions are also warranted.  
3.5 Conclusion 
This study determined whole body alternate electrode placements are a feasible 
alternative when wounds preclude the use of standardised placement for monitoring 
R0, Ri, Rinf and ECF within dressing conditions in burns >12% TBSA. Further 
research is required to establish the best alternate electrode placements to measure all 
BIS variables in moderate to large burns. 
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Foreword 
The preceding study determined whole body and upper limb segmental resistance 
variables and whole body ECF and TBF volumes only in alternate electrode 
positions were interchangeable with standardised positions in specified dressing 
conditions. Hence providing a substitute when wounds preclude standardised 
electrode placement to enable monitoring of fluid volume change in acute major 
burns. Following on, applying these findings, the next study investigated the 
reliability and validity of BIS as a measure of fluid shifts in acute major burns, and 
the impact of dressings on BIS measures. Bioimpedance spectroscopy has been 
shown to be sensitive measure of oedema volume change in large burns. It is reliable 
in burns less than 30% TBSA across different dressing conditions but it is yet to be 
validated as a method of fluid shift over time in moderate to large burns. Acticoat
TM
, 
a nanocrystalline silver dressing used in the first 48 hours of care in the BSWA, has 
been demonstrated to effect BIS measures in burns not receiving fluid resuscitation 
however the effect on those receiving fluid resuscitation is not known. 
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4.1 Introduction 
Large fluid shifts and local and distant tissue swelling are features of burn injuries. 
Swelling hampers burn wound healing and the volume created is directly related to 
the size and depth of the burn (1). Major burns greater than 15-20% total body 
surface area (TBSA) with a depth of partial to full thickness result in both a local and 
systemic inflammatory response (2, 3). This can be a life threatening scenario which 
requires formal fluid resuscitation. Acute burn fluid resuscitation is vital in 
decreasing patient morbidity and mortality in the first 24-48 hours of injury but can 
contribute to already large amounts of oedema (4). 
Despite the importance of fluid resuscitation in the early management of traumatic 
burn injuries, there is currently no single, simple, non-invasive and accurate outcome 
measure which can assist clinicians to titrate fluid volumes in acute burns or monitor 
the effect of treatments on swelling. Thus, the objective, timely adjustment of fluid 
resuscitation is challenging, particularly when patients are not supported by critical 
care and invasive monitoring. This research investigates the accuracy of 
bioimpedance spectroscopy (BIS) in monitoring whole body fluid volume and 
oedema change in moderate to large acute burns. 
There has been little advancement in the area of burn fluid resuscitation over the last 
30 years (4) and in recent times there has been a trend to over resuscitate patients (5, 
6), necessitating a descriptor known as fluid creep. Excess fluid can contribute to 
burn wound progression, lead to complications such as peripheral and abdominal 
compartment syndromes, pulmonary oedema and peripheral tissue oedema. Any one 
or a combination of these will affect patient recovery, increase medical costs and is 
likely to increase patient length of stay (3, 7-10). 
Fluid resuscitation formulas such as the Parkland and Brookes are used to instigate 
intravenous (IV) fluid rates but are guidelines only and fluid must then be titrated 
according to particular endpoints of resuscitation (11-13). The most commonly used 
outcome measure for fluid therapy is urine output, with the aim to maintain a rate of 
30-50ml per hour for an average sized man while preserving haemodynamic 
properties such as oxygen saturation and blood pressure (5, 14). There are other 
 96 
objective measures to guide volume titration however they are invasive and not 
without limitations (6, 14, 15). oedema 
Bioimpedance spectroscopy has historically been used in healthy populations to 
measure body composition. However in the last 20 years it has gained increasing 
popularity in clinical populations and is now commonly used to measure arm 
lymphoedema post breast surgery (16) and dry weight in haemodialysis patients (17, 
18). Bioimpedance spectroscopy has demonstrated sensitivity, high reliability 
(repeatability) of measures in a number of clinical areas (19). The method has also 
been validated (determined credible) in both healthy and clinical populations against 
MRI and bromide and potassium dilution techniques, which are considered gold 
standard in the assessment of fluid compartment volumes and lean body mass (LBM) 
(20-23). It can investigate the body’s physiological parameters such as extracellular 
fluid (ECF), intracellular fluid (ICF) and total body fluid (TBF). It achieves this by 
passing a small alternating current, over a number of frequencies (4-1000 kHz), 
through the tissues and fluid compartments of the body via electrodes on intact skin. 
It provides instantaneous measures of resistance (R) and reactance (capacitive 
resistance (Xc)). Resistance is the opposition to flow of an electric current, is 
reflective of the body’s water compartments and is inversely proportional to fluid 
volume and therefore oedema (24, 25). Capacitance is the delay in the passage of 
current through the cell membranes and tissue interfaces (25). The current flow is 
frequency (Hz) dependent and varies according to the composition of the body (26). 
Resistances at zero and infinite frequencies (considered ideal measurement 
frequencies) are estimated utilising the Cole-Cole plot embedded in the BIS 
software, due the constraints of using a direct or very high frequency alternating 
current in humans (27). The resistance at zero (R0) and infinite (Rinf) frequencies (25) 
are representative of extracellular fluid (ECF) and total body fluid (TBF) 
respectively. Resistance (Ri) of the intracellular fluid (ICF) is extrapolated using the 
other raw variable data. At low frequencies the current can penetrate the ECF only 
and at high frequencies it passes through both the ECF and ICF measuring TBF.  
The ability of BIS to quantify individual body fluid compartments, the ease of use 
and non-invasive nature has led to a small number of papers examining its use in the 
burn population. Miller et al (1999) and Zdolsek et al (1998) were able to determine 
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the development of oedema post burn injury but each study lacked power and neither 
was able to provide statistical conclusions regarding the reliability of BIS in the 
burns populace. In 2009 Edgar et al demonstrated whole body bioimpedance 
spectroscopy was a reliable means of quantifying real time oedema shifts in patients 
with burns less than 30% TBSA across numerous dressing conditions (28). However 
the study only had 6 participants with burns greater than 15% TBSA and was 
therefore inconclusive in this subset of patients. Further each study utilised standard 
whole body electrode positions only and it is unknown whether alternate electrode 
positions, for both whole body and limb segmental BIS, are reliable in this particular 
population. Grisbrook et al (2015) investigated whether alternate electrode 
configuration BIS measurements were interchangeable with standard electrode 
configurations in the healthy population but reliability was not determined (29). In 
Edgar et al’s (2009) study it was also apparent the dressing condition affected the 
sensitivity of the BIS results. Bioimpedance measures were found to be less sensitive 
in older dressings (> 8 hours old) than in an open wound or new dressing condition.  
Dressing-type may pose a further challenge in the assessment of fluid shifts by BIS. 
Acticoat
TM
 (Smith & Nephew) is an antimicrobial dressing, composed of 
nanocrystalline silver particles (30). It is the standard dressing used in the first 48 
hours of burn care, and as indicated after, in the Burn Service of Western Australia 
(BSWA). Understanding that BIS measures the resistance of the body’s tissues and 
inter-compartmental fluid volumes by introducing a low amplitude electrical current 
into the body, it would not be unexpected that Acticoat
TM
 may affect the BIS 
measures. Silver is a highly conductive material, and such dressings release ionic 
silver species and are applied in a wet condition. Both the silver ions and wet 
condition would therefore be expected to reduce the BIS resistance measured, thus 
potentially limiting the use of monitoring fluid shifts with BIS in acute burns 
patients. 
To extend Edgar et al’s (2009) reliability study and on the premise that BIS can 
reliably quantify tissue fluid, it was hypothesized BIS would provide a method for 
real time accurate measures of fluid shifts in the acute major burn. The study aimed 
to a) examine the reliability with respect to dressing condition and electrode position, 
b) investigate the influence of Acticoat
TM
 on BIS variable outputs and c) determine 
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the validity of whole body BIS to assess net fluid shift in the presence of moderate to 
major burns, greater than 15%  TBSA. 
4.2 Methods 
4.2.1 Participants 
An observational longitudinal cohort study was conducted from December 2014 to 
February 2016. Patients were recruited into the study if they were: over eighteen 
years old, receiving formal fluid resuscitation had a flame and/or scald burn and the 
injury was less than 48 hours old. The BSWA medical team instigates fluid 
resuscitation for partial to deep thickness burns greater than 15% TBSA (modified 
however based on each individuals clinical presentation and nutritional status at 
admission) and uses Ringer’s Lactate (crystalloid) solution with volumes initially 
determined by the modified Parkland’s formula. Fluid volumes were titrated to 
maintain an adequate urine output of 0.5-1.0ml/kg/hr for the first 36-48 hours after 
burn injury. Participants were excluded from the research if they had: hand and/or 
feet burns precluding placement of standard whole body electrode placement, body 
mass index (BMI) ≤ 15 and ≥ 40 kg/m2 (manufacturer’s guidelines) and if they met 
Impedimed SFB7 (ImpediMed, Brisbane, Queensland, Australia) manufacturer’s 
contraindications which includes pregnant or breast-feeding patients, patients with 
surgical implants, cardiac pacemakers and/or are on electronic life support devices 
(ventilated patients).  
Burn inpatients were recruited initially from the Burn Unit at Royal Perth Hospital 
(RPH) and then at Fiona Stanley Hospital (FSH) due to the transition of the adult 
care of the BSWA to the new Fiona Stanley Hospital. There was no change to the 
study protocol or equipment used in the study. 
4.2.2 Equipment 
The ImpediMed SFB7 was used to collect whole body and segmental BIS measures 
(Figure 4.1). The calculated fluid volumes are stable when the subject’s BMI is > 15 
kg/m
2
 (as per the manufacturer). 
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The BIS equipment measures both raw resistance variables and derived fluid 
distribution values such as whole body ECF, ICF, and TBF using manufacturer’s 
algorithms. It achieves this by applying 256 discrete current frequencies (4-1000 Hz) 
through the body. Extra and intracellular fluids behave as resistive (R) components 
and R is inversely proportional to fluid volume (26, 31). 
Diagnostic tab electrodes, Kendall CA610 (reference code 31447793, Covidien, 
Mansfield, MA, USA), were utilised. 
 
Figure 4.1: Bioimpedance spectroscopy: standard whole body 
electrode positions 
4.2.3 Procedures  
Firstly, the patient’s weight and height was measured and input into the Impedimed 
instrument along with their age and gender. All BIS measures were taken using 
manufacturer’s recommended and standardised positions with the patient lying 
supine and with arms and legs abducted away from the body. BIS electrodes were 
placed over intact, cleaned skin (using alcohol swabs). 
4.2.3.1 Electrode Configurations 
Standardised tetrapolar electrode placements (EP) were utilised (25, 32) and alternate 
electrode configurations were placed based on the theory of equi-potentials (see 
Cornish et al (1999) for further details of equipotential points) (32) and were placed 
as per Grisbrook et al (2015). Electrodes were placed on intact skin only. Participants 
with bilateral hand or foot injuries which precluded the application of standardised 
electrode placements were excluded. Bioimpedance measures were taken on the right 
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side of the body unless precluded by wounds, then the left side was utilised. The 
location of their wounds determined whether all other electrode placements 
(segmental) could be used and measured.  
BIS measures were taken in triplicate in an open wound (time point 0 (T0)) and in 
the new Acticoat
TM
 dressing condition at five (5) half hour intervals (T1-5) after the 
baseline measure i.e. five measures in total (Figure 4.2). The time between T0 and 
T1 was recorded, as this was unable to be standardised. Standard and alternate whole 
body, upper limb segmental and lower limb segmental BIS measures were taken at at 
T0-T1. Standard whole body EP’s only were utilised at T2-T5 (Figure 4.2). Burn 
wounds often prevent electrodes being applied in the standard position, therefore 
alternative whole body and limb segment electrode positions were utilised as able at 
T0-T1 and their reliability investigated. The data to determine the validity of 
alternate electrode placement has been analysed separately (33). The segmental 
measures were included in the reliability analysis only. The effect of Acticoat
TM
 on 
whole body BIS results was determined from T0-T1 BIS readings. Electrodes 
remained in situ between triplicate measures where possible, unless prohibited by 
dressing changes or adhesive loss. 
Net fluid shift was recorded between each time point (T1-5), in conjunction with the 
BIS measures. Net fluid shift was calculated by subtracting urine output and other 
bodily fluid output recorded (e.g. emesis) from fluid intake (IV and oral fluids and 
food). 
The researcher was blinded to all BIS measurements as only a file name was viewed 
and recorded, not the actual BIS values. 
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Figure 4.2: Consort Diagram-Flow diagram of data collection process  
4.2.4 Ethics 
This study was approved by RPH Ethics Committee (EC 2011/028), FSH Research 
Governance Committee (2014 106) and The University of Notre Dame, Australia 
Human Research Ethics Committee (014139F).  
4.2.5 Data Analysis  
Stata statistical software, release 14 (StataCorp LP 2014, College Station, TX), was 
utilised to analyse all results. Descriptive analyses were performed and are reported 
using the means and standard deviations (SD).  
4.2.5.1 Reliability  
A three level nested mixed effects linear regression was performed to examine the 
reliability of the BIS triplicate measures, taking into account random effects of 
confounders of electrode position, time and dressing condition. The multilevel mixed 
effects (MLME) linear regression also explored whether there was a significant 
within-session difference between the triplicate measures for each of the BIS 
variables.  Reliability is presented as the intra-class correlation coefficient (ICC) 
(acceptable, 0.75-0.89, excellent ≥ 0.9) (34),  variance indicated by 95% confidence 
Screened 
for eligibility 
n = 31 
Consented and included 
n = 21 
Time point 0 
No Dressing 
BIS: standard and 
alternate electrode 
montage 
Fluid Balance 
Time point 1 
 New ActicoatTM 
Dressing 
BIS: standard and 
alternate electrode 
montage 
Net fluid shift 
Time point 2-5 
(30 min intervals) 
ActicoatTM Dressing 
BIS: standard whole body 
electrode montage only 
Net fluid shift 
Excluded 
n = 10 
(n = 9 in ICU, n = 1 went 
to surgery) 
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intervals (CI) and systematic bias between within session trial measures (p < 0.05 
considered significant). All BIS triplicate measures were used in the analysis. 
Analysis was completed using the MLME model as it can account for random effects 
from individuals and responses within individuals (35). It is a robust method 
providing hierarchical analysis, adjusting for nested observations of measures for 
each individual and gives the most precise and least biased estimates of treatment 
effects. Prior to interpreting the results of the MLME, several assumptions were 
evaluated, confirming that each variable in the regression was approximately 
normally distributed. 
4.2.5.2 Factors influencing BIS readings 
The effect of dressing condition, %TBSA and initial TBF on the BIS whole body 
variables only was determined by MLME linear regression. A separate model was 
performed for each BIS variable. The interaction between Acticoat
TM
 and %TBSA 
and their influence on the BIS variables was also examined. The whole body 
standard and alternate electrode placement BIS variable outputs were grouped 
together for use in the analysis for the effect of Acticoat
TM
 and %TBSA. Time point 
0 (open wound) and TP1 (new Acticoat
TM
 dressing) were used only.  
4.2.5.3 Validity 
Validity was determined using a series of MLME linear regression models including 
the data with the Acticoat
TM
 dressing condition only, and whole body standard 
electrode placement (T1-T5) and alternate electrode placement (T1) only. The final 
model was produced by completing step-wise, backward elimination of predictor 
variables on each of the dependent BIS variables. The final model included %TBSA, 
time, net fluid shift and initial TBF volume. Initial TBF volume was derived from the 
mean of the TBF measured with an open wound using standard tetrapolar whole 
body electrode placement as single frequency BIA has been shown to measure TBF 
accurately in burns patients with no dressings (36). This provided a baseline total 
body volume (L). A correlation matrix was performed to determine the relationship 
between initial TBF, weight and height and the skewness-kurtosis test demonstrated 
that they were each normally distributed.   
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Change scores or calculated difference of the BIS variables between time points (e.g. 
R0 at T2 - R0 at T1) were not used in the validity analysis, as the calculation of a 
change score requires measurement of the outcome twice and in practice it is 
proposed that it is more efficient to use a (single) change from baseline measurement 
to derive outcomes. In addition by not analysing change (difference) data, the 
additive effect of the random errors is potentially reduced (37). 
4.2.5.4 Calculator 
A calculator was developed to estimate the net fluid shift between consecutive BIS 
measures, when an Acticoat
TM 
dressing is in place. Algorithms, for calculation of 
estimated fluid volumes were developed incorporating the significant and influential 
variables (on BIS variables) from the MLME models.  
4.3 Results 
Twenty one patients, 7 females and 14 males, were recruited post burn injury. One 
patient had an incomplete set of fluid recordings and 2 patients only had repeated 
measures completed 4 times in the new Acticoat
TM
 dressing condition. The mean net 
fluid shift (SD) at each time point, separated by ~30 minutes for T1-T5, were as 
follows, T1 174.72 ml (533.18), T2 189.15 ml (164.23), T3 204.00 ml (135.37), T4 
141.48 (253.25) and T5 123.20 (114.33). The average time between T0 –T1 (SD) 
was 67 minutes (31). The mean TBF (SD) of patients on initial assessment was 46.06 
L (9.71). Other patient data are presented in Table 4.1. 
Table 4.1: Patient data (n=21). 
%TBSA Age (years) Recruitment 
post burn 
injury (hrs) 
Height (cm) Weight (kg) 
24 (13) 
Range 12-80 
36.4 (13.5) 25 (11) 172.2 77.4 (16.3) 
Values presented as means (SD) ± range 
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4.3.1 Reliability 
BIS triplicate measures were reliable within any electrode position, dressing 
condition and over time. Table 4.2 presents that BIS was a reliable measure in all 
circumstances, as confirmed by the ICC’s. There were no significant differences 
between the estimated means of within session triplicate trial measures for each of 
the BIS variables (ie no systematic bias) (Table 4.2). Final numbers included in each 
EP analysis were WBS (n=21), WBA (n=18), ULS (n=14), ULA (n=14), LLS 
(n=15), LLA (n=14). 
Table 4.2: BIS Reliability 
BIS 
Variable 
ICC (95% CI) BIS trial 
number* 
BIS measure 
Coefficient (95% 
CI) 
p-value 
R0 0.999 (0.999-0.999) 2 -0.07 (-0.68-0.54) 0.83 
  3 -0.06 (-0.68-0.55) 0.84 
Ri 0.999 (0.998-0.999) 2 0.41 (-1.90-2.71) 0.73 
  3 2.06 (-0.24-4.37) 0.80 
Rinf 0.9996(0.999-0.999) 2 0.01 (-0.30-0.32) 0.94 
  3 0.07 (-0.24-0.38) 0.66 
ECF 0.999 (0.998-0.999) 2 0.03 (-0.17-0.22) 0.78 
  3 0.12 (-0.07-0.32) 0.22 
ICF 0.997 (0.996-0.998) 2 -0.12 (-0.46-0.22) 0.49 
  3 -0.26 (-0.61-0.08) 0.13 
TBF 0.999 (0.999-0.999) 2 -0.09 (-0.38-0.20) 0.53 
  3 -0.14 (-0.43-0.15) 0.33 
ICC = intraclass correlation coefficient, R0 = resistance at zero frequency, Ri = intracellular resistance,  
Rinf =resistance at infinite frequency, ECF = extracellular fluid, ICF = intracellular fluid,  
TBF = total body fluid. *Each BIS measure coefficient is in reference to measure 1 of the triplicate 
measures. 
The means and CI for each of the BIS variables for the standard whole body 
electrode placement and time point are presented in Table 4.3. 
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Table 4.3: BIS variable values for the standard whole body electrode 
placement and time point. Values presented as means 
(confidence intervals). 
BIS 
Variable 
At WBS 
Time Point 
T0 T1 T2 T3 T4 T5 
R0 (ohms) 498.77 
(467.17- 
530.37) 
351.94 
(295.56-
408.32) 
366.70 
(314.94-
418.45) 
371.18 
(319.50-
422.86) 
371.76 
(322.20-
422.33) 
401.01 
(348.18-
45384) 
Ri (ohms) 1412.47 
(1225.51-
1599.42) 
715.75 
(505.83- 
925.68) 
715.51 
(536.09    
894.93) 
721.81 
(546.31-
897.31) 
713.41 
(541.38-
885.44) 
798.52 
(611.02-
986.02) 
Rinf  
(ohms) 
361.89 
(337.57-
386.20) 
226.58 
(183.50-
269.67) 
234.35 
(195.19-    
273.52) 
237.45 
(198.23-
276.67) 
238.65 
(200.24-
277.06) 
261.95 
(220.50-
303.40) 
ECF (L) 20.76 (17.56- 
23.97) 
34.77 (14.00- 
55.54)    
32.50 (13.22-
51.78) 
31.93 (14.21-
49.66) 
31.50 (15.07-
47.92) 
24.84 (10.44-
39.25) 
ICF (L) 25.26 (21.62-
28.91) 
48.47 (27.74-
69.21)    
46.97 (27.11-
66.83) 
46.71 (27.15-
66.27) 
46.18 (27.20-
65.16) 
37.80 (21.38-
54.23) 
TBF (L) 46.03 (39.67-
52.38) 
83.16 (43.11-
123.20)     
79.48 (41.84-
117.12) 
78.53 (42.85-
114.20) 
77.65 (43.18-
112.11) 
62.65 (33.67-
91.63) 
WBS = standard whole body electrode position, R0 = resistance at zero frequency, Ri = intracellular resistance, Rinf =resistance at 
infinite frequency, ECF = extracellular fluid, ICF = intracellular fluid, TBF = total body fluid. T0 = initial BIS measurement 
with no dressing, TBSA = total body surface area, T1= first BIS measure with new ActicoatTM dressing, T2-5= BIS measures 
taken at half hourly intervals. intervals. Values presented as means (confidence intervals). 
4.3.2 Factors influencing BIS readings 
The regression analysis demonstrated Acticoat
TM 
had a significant effect on the raw 
variables Ri and Rinf (but not R0) and on all the calculated variables (ECF, ICF, TBF) 
in whole body BIS (Table 4.4). The resistance variables reduced between 182.22 and 
23.87 ohms for Ri and Rinf and the calculated volumes were increased by 31.00 – 
67.23 L when an Acticoat
TM 
dressing was in place, compared to the open wound 
condition. 
There was no evidence of an effect of TBSA on any of the BIS variables (Table 4.4). 
However there was a statistically significant interaction (p <0.01) between TBSA 
and Acticoat
TM 
for all BIS variables, raw and calculated. When an Acticoat
TM 
dressing was in place and for every 1% increase in TBSA R0 decreased by 4.68 
ohms, Ri by 17.98 ohms and Rinf by 3.96 ohms. This results in a divergence away 
from the open wound R values as TBSA% increases. Extracellular fluid, ICF and 
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TBF volumes all increased with greater TBSA when an Acticoat
TM 
dressing was in 
place also resulting in divergence away from the open wound fluid volumes as TBSA 
increased (Table 4.4). 
As expected, there was a strong positive correlation between initial TBF and weight, 
with a correlation coefficient (r) of 0.83 (p <0.01). There was also a moderate 
positive correlation between initial TBF and height, r = 0.67 (p <0.01). Initial TBF 
was therefore included in the model, and height omitted, to reduce collinearity. Initial 
TBF was included in preference to BMI as it was determined to be a more robust 
indicator of a person’s size as the random error was reduced when compared to BMI 
(as it is one variable compared to two (height and weight)). Initial TBF is 
significantly associated with all BIS variables. For every 1 L increase in initial TBF 
R0 decreased by 5.71 ohms (p <0.01), Ri decreased by 32.52 ohms (p <0.01) and Rinf 
decreased by 5.30 ohms (p <0.01). All estimated fluid volumes increased (ECF 0.93 
L, ICF 1.08 L, TBF 2.02 L) with every 1 L increase in initial TBF. 
Algorithms were developed to correct for the effect of Acticoat
TM
 for the BIS 
variables. They are as follows:  
Corrected ECF = measured ECF with Acticoat dressing – (-59.02 + (time since 
dressing applied*1.38) + (initial measured ECF*2.69)) 
Corrected ICF = measured ICF with Acticoat dressing – (-79.26 + (time since 
dressing applied*-0.0006) + (%TBSA*1.85) + (initial measured ICF*3.088918)) 
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Table 4.4: Predictor variable effects on whole body BIS variables for 
determining the effect of ActicoatTM 
BIS 
variable 
Covariate Co-efficient 
Confidence intervals 
p-value 
Lower Upper 
R0 Acticoat
TM -17.42 -39.35 4.52 0.12 
 % TBSA -1.07 -2.75 0.61 0.21 
 ActicoatTM#% TBSA -4.68 -5.37 -3.98 <0.01* 
 Initial TBF (L) -5.71 -8.32 -3.09 <0.01* 
Ri Acticoat
TM -182.22 -265.27 -99.16 <0.01* 
 % TBSA 6.50 -3.45 16.46 0.20 
 ActicoatTM#% TBSA -17.98 -20.61 -15.36 <0.01* 
 Initial TBF (L) -32.52 -48.16 -16.87 <0.01* 
Rinf Acticoat
TM -23.87 -38.57 -9.17 <0.01* 
 % TBSA -0.01 -1.33 1.32 0.99 
 ActicoatTM#% TBSA -3.96 -4.42 -3.49 <0.01* 
 Initial TBF (L) -5.30 -7.37 -3.23 <0.01* 
ECF Acticoat
TM -36.23 -41.91 -30.55 <0.01* 
 % TBSA -0.04 -0.31 0.23 0.76 
 ActicoatTM#% TBSA 1.86 1.68 2.04 <0.01* 
 Initial TBF (L) 0.93 0.53 1.33 <0.01* 
ICF Acticoat
TM -31.00 -36.07 -25.92 <0.01* 
 % TBSA -0.15 -0.36 0.07 0.18 
 ActicoatTM#% TBSA 2.01 1.85 2.17 <0.01* 
 Initial TBF (L) 1.08 0.77 1.40 <0.01* 
TBF Acticoat
TM -67.23 -77.13 -57.32 <0.01* 
 % TBSA -0.19 -0.63 0.25 0.40 
 ActicoatTM#% TBSA 3.87 3.55 4.18 <0.01* 
 Initial TBF (L) 2.02 1.36 2.67 <0.01* 
R0 = resistance at zero frequency (ohms), Ri = intracellular resistance (ohms), Rinf = resistance at infinite frequency (ohms), 
ECF = extracellular fluid (L), ICF = intracellular fluid (L), TBF = total body fluid (L), TBSA = total body surface area,  # =  
interaction term, *p= <0.05. ActicoatTM is  in reference to an open wound 
4.3.3 Validity 
BIS resistance and fluid volume variables were analysed to determine BIS validity. 
The MLME linear regression univariate analysis, in the Acticoat
TM
 dressing 
condition only, showed R0, Ri and Rinf significantly changed with time  (Table 4.5). 
Compared to T1 (new Acticoat
TM
 dressing), for every minute increase in time, R0 
decreased 0.40 ohms (p <0.01), Ri decreased 2.51 ohms (p <0.01) and Rinf decreased 
0.40 ohms (p <0.01). The BIS calculated fluid volumes ICF and TBF were also 
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significantly associated with time, increasing by 60 ml and 20 ml for every minute 
increase in time (p < 0.01). ECF was not significantly associated with time. 
The regression analyses demonstrated all resistance values significantly decreased 
with increasing net fluid volume in a linear relationship (Table 4.5, Figure 4.3 A). 
Net fluid volume was significantly associated with ICF and TBF BIS fluid volume 
change, increasing with increasing net fluid shift (Figure 4.3 B). All BIS variables 
were significantly associated with % TBSA. For every 1% increase in TBSA R0 
decreased 5.09 ohms, Ri decreased 8.85 ohms and Rinf decreased 3.25 ohms. Fluid 
volumes increased between 1.20 – 2.77 L with every 1% increase in TBSA (p < 
0.01) (Table 4.5). 
Two individuals who had large negative fluid shifts >850 ml across a single time 
point were removed from the analysis after step wise analysis found they 
significantly altered the results of the final model Leaving these patients in the 
analysis would have resulted in a non-homogenous sample. It appears a large loss of 
fluid volume compromises the interpretation of BIS measures. Both patients suffered  
loss of large volumes of ionic fluid due to emesis which likely altered the measured 
BIS resistance (27). 
When a patient’s initial TBF increased by 1 L R0 decreased 5.78 ohms (p <0.01), Ri 
decreased 28.79 ohms (p <0.01) and Rinf decreased 5.31 ohms (p <0.01).  
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Table 4.5: Univariate analysis of variable correlation on whole body 
BIS measures 
BIS 
variable 
Covariate Co-efficient 
Confidence intervals  
p-value 
Lower Upper 
R0 Time (minutes) -0.40 -0.54 -0.27 <0.01* 
 % TBSA  -5.09 -7.08 -3.10 <0.01* 
 Net fluid shift (ml) -0.05 -0.07 -0.02 <0.01* 
 Initial TBF (L) -5.78 -8.95 -2.61 <0.01* 
Ri Time (minutes) -2.51 -3.09 -1.92 <0.01* 
 % TBSA  -8.85 -16.98 -0.74 0.03* 
 Net fluid shift (ml) -0.25 -0.36 -0.15 <0.01* 
 Initial TBF (L) -28.79 -41.74 -15.84 <0.01* 
Rinf Time (minutes) -0.40 -0.51 -0.28 <0.01* 
 % TBSA  -3.25 -4.69 -1.81 <0.01* 
 Net fluid shift (ml) -0.05 -0.07 -0.03 <0.01* 
 Initial TBF (L) -5.38 -7.68 -3.07 <0.01* 
ECF Time (minutes) 0.02 -0.01 0.05 0.15 
 % TBSA  1.40    0.99 1.80 <0.01* 
 Net fluid shift (ml) 0.01 -0.001 0.01 0.09 
 Initial TBF (L) 1.20 0.56 1.85 <0.01* 
ICF Time (minutes) 0.06 0.03 0.10 <0.01* 
 % TBSA  1.52 1.17 1.88 <0.01* 
 Net fluid shift (ml) 0.01 0.01 0.02 <0.01* 
 Initial TBF (L) 1.56 0.99 2.13 <0.01* 
TBF Time (minutes) 0.08 0.02 0.14 <0.01* 
 % TBSA  2.92 2.18 3.65 <0.01* 
 Net fluid shift (ml) 0.02 0.01 0.03 <0.01* 
 Initial TBF (L) 2.77 1.59 3.94 <0.01* 
R0 = resistance at zero frequency (ohms), Ri = intracellular resistance (ohms), Rinf = resistance at 
infinite frequency (ohms), ECF = extracellular fluid (L), ICF= intracellular fluid (L), TBF = total body 
fluid. *p= <0.05. 
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A  
B  
Figure 4.3: Predicted margin plots of BIS variable (Ri, ICF) and net 
fluid shift relationship 
* The predicted margin plots of R0 and Rinf, and ECF and TBF have a similar linear 
relationships to net fluid shift as Ri and ICF above. Ri = resistance of intracellular fluid, ICF 
= intracellular fluid 
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4.3.4 Calculator 
A calculator was developed to estimate the net fluid shift between consecutive BIS 
measures, accounting for dressing condition, %TBSA and time since dressing 
(Appendix C). The significant and influential variables from the MLME models 
(Table 4.5) were incorporated into the newly developed algorithms (for calculation 
of fluid volumes), which were then embedded in an excel calculator to allow 
clinicians access to them. The variables required for input into the calculator by the 
clinician include dressing condition, %TBSA, time since application of Acticoat
TM 
dressing (minutes) and the measured BIS variables. The calculator does not require 
the clinician to monitor or include net fluid shift, namely urine output and fluid input. 
The validity analysis utilised the measured BIS fluid volumes and did not correct for 
the Acticoat
TM
 effect, as it was not considered necessary for this preliminary study. 
4.4 Discussion 
The principal novel finding of this study show bioimpedance spectroscopy was a 
reliable method for monitoring fluid change in moderate to large burn patients. 
Bioimpedance resistance measures can be interpreted in the presence of Acticoat
TM 
to monitor changes in fluid volume over time, if corrected for using the provided 
calculator. Thus, the study also established BIS as a valid indicator of fluid change 
over time during burns resuscitation while Acticoat
TM 
dressings are in situ. 
Bioimpedance spectroscopy at the bedside has the potential to improve fluid 
management in an acute major burn by providing real time measures of fluid shifts 
thus reducing the risk of over resuscitation and associated adverse outcomes. 
4.4.1 Reliability 
The results of the study demonstrate BIS produces reliable raw and predicted 
measures in patients with >12% TBSA burns, regardless of dressing condition (open 
wound or Acticoat
TM
)
 
and electrode placement (Table 4.5). This data suggests BIS is 
a reliable method for assessing oedema change over time in moderate to large area 
burns. This concurs with and adds to the findings of Edgar et al’s (2009) study which 
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found BIS reliability applicable to burns with <30% TBSA across different dressing 
conditions (28). 
4.4.2 Factors influencing BIS readings 
Bioimpedance whole body calculated fluid volumes were grossly and significantly 
overestimated and resistance of the ICF and TBF underestimated when an Acticoat
TM 
dressing was in place. The under or overestimation of BIS variables increased with 
increasing TBSA. Grisbrook et al (2016) and Kenworthy et al (2017) also found the 
effect of silver dressings on BIS variable measures increased with increasing size of 
the burn.  
Body mass index is also well known to be associated with BIS variable output as 
larger people have a greater amount of body fluid (38). This has been demonstrated 
in the present results where a larger initial TBF (indication of the bulk of the person 
and collinear with BMI) significantly decreased BIS resistance and therefore 
increased calculated fluid volumes. 
It can be concluded that BIS was appropriate for use in a moderate to large burns 
population when an Acticoat
TM 
dressing was in place only with adjustment, as 
resistance measures and fluid volumes are significantly under and overestimated with 
significantly different values to those in an open wound. The SFB7 impedimed 
embedded algorithms are not appropriate for use in burns with Acticoat
TM
 insitu. 
This is consistent with the findings of Grisbrook et al (2016) (39) though the burns 
population sample in that study did differ from those recruited in this study sample 
with respect to %TBSA (range 5.5-28.5% compared to our 12-80%) and fluid 
resuscitation requirements. Therefore, to monitor fluid shifts it is recommended the 
resistance and fluid volume variables measured when an Acticoat
TM
 dressing is 
insitu, be corrected using the provided calculator. 
4.4.3 Validity 
The present results show BIS is a valid indicator of fluid volume change over time in 
moderate to large burn resuscitation with TBSA, time, net fluid shift and initial TBF 
all significantly associated with BIS resistance and calculated fluid volumes. For 
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clinically interpretable resultsthe measured BIS variables need to be adjusted using 
the provided calculator if Acticoat
TM
 is in place. 
Time was significantly associated with resistance variables, with an increase in time 
decreasing all estimated resistances and increasing ICF and TBF volumes. This may 
be explained by a combination of factors including the time since dressing 
application, the effect of Acticoat
TM
 and the amount of fluid resuscitation 
administered. Firstly, over time the Acticoat
TM
 dressing deposits more silver ions 
into the wound, therefore decreasing the raw resistance values and in turn increasing 
the ‘equivalent’ fluid volumes as calculated by BIS embedded algorithms (40). 
Secondly, the total mean volume of fluid resuscitation over time increased, thus 
increasing all inter-compartmental fluid volumes and consequentially decreasing the 
associated estimated resistance values. Although ECF was not associated with time, 
the p-value (0.15) is arguably low enough to accept that a clinical relationship may 
exist despite a small sample. In contrast, the embedded algorithm of analysis may 
explain why ECF is not associated with time in this population (each algorithm has 
different constants for estimating the individual fluid compartments (41)). However, 
R0 the equivalent resistance of ECF significantly changed with time, suggesting fluid 
volume change in the extra cellular compartment is associated with time.  
It is known BIS resistance is inversely proportional to fluid volume (22, 24). The 
results of this study support this. Bioimpedance variables and net fluid shift were 
found to have a negative inverse linear relationship with resistance and as expected, 
calculated fluid volumes a positive linear relationship (Figure 4.3) providing the net 
fluid shift (at each half hour measure) was greater than 100 ml. There were two 
patients who had a large (> 850 ml) negative fluid shift, both noted to have emesis 
during the single measurement period, and thus these data were excluded from the 
analysis, as they were assumed to have an altered, uncorrected physiological (ionic) 
state at the time of measurement and thus, significantly differed from others in the 
sample. It appears a large loss of fluid consequentially affects the following repeated 
BIS measures (within at least the following two hours). It is proposed that not only 
was the volume change a contributor to the difficulty in interpretation of the BIS 
measures but also the loss of electrolytes from the gut following emesis. The emesis 
could have altered the whole body fluid ionic state for a short period until it was 
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corrected by the body systems. Bioimpedance resistance is inversely proportional to 
fluid volume and electrolyte concentration. Therefore significant changes in the ionic 
status of the fluid or tissues measured will alter the BIS raw variables and render the 
machine embedded algorithms for calculated volumes, invalid. Clinicians are advised 
not to use BIS measures in the period after an episode of emesis (42). Further, the 
results suggest the BIS measure is only sensitive to fluid losses ≤ 100ml per half hour 
in the burns resuscitation period. The sensitivity of the BIS measure for fluid losses 
greater than 100 ml and less than 850 ml cannot be predicted as the patient cohort did 
not experience losses in this range. 
4.4.4 Calculator 
On the basis of the results a calculator was developed to improve the clinical utility 
of BIS in burns resuscitation patients at the bedside. It adjusts for the Acticoat
TM
 
effect and provides an estimated change in BIS resistance and fluid volumes between 
consecutive BIS measurements, hence allowing fluids to be titrated accordingly. It 
has been established however that BIS is reliable and valid in the open wound 
condition. Therefore BIS can be utilised without variable adjustment when no 
dressings are in place. 
4.4.5 Clinical Practice Recommendations 
Optimum fluid resuscitation requires maintenance of the intracellular volume with 
minimal expansion (extravasation) of the extracellular volume. The results of this 
study indicate that using the relationship or pattern between R0 or ECF and Ri or ICF 
is a non-invasive, interpretable method of monitoring or titrating fluid resuscitation. 
A stabilised Ri or ICF volume, over time, equal to or greater than the normal range 
(ICF 22.9-25 L) (24) represents a fluid resuscitation target. Fluid volumes should 
then be titrated to maintain R0 or ECF at a steady state whilst continuing to preserve 
Ri or ICF at the target volume. Ideally ECF volumes would be maintained as close to 
normal (or the average for a healthy person) as possible (13.2-15.3 L). However due 
to the body’s systemic “leaky vessel” inflammatory response to a major burn injury, 
with extravasation of fluid into the extracellular space, volumes within 5-10% of 
these norms would be a suggested acceptable target range (43, 44). In postoperative 
surgical patients fluid overload has been defined as >15% of preoperative fluid 
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volume (43) and in haemodialysis patients reaching ECF volumes within one to two 
litres of normal values is deemed acceptable (45). An example of how to titrate 
fluids: If Ri or ICF is stable and the change values of R0 or ECF continue to increase, 
the fluid administered is adding to the extracellular compartment (swelling) rather 
than preferentially maintaining the intracellular compartment. Infused fluid volumes 
therefore need to be reduced if Ri (ICF) is stable and R0 (ECF) is trending upward. 
However, in a recent study, intracellular volume actually decreased (~0.8L over 70 
minutes) upon rapid infusion of intravenous fluid (~2L in ~ 60 minutes) into healthy 
male volunteers (46). It was suggested the infusion of fluid was responsible for the 
increase in extracellular fluid. The fluid administered in this study was <500ml/hr 
therefore difficult to conclude whether this may have the same effect. It however 
does suggest potentially accepting an ICF volume of ~ 1L less than average volumes 
when considering titrating fluid as above. For greater sensitivity to change, at this 
time this study suggests it is more advantageous to use the change in BIS raw 
resistance values (adjusted in the presence of Acticoat
TM
) rather than the calculated 
volumes as it removes the need for specific predictive equations and eliminates the 
need for height and weight measures measures (47). There are a growing number of 
studies suggesting raw BIS variables may be more useful in predicting clinical 
outcomes (48, 49). BIS raw variables may also be able to indicate changes associated 
with cell membrane damage and cell wall integrity (49).  
Further work is required to increase the confidence and promote greater utility of this 
sensitive measure over standard haemodynamic monitoring. In contrast urine output, 
a ‘quasi’ measure of fluid shifts and whole body perfusion (8) has been suggested to 
lag behind the actual events of hypoperfusion by up to two hours (50, 51). 
Bioimpedance also removes the need to rely heavily on initial fluid volume 
calculations such as the Parkland or Brooke’s. This could prove highly useful out in 
the field with paramedics and in isolated country hospitals where clinician’s burns 
experience may be limited and where Western Australia’s vastness means it is not 
uncommon for people to travel greater than eight hours to be admitted to a tertiary 
hospital.  
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4.4.6 Future Research  
Additional research is warranted in evaluating the effect of other silver and non-
silver dressings such as sulfadiazine and hydrocolloids, in moderate to large burns to 
increase the utility of BIS across burns services.  
Further, consideration may need to be given of the type of resuscitation fluid (e.g. 
crystalloids versus colloids) in future studies as BIS electrical conductivity is 
affected by electrolyte concentration. This may therefore influence BIS variable 
measurements. Electrical and chemical burn injuries may also influence or change 
the ionic state of the tissue. Thus future research should include these modes of 
injury. 
Ideally BIS would be able to be used on burns patients on life support or mechanical 
ventilation however further study needs to be done to determine whether electronic 
equipment interferes with the BIS instrument. Several studies have been conducted 
in intensive care units however they did not stipulate whether ventilated patients 
were included (52, 53). 
4.5 Conclusion 
In moderate to large burn patients, BIS is a reliable and valid method of oedema 
change. The Acticoat
TM
 dressings significantly alter the BIS raw outputs. To allow 
clinical interpretation of BIS, measures must be adjusted for silver dressings.  
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Foreword 
The first two studies presented in this thesis demonstrated BIS is a reliable method in 
the assessment of fluid shifts in acute burns >12%TBSA receiving fluid 
resuscitation, across different dressing conditions and electrode positions. Validity of 
BIS as a measure of fluid shift over time, with the use of the provided calculator to 
adjust for the presence of an Acticoat
TM 
dressing, was also established. Solutions to 
particular barriers in the use of BIS were also established. For broad clinical 
applicability across the spectrum of burns, BIS reliability and validity as a measure 
of oedema change needed to be determined in localised minor limb burns.  
Minor burns experience localised wound oedema, not a systemic inflammatory 
response like major burns, and are also managed with both non-silver and silver 
dressings in the acute period. It is unknown whether whole body BIS is a sensitive 
measure of oedema change in minor burns, less than five percent TBSA. Therefore 
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standardised electrode placements and a novel localised electrode placement were 
investigated as well as the influence of dressing conditions on the BIS measures.    
5.1 Introduction 
Oedema as a result of inflammation is the body’s normal response to injury (1). In 
burns, this process is exaggerated, causing an excessive volume of fluid in the tissues 
(2, 3). Oedema contributes to burn wound progression, slows healing and can 
increase risk of infection (4-7). Burn wound healing time is directly related to scar 
outcome (7, 8). Oedema can alter the severity of the wound by increasing the oxygen 
diffusion distance within the wound, exacerbating hypoperfusion thus forming a 
physical barrier to healing (9, 10). Limb oedema can also impact an individual’s 
immediate physical function by limiting the range of motion of joints, causing pain 
with movement and mobilisation and increasing the effort required to move (11). 
Proactive, early management of oedema is therefore an integral part of a 
multidisciplinary intervention program to minimise the negative impact of swelling 
and optimise patient recovery (12). However, there is little high level evidence to 
support traditional oedema management regimes, nor is there emergent interventions 
for more proactive oedema removal (2). Thus, to guide improvements in oedema 
management in the burn population, a non-invasive, easy to use accurate assessment 
of swelling is required (13). 
At present, the widely accepted methods for clinical monitoring of peripheral 
swelling are volume displacement and circumferential measures (14, 15). 
Circumferential measures are prone to subjective bias and lack sensitivity while 
volumetry is cumbersome to perform and rarely used in clinical practice (16). In the 
burns population both methods may pose an increased risk of infection, increased 
pain and can only be used when dressings are removed. Clinical examination of the 
burn wound such as visual analysis of depth, healing (re-epithelialisation) and signs 
of infection can also indicate presence of oedema (as a wound heals oedema 
decreases), however these are largely subjective (4, 17).  
Techniques designed for the serial measurement of wound oedema would ideally be 
sensitive, reliable, user independent and minimally or non-invasive. Bioimpedance 
spectroscopy (BIS) is a technique, which may provide such a solution (18, 19). It is a 
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technique used frequently in healthy populations and more recently in clinical 
populations to measure an individual’s body composition, including inter-
compartmental fluid volumes, fat free mass (FFM) and cell (membrane) mass and 
function (20-22). By applying a small alternating current into the body via adhesive 
electrodes placed on intact skin, assessment of tissue resistance (R) and reactance 
(Xc) is possible. The R and Xc values are measured over a range of frequencies (5-
1000hz). Bioimpedance spectroscopy software then utilises the Cole – Cole model 
applying non-linear curve fitting to estimate the resistance at zero frequency (R0, 
extracellular fluid (ECF) equivalent), infinite frequency (Rinf, total body fluid (TBF) 
equivalent) (23). The intracellular fluid (ICF) resistance (Ri,) is extrapolated using 
the other raw variable data (24). Extra and intracellular fluids behave as resistive 
components and resistance is inversely proportional to fluid volume and therefore 
swelling (20, 25). The pathway the current takes is dependent on the frequency. At 
low frequency (5 Hz), currents travel through ECF only and at higher frequencies 
(>50 Hz) it travels through both ICF and ECF (26), thus providing the potential to 
develop a correlate measure of oedema volume (ECF).  
Traditionally BIS technology measures fluid flux at a whole body level with 
electrodes placed in standardised locations on the hands and feet (23). However, 
segmental BIS, the measurement of the body in segments, brings the electrode-
dependent field of measurement closer to the site of interest and is more sensitive to 
fluid volume changes of single limbs compared to whole body measures (25). 
Grimnes and Martinsen (2007) state as the distance between electrodes decreases, the 
deeper layers of tissue contribute less to the BIS result, therefore increasing 
sensitivity of the measured signal and oedema volumes (27). Codognotto et al (2008) 
used segmental electrode placement to assess single limb oedema as whole body 
electrode placement was shown to be insensitive to decreases in volumetric measures 
during the treatment of lymphedema (25, 28). Also in muscle injures, localised 
bioimpedance analysis (BIA) was able to detect changes in swelling and cellular 
injury consistent with MRI imaging over time (29). Localised BIA is not 
standardised and electrode placement differs depending on the site of injury or 
swelling. Electrodes are normally placed longitudinally and parallel to the axis of the 
limb. However, in a in a proof of concept study in uninjured adults, Ward et al 
(2013), demonstrated localised BIS to be a highly sensitive measure of fluid volumes 
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and highly reproducible data was obtained from electrodes located at different 
(localised) positions around the region of interest (19).  
A challenge to measuring oedema in the acute burn environment with traditional 
methods is the presence of dressings and wounds. It is yet to be established if this 
invalidates, or is also a potential barrier to, the use of BIS. Acute burn wounds in the 
Western Australian context are dressed with a number of different products including 
hydrocolloid and ionic silver anti-microbials. Bioimpedance technology is based on 
the flow of an electrical current delivered at different frequencies through the body 
and is directly related to the amount of electrolyte rich (ionic) fluid in the field of 
measure. Therefore, silver (a conductive material) and hydrocolloid (water based) 
dressings have the potential to influence BIS variable outputs, independently of the 
oedema volumes in the tissues. 
The ability to objectively assess local changes in fluid composition and fluid 
accumulation around the site of a wound would be helpful in determining the 
efficacy of the interventions currently aimed at reducing peripheral or limb oedema. 
Thus, the current study aims to examine the reliability and validity of the BIS 
technique for the measurement of localized burn wound oedema with respect to 
electrode position and dressing condition. It is hypothesised that bioimpedance 
resistance variables, R0, Ri, Rinf will increase as limb volumes decrease.  
5.2 Methods 
5.2.1 Participants  
A longitudinal, prospective, single service study was conducted between December 
2014 and December 2016. Participants were included in the study if they were: over 
18 years old, had a minor burn wound less than five percent TBSA, the injury was 
less than four days old and involved the limbs only and had a body mass index of 
between 15-40 kg/m
2
. Patients were excluded if they were unable to lie supine for the 
duration of the testing. Manufacturer’s requirements were adhered to thereby 
preventing inclusion of the following patients: pregnant or breast-feeding patients, 
patients with surgical implants and/or cardiac pacemakers.  
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Patients were initially recruited from Royal Perth Hospital (RPH) burns outpatient 
clinics or as inpatients on the RPH Burns Unit. Recruitment was then completed at 
Fiona Stanley Hospital (FSH) burns inpatient and outpatient areas due to the Western 
Australian State Burns Service moving in February 2015. The change of State Burns 
Service location did not alter the study protocol, patient population sampled or the 
equipment used. 
5.2.2 Data Collection 
Upon recruitment, participant’s height, body mass, age and gender were recorded 
and input into the BIS device (SFB7 ImpediMed, Brisbane, Queensland, Australia). 
BIS measures were taken with participants in a supine position, limbs abducted away 
from the body and electrodes placed over cleaned, intact skin. The flow of the data 
collection process can be seen in Figure 5.1. 
 
Figure 5.1: Flow diagram of data collection process.  * Occurs at time 
point 1 and 2. 
5.2.2.1 Reliability 
Circumference limb measures (CLM) of the 1) affected limb were measured to 
determine localised limb volume and 2) unaffected limb were measured to determine 
our raters’ CLM reliability. Measurements were taken at three points. On initial 
assessment they were taken 3cm proximally and distally to the wound and at the mid 
point (across the wound) between these two measures. The proximal and distal 
measurement points were also measured in reference to specific anatomical 
Assessed for eligibility 
n = 42 
Included 
n=30 
Excluded or declined n=10 
Withdrawn 
n = 2 
Height and *weight taken 
and input into SFB7 
Patient lies supine with 
legs abducted 
*NoDressing   
CLM (affected limb), 
*scaled photo 
*BIS: WB, Segmental 
affected limb, localised  
*New wound dressing 
(dressing type recorded) 
*BIS: WB, Segmental 
affected limb, localised  
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landmarks, with the patient supine in the anatomical position, so they could be 
replicated on the unaffected side and at follow up. This has been shown to increase 
the accuracy and reliability of circumference limb measures (30). The tape measure 
was cleaned with alcohol wipes to adhere to infection control protocols. 
The localised sense electrodes were placed at the same measurement points as the 
proximal and distal CLM’s, on initial assessment (Figure 5.2), making sure there was 
3cm between the wound edge and the edge of the electrode. The distance between 
the two electrodes was also measured and recorded to 1) minimise electrode 
placement error at follow up and 2) to calculate localised limb segment volume. This 
inter electrode distance was termed the ‘localised inter-electrode distance’. 
 
Figure 5.2: Position of distal localised electrode on a thigh, 3 cm from 
wound edge. Day 4 post burn. 
Within each assessment session, triplicate BIS measures were taken for each 
electrode configuration (Figure 5.2 and Figure 5.3) and in both dressing conditions 
(no dressing and new dressing). Bioimpedance spectroscopy has been found to be 
reliable and valid in healthy and clinical populations (16, 31-33). In 2009, Edgar et al 
demonstrated the use of whole body BIS measurements of acute oedema shifts in 
human burn survivors, with injuries less than 30% total body surface area (TBSA) 
(mean 10.45% TBSA), with excellent reliability across different dressing conditions 
(16). 
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Electrode Montage Electrode placement 
Sense Drive 
Whole Body 1,3 2,4 
Right Upper Limb 1,5 2,4 
Right Lower Limb 3,6 2,4 
Figure 5.3: Schematic representation of the BIS whole body and limb 
segment electrode positioning: measurement (sense) electrode 
sites (solid circles) and drive (current injecting) electrode sites 
(open circles).  
5.2.2.2 Validity 
BIS measures were taken in three different electrode positions to determine which is 
most sensitive to oedema change. They were 1) whole body BIS using standard tetra-
polar whole body electrode placement (electrode position (EPWB) (34); 2) whole limb 
segmental measures of the affected (EPlimb) limb (electrode placement as per 
Cornish, Jacobs et al 1999) (35) (Figure 5.3); and 3) localised BIS (EPlocal) with the 
sense electrodes placed 3cm adjacent to the burn wound along the longitudinal axis 
of the limb (localised inter-electrode distance) and drive electrodes in the standard 
position (dorsum of the foot and hand) (Figure 5.3). This allowed a dressing to be 
accommodated where needed during the assessments. All measures were taken with 
1) an open wound or no dressing and 2) with a new dressing (less than 2 minutes 
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old). The dressing type were categorised as either a non silver dressing or a silver 
dressing. 
The volume of the novel limb segment was calculated using the truncated cone 
volume formula (36). Two truncated cone volumes were calculated for each localised 
limb segment and then added together (volume between mid and proximal, and mid 
and distal CLM).  
V = [h (CP
2
 + CPCM + CM
2
)]/ 12 𝜋 + [h (CD
2
 + CDCM + CM
2
)]/ 12 𝜋 
Where: 
C P,M,D = circumference limb measures (P = proximal, M = mid, D = distal) 
h = height of each segment = localised inter-electrode distance /2 
Participants had initial measures taken within 96 hours of injury (time point 1 (T1)) 
and follow up measures at a second time point (time point two (T2)), within fourteen 
days, after initial assessment to enable comparison of acute outcomes (BIS raw 
variables; localised limb segment volume) over time. It is known that in burns not 
requiring fluid resuscitation, oedema peaks on about day one post injury and by day 
four post- burn, the rate of volume change over time tapers to clinically insignificant 
levels (37). Therefore the method planned was to capture individuals within this 
initial time period to increase the likelihood of detecting changes in swelling over 
time. 
Researchers (data analysers) were blinded to circumferential limb and BIS measures 
between time point one and two by using separate data collection sheets and only a 
BIS file name was recorded, not the actual variable values.  
5.2.3 Equipment 
The ImpediMed SFB7 was used to collect whole body, segmental and localised BIS 
measures. The equipment applies a small AC current across 256 discrete current 
frequencies (4-1000 Hz) to interpret each measurement. BIS computes both raw 
impedance values and derived fluid distribution values such as whole body ECF, 
ICF, and TBF using manufacturer’s algorithms (23) and are stable when the subject’s 
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body mass index is > 15 kg/m
2
 (as per the manufacturer). Only raw BIS variables are 
used in this study, as the algorithm is not applicable to localised or segmental BIS. 
Kendall CA610 diagnostic tab electrodes (reference code 31447793, Covidien, 
Mansfield, MA, USA) were utilised. 
A thin 150cm tape measure was used for circumference limb measures. 
5.2.4 Ethics 
Approval for the study was granted by the RPH Human Research Ethics Committee 
(EC 2011/028), FSH governance committee (2014-106) and The University of Notre 
Dame Australia Human Research Ethics Committee (014139F). 
5.2.5 Statistical Analysis  
Stata Statistical Software, release 14 (StataCorp LP 2014, College Station, TX) was 
utilised to complete all data analysis. The Shapiro-Wilk test was used to assess the 
normality of the data. Normally distributed variables were described as means and 
standard deviations (SD). Where the data was not normally distributed, as for BIS 
measures, CLM and other co-variates, non-parametric statistics were performed. 
Where the variable was skewed it was transformed using the log function and the 
geometric mean and confidence intervals (CI) were reported, as for BIS resistances, 
localised inter-electrode distance, TBSA and CLM. A p value of less than 0.05 was 
considered statistically significant for all analysis. 
5.2.5.1 Reliability 
Two sample Wilcoxon rank sum (Mann-Whitney) tests were applied to determine if 
there were any significant differences between CLM of the unaffected limb between 
the two time points. As the patients were not undergoing resuscitation, it was 
assumed there would be no change in the size of the unaffected limb between 
sessions. 
Reliability of the within session triplicate BIS resistance measures was determined 
by concordance (intra-class correlation coefficients (ICC)) (acceptable, 0.75-0.89; 
excellent, ≥ 0.9) (38), acceptable variance estimated by 95% confidence intervals 
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(95% CI) and systematic bias between trials (considered significant at P < 0.05) (38). 
The ICC’s were obtained using a three level nested mixed-effects linear regression 
model. Multilevel mixed-effects (MLME) linear regression analysis was also utilised 
to determine if there was a significant change in BIS mean resistance values between 
triplicate measures. Initial and follow up triplicate BIS measures were included in the 
analysis.  
5.2.5.2 Validity  
A series of multilevel mixed effects (MLME) linear regression analyses were used to 
determine the effect of the measurement, patient and time characteristics on the 
dependent BIS variables (R0, Ri, Rinf). Step-wise, backward elimination of the 
variables was completed, to produce the final model. A MLME linear regression 
analysis was also used to determine the effect of time on mean localised segment 
volume. The regression coefficients, with 95% confidence intervals were reported. A 
p value of less than 0.05 was considered statistically significant for all analysis. 
The MLME model is a robust method allowing for nested observations of measures 
for each individual and provides a hierarchical analysis with generalisations for non-
normalised data.  The method can account for random effects from individuals and 
responses within individuals (39). 
5.3 Results 
5.3.1 Demographics 
Thirty burn patients (20 males and 10 females) with a mean age of 37 (SD=10.57) 
years and a mean TBSA of 1.39% (SD=0.96) were included in the analysis. An 
additional two patients were excluded from the analysis. One was lost to follow up 
and the second due to equipment malfunction. The mean days post burn at initial 
recruitment (T1) was 2.35 days (SD 1.18,) and at follow up (T2) was 7.05 days (SD 
3.98). The burns were located on upper limbs (n=16, 53%) and lower limbs (n=14, 
47%) only. The localised inter-electrode distance mean was 18.19cm (CI 15.61-
21.19). The total percentage of dressing by type in the final analysis was no dressing 
53.23%, non-silver 30.07% and silver 16.70%. The median limb localised segment 
volume was 1861.94 ml (inter quartile range 850.63 ml– 3010.36 ml).  
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5.3.2 Reliability 
The mean CLM scores of the unaffected limb at T1 and T2 for each point of measure 
are displayed in Table 5.1 
Table 5.1: Geometric means of unaffected CLM (cm) at time point 1 and 
time point 2 
Unaffected CLM point of 
measure  
Mean CLM (cm) (CI) 
Time point 1 
Mean CLM (cm) (CI)  
Time point 2 
Proximal 33.19 (32.29-34.12) 33.52 (32.54-34.53) 
Mid 29.27 (28.43-30.08) 29.66 (28.77-30.58) 
Distal 23.98 (23.23-24.75) 24.69 (23.86-25.54) 
CLM = circumference limb measures 
A two sample Wilcoxon rank-sum test determined there was no significant difference 
between the medians (p value range 0.19-0.86) of the unaffected CLM (proximal, 
mid, distal) between repeated measures at the first and second time point. This 
indicates consistency of CLM’s over time and between raters. 
Table 5.2 presents the analysis of the within session triplicate BIS measurements 
reliability. There is a high correlation (level 3 intra class correlation) of the within 
session BIS triplicate resistance measures within the same electrode position, time 
point and dressing condition (BIS resistance is reliable in any circumstance) as 
determined by the ICC’s which are as follows. R0 0.9999 (CI (0.9999 - 0.9999); Ri 
0.9999 (CI 0.9999 - 0.9999); Rinf 0.9999 (0.9999 - 0.9999). There were no significant 
differences between the estimated means of the within session triplicate measures for 
each of the BIS variables (p = 0.11-0.72).  
Table 5.2: BIS reliability results 
BIS Variable 
Triplicate BIS 
within session 
measure 
Co-efficient (CI) p-value 
R0 2 -0.06 (-0.17 - 0.04) 0.257 
 3 -0.02 (-0.12 - 0.09) 0.72 
Ri 2 1.65 (-0.38 - 3.68) 0.110 
 3 1.12 (-0.90 - 3.15) 0.278 
Rinf 2 0.02 (-0.08 - 0.11) 0.721 
 3 0.02 (-0.07 - 0.12) 0.602 
*Triplicate BIS measures are in reference to the first triplicate measure  
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5.3.3 Validity 
The series of MLME regression analysis conducted and univariate analyses 
established there was no significant effect of gender, age, weight, surgery, burn agent 
or burn depth on the BIS variables. Further associations and interactions between the 
independent variables and BIS resistance variables are reported below. 
5.3.4 Effect of electrode position on BIS variables 
Table 5.3 demonstrates the interaction between electrode position and time point.  
The BIS variables at localised EP (EPlocal) had the biggest percentage change from 
T1 to T2 compared to the whole body (EPWB) and affected limb (EPlimb) EP’s as 
shown with the electrode position and time point interaction, however not significant. 
From T1 to T2 for EPlocal: R0 increased by 12% (p= 0.121); Ri increased by 12% 
(p=0.288); and Rinf by 11% (p= 0.241) whereas EPlimb had a percentage change less 
than 9% (p = 0.410-0.850) for all resistance variables, compared to EPWB. Although 
none of the electrode positions and time point interactions was significant (p≤0.05), 
EPlocal demonstrated the greatest power to detect change over time and was therefore 
the EP used for further MLME analysis. 
Table 5.3: Change in BIS resistance variables with the interactions 
between time point and electrode position (in reference to time point 
1 and EP1) 
BIS 
Variable 
Covariate 
Interactions 
Co-
efficient 
95% Confidence 
Interval 
p-
value 
Lower Upper 
R0 Time point 2#Electrode 
position 2  
1.02 0.87 1.18 0.85 
 Time point 2#Electrode 
position 3 
1.13 0.97 1.32 0.12 
Ri Time point 2#Electrode 
position 2  
1.09 0.89 1.35 0.41 
 Time point 2#Electrode 
position 3 
1.13 0.90 1.39 0.29 
Rinf Time point 2#Electrode 
position 2  
1.03 0.85 1.26 0.73 
 Time point 2#Electrode 
position 3 
1.11 0.92 1.36 0.24 
# = Interaction term. Time point#Electrode position interaction is in reference to time point 1 
and electrode position 1 (whole body). Electrode position (EP) 2 = affected segment, 
Electrode position (EP) 3 = localised.  
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5.3.5 Effect and interactions of burn size, localised limb 
segment volume and dressings on BIS variables 
Univariate analysis of time point determined R0 and Rinf significantly decreased over 
time (p = 0.04 and 0.04 respectively). Ri did not change significantly over time (p = 
0.07) (Table 5.4). When time, as indicated by assessment points (T1, T2) was 
included in the regression it did not significantly improve the prediction of any of the 
BIS variables using the MLME model. Time point was therefore not needed in the 
following analysis and results from the MLME regression analysis included EPlocal 
from T 1 only.  
Localised inter-electrode distance had a significant association with R0 and Rinf only 
and TBSA had a significant association with R0 only (p=0.05) (Table 5.4). As 
localised inter-electrode distance increased by 1cm, R0 increased by 2.38 ohms (p= 
<0.01) and Rinf by 2.24 ohms (p=<0.01).  
The mean volume of the burnt limb segment was significantly associated with each 
of the BIS resistance variables. A 1 ml increase in calculated volume reduced R0 by 
0.68 ohms (p = <0.01), Ri by 0.53 ohms (p = <0.01) and Rinf by 0.63 ohms (p= 
<0.01), indicating an inverse relationship between resistance and fluid volumes. 
Mean localised segment volume also changed significantly over time. From time 
point 1 to time point 2, mean volume had a mean decrease of 0.98
 
ml (CI 0.96-1.00) 
(p=0.05). There was no significant interaction between time point and mean localised 
segment volume for any of the resistance variables, suggesting the relationship 
between mean localised segment volume and resistance is consistent over time. 
Regression analysis of the effect of dressing condition on BIS resistance values 
indicated there was a significant difference between no dressing and silver dressings 
at EPlocal and T 1 for R0 and Rinf measured. R0 increases by 4.98 ohms (p = <0.01) 
and Rinf by 8.25 ohms (p = <0.01) with a silver dressing in place compared to no 
dressing (Table 5.4). A non-silver dressing also significantly increased resistance 
values in all measured BIS variables (p = <0.01) (Table 5.4) when compared to no 
dressing condition.  
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Table 5.4: BIS resistance measures relationships with covariates at 
electrode position ‘local’ only  
BIS 
Variable 
Covariate Co-
efficient 
 
95% Confidence 
Interval 
p-
value 
Lower Upper 
R0 (ohms) Time point 2 1.13 1.01 1.28 0.04* 
 Localised inter-electrode 
distance (cm) 
2.38 1.28 4.45 <0.01* 
 TBSA (%) 1.43 1.00 2.16 0.17 
 Non silver dressing 6.75 3.75 12.12 <0.01* 
 Silver dressing 4.98 2.57 9.65 <0.01* 
 Mean volume of localised 
limb segment  
0.68 0.52 0.87 <0.01* 
 Non silver dressing#mean 
volume  
0.90 0.81 1.00 0.05* 
 Silver dressing#mean 
volume  
0.84 0.73 0.96 0.01* 
 Non silver dressing# 
Localised inter-electrode 
distance  
0.55 0.45 0.67 <0.01* 
 Silver dressing# Localised 
inter-electrode distance 
0.53 0.43 0.66 <0.01* 
Ri (ohms) Time point 2 1.17 0.99 1.40 0.07 
 Localised inter-electrode 
distance (cm) 
1.81 0.77 4.27 0.17 
 TBSA (%) 1.42 0.84 2.41 0.19 
 Non silver dressing 6.86 3.33 14.11 <0.01* 
 Silver dressing 18.66 8.26 42.16 <0.01* 
 Mean volume of localised 
limb segment  
0.53 0.39 0.71 <0.01* 
 Non silver dressing#mean 
volume  
0.81 0.71 0.93 <0.01* 
 Silver dressing#mean 
volume  
0.81 0.68 0.97 0.02* 
 Non silver dressing# 
Localised inter-electrode 
distance  
0.55 0.43 0.71 <0.01* 
 Silver dressing# Localised 
inter-electrode distance 
0.32 0.24 0.42 <0.01* 
Rinf (ohms) Time point 2 1.17 1.01 1.36 0.04* 
 Localised inter-electrode 
distance (cm) 
2.24 4.14 16.44 <0.01* 
 TBSA (%) 1.48 0.97 2.25 0.07 
 Non silver dressing 6.78 3.68 12.48 <0.01* 
 Silver dressing 8.25 4.14 16.44 <0.01* 
 Mean volume of localised 
limb segment  
0.63 0.48 0.81 <0.01* 
 Non silver dressing#mean 
volume  
0.88 0.79 0.99 0.03* 
 Silver dressing#mean 
volume  
0.81 0.70 0.94 <0.01* 
 Non silver dressing# 
Localised inter-electrode 
distance  
0.55 0.44 0.68 <0.01* 
 Silver dressing# Localised 
inter-electrode distance 
0.44 0.35 0.55 <0.01* 
R0 = resistance at zero frequency, Ri = intracellular resistance, Rinf = resistance at infinite frequency; 
 # = interactions between 2 variables; *p= <0.05. Values for non silver and silver dressings are in 
reference to no dressing condition.  
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There was a significant interaction (p <0.01-0.012) between silver dressings and the 
mean volume of the localised burnt limb segment for all resistance values (Figure 
5.4). When a silver dressing was in place R0, Ri and Rinf decreased with increasing 
volume, resulting in divergence away from no dressing R values as the limb segment 
volume increased (Figure 5.4 A,B,C). A significant interaction also existed between 
non-silver dressings and the mean volume of the localised burnt limb segment for all 
resistance values. When a non-silver dressing was in insitu R0, Ri and Rinf decreased 
with increasing volume but resulted in a convergence toward the no dressing R value 
with increasing volume (Figure 5.4 A,B,C). 
Significant interactions existed between the localised inter-electrode distance and 
each of the dressing conditions for all BIS R values at EPlocal and T 1 (Table 5.4, 
Figure 5.5). A 1cm increase in the inter-electrode distance increased R0 by 0.53 ohms 
(P <0.01) when a silver dressing was insitu and the difference between silver 
dressing and no dressing R0 increased as the inter-electrode distance increased 
(Figure 5.5 A). This relationship was opposite for Ri and Rinf, where Ri and Rinf 
decreased significantly (p <0.001) with increasing inter-electrode distance with a 
silver dressing in place and resulted in divergence away from the no dressing R value 
with increasing inter-electrode distance (Figure 5.5 B,C). 
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A 
B 
C 
Figure 5.4: The interaction between dressing condition and mean 
localised segment volume (logarithmic scale) for R0 (A), Ri (B) 
and Rinf (C). 
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A 
B 
C 
Figure 5.5: The interaction between dressing condition and localised 
inter-electrode distance (logarithmic scale) for R0 (A), Ri (B) 
and Rinf (C). 
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There was a significant interaction (p <0.01) between non-silver dressings and the 
inter-electrode distance for all resistance values (Figure 5.5). When a silver dressing 
was in place R0, and Rinf increased with increasing inter-electrode distance, with the 
difference in R values between the no dressing and non-silver dressing conditions 
decreasing with increasing inter-electrode distance (Figure 5.5 A,C). Ri also had a 
significant and similar interaction but with minimal increase with increasing inter-
electrode distance (Figure 5.5 B). 
Algorithms were therefore developed to adjust R0 when a dressing is in situ. They are 
as follows: 
Adjusted (Ag) R0 = R0 (Ag) / (10.47 + 0.53* inter-electrode distance + 2.38* inter-
electrode distance) 
Adjusted (non Ag) R0 = R0 (Non-Ag) /(12.24 + 0.55* inter-electrode distance + 2.38* 
inter-electrode distance)  
Where: 
 R0 (Ag) = measured BIS R0 when a silver dressing is in place 
 R0 (Non-Ag) = measured BIS R0 when a non-silver dressing is in place 
 Inter-electrode distance = the measured inter-electrode distance 
The above equations can be used to adjust R0 when BIS is used in the presence of 
any dressings, thus providing a measure of oedema change. 
5.4 Discussion  
In patients with minor limb burns, resistance as measured by BIS is a reliable and 
valid index of oedema change. In patients with an acute wound, this study 
demonstrated that localised BIS was sensitive and accurate for use with and without 
a dressing in situ. Further, to improve the clinical application in burns, the 
interpretation of the BIS resistance variables is enhanced by adjusting for the 
presence of a silver impregnated and non-silver dressings. From the results of this 
study, adjustment of BIS resistance is now possible due to the development of an 
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algorithm, which can be embedded as formulae in readily available spread sheet 
software. 
The SFB7 instrument provided reliable BIS resistance output regardless of dressing 
condition and type, and electrode position. The data demonstrated high intra-class 
coefficients (>0.999) with minimal variance (95% confidence interval range 0.996-
0.999) and no indication of significant systematic bias. This suggests BIS is a reliable 
tool for monitoring changes in BIS R values in minor limb burns. These results are 
consistent with the literature (40). Edgar et al (2009) found BIS to be a reliable 
method for assessment of oedema shifts in burns (%TBSA < 30%) regardless of 
dressing condition and dressing age (16). Circumferential limb measures of the 
unaffected limb were also found to be reliable with no significant difference in 
measures found over time. This indicates the CLM’s and thus truncated cone volume 
estimates of the affected limb in this study were reliable, as the unaffected limb 
volume was not expected to change appreciably between time points. This is due to 
minor burns causing a localised inflammatory response (not systemic) with swelling 
concentrated around the burn wound (2, 3, 41). 
A primary aim of this study was to establish whether BIS is a valid measure of 
oedema volume change in minor limb burns (<5% TBSA) with respect to electrode 
position and dressing condition. A localised (EPlocal) electrode montage was found to 
be the most sensitive arrangement when compared to the calculated truncated cone 
measurement and when compared to whole body and segmental electrode positions. 
Localised BIS electrode placement was best option to detect and measure oedema 
volume change over time. The change in resistance values detected over time ranged 
from 0.11- 0.12% at electrode position 3 and 0.2 - 0.9% at electrode positions 1 and 
2. This compares similarly with other studies where localised electrode positions 
were superior at detecting change in fluid volumes (42, 43). It has been demonstrated 
that narrowing the field of measurement closer to the site of interest increases the 
sensitivity of bioimpedance measures (44). As localised electrode positioning is not 
standardised to manufacturer’s specifications, it is recommended strict measurement 
and placement protocols be adhered to, to ensure consistency (comparability) of BIS 
assessments and minimisation of the introduction of type two measurement error, on 
the same individual. 
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The MLME regression analysis allowed us to accept our hypothesis, bioimpedance 
resistance variables, R0, Ri, Rinf increase as limb volume decreases (Figure 4 A,B,C). 
Additionally, all BIS resistance values, R0 and Rinf, at EPlocal had significantly 
increasing mean values (1.13-1.17 ohms) over time and the burnt limb segment 
volume significantly reduced over time. It is known BIS resistance is inversely 
proportional to fluid volumes and therefore swelling (33, 45). Burn wound healing 
clinically manifests as reduced oedema, in the acute phase (3, 46). This suggests BIS 
resistance variables can monitor changes in minor acute burn wound oedema over 
time and is supported by Ward et al (2006) (47). They reported raw resistance values 
can be used as a surrogate index of volume due to the inverse relationship between 
the two. Further, there was a greater percentage change in BIS resistance variables 
(R0 5.27%, Ri 7.68%, Rinf  8.80%) over time than with burnt limb segment volume 
(0.13%), indicating BIS is more sensitive to fluid volume change than calculated 
truncated cone volume measures from CLM. This concurs with Cornish et al 2001 
who found BIA was 100% sensitive at detecting those at risk of lymphoedema and 
CLM had a sensitivity of only 5% (43). The study demonstrated that BIS has a 
superior ability to detect small oedema volume changes in a clinical setting, 
compared to CLM, and thus could be better placed to help guide early decisions and 
oedema management practices. 
After establishing the reliability and validity of BIS in patients with a wound, the 
focus of this study following on was to examine the influence of silver impregnated 
and non-silver dressings in assessment of limb oedema in the clinical context. 
Dressings certainly render other common assessment techniques such as WDV and 
CLM, uninterpretable. In this study we found regularly used silver impregnated 
burns dressings significantly affected BIS resistant values. As expected, due to the 
delivery of ionic silver from dressings, BIS resistance values decreased compared to 
the no dressing conditions, measured in the same session. In addition, the difference 
increased as the 1) localised inter-electrode distance increased and 2) limb segment 
volume increased. This is consistent with the findings of Grisbrook et al (2016), who 
documented that silver dressings interacted similarly with TBSA in burns with a 
median TBSA of 15%, where an increasing %TBSA had a measurable decrease in 
BIS resistance variables when a silver dressing was in situ (48). As the localised 
inter-electrode distance increases, the greater the depth of the BIS current and 
  
140 
therefore the greater amount of tissue it passes through. This explains the significant 
relationship of increasing R0 and Rinf values with increasing localised inter-electrode 
distance (44, 49). 
Non-silver dressings also significantly affected within session BIS resistance 
variables compared to no dressing conditions. However the measured resistance 
values were increased in comparison to no dressing conditions and the difference 
decreased with increasing 1) localised inter-electrode distance and 2) limb segment 
volume. Hydrocolloid dressings, the main non-silver dressings used in this patient 
sample, contain gelatin and cellulose and are adhesive (50). Gelatin is a highly 
viscous protein and coupled with the adhesive properties may act like a cell 
membrane or skin, thus resulting in a measured increase in BIS resistance (51). 
To increase the clinical utility of BIS at the bedside the provided algorithm can 
provide adjusted R values when a dressing is in situ. Resistance at zero frequency, 
equivalent to ECW and therefore oedema, would be the most clinically useful BIS 
variable to track changes in oedema volume. The localised inter-electrode distance, 
significantly associated with BIS R values, is a measure that can be taken clinically 
with or without a dressing insitu and with relative ease and accuracy, unlike CLM. In 
minor burns it can be used as quasi measure of percent TBSA, as TBSA estimation 
can be highly variable and inaccurate (52). Localised inter-electrode distance was 
therefore included in the final MLME regression analysis, instead of limb segment 
volume, to estimate BIS R values and formulate the algorithm to adjust the BIS R 
variables when a dressing is insitu. 
It is recommended localised BIS be utilised to improve responsiveness of the BIS 
measures. As long as the localised inter-electrode distance and the measured BIS R 
(with dressings) is entered into the provided algorithm BIS can be used in a clinical 
setting to assess oedema change over time and the effectiveness of treatment 
interventions. 
Bioimpedance spectroscopy was demonstrated to be more sensitive in the assessment 
of oedema volume change, than traditional methods. It is simple and rapid to use. 
Anecdotally, during this study it took ~two minutes to complete measures from set 
up to finish, This concurs with other authors who have quoted one minute for BIS 
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measures versus seven minutes for tape measurements in the assessment of limb 
lymphoedema (53). They also reported BIS is better accepted by clinicians, 
therapists, and patients than serial CLM or WDV methods. It is non-invasive and can 
be used accurately with dressings in place or an open wound (54). Further, it is more 
sensitive to oedema volume changes over time than truncated volume measures. 
Therefore, the BIS methodology can provide the earliest possible objective data 
regarding oedema volume and guide management interventions in the same 
timeframe. Thus, BIS has the potential to assist in limiting the impact of adverse 
outcomes associated with burn wound oedema. 
5.4.1 Future Studies 
This study examined the use of BIS in minor limb burns and the effect of electrode 
position and new dressings on the measured resistance variables. To enhance clinical 
utility however, investigation of the effect of dressing age is necessary as the 
properties of common dressings change with time. Silver dressings deposit silver 
ions over a particular amount of time and hydrocolloid dressings absorb fluid and 
wound exudate forming a gel. Both conditions are likely to affect the electrical 
conductivity based on the principles that resistance is proportional to the amount of 
electrolyte rich fluid (23). Clinically this is relevant as minor burns often have 
dressings left in place for up to five days with physical rehabilitation and oedema 
management strategies occurring within this time period, thus necessitating oedema 
monitoring in these timeframes. Further studies may also include quantifying limb 
and whole body oedema with BIS, so a true magnitude of oedema change over time 
can be measured. The magnitude of change in research is relevant to determine the 
best intervention however further research is required to determine this. This was 
beyond the scope of this study. In addition, investigation of BIS in the assessment of 
oedema shifts in major burns and the effect of regularly used silver dressings on BIS 
variables would further enhance the clinical applicability of BIS in the burns 
population. 
5.5 Conclusion 
Localised bioimpedance spectroscopy is a reliable, valid and non invasive technique 
for the assessment of oedema after minor limb burns with and without dressings in 
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situ. BIS provides an interpretable measure of oedema change in minor limb burns 
when dressing condition is accounted for using the provided algorithm.  
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Foreword 
The first 3 studies have demonstrated the reliability of BIS across different electrode 
positions and dressing conditions and have established the validity of BIS, after 
adjusting for dressing condition, as a measure of fluid change across the spectrum of 
burn severity. As a result of these previous studies, it is possible to recommend BIS 
as an adjunctive objective measure of oedema and fluid shifts in burn injured 
patients, major and minor, which will i) assist in improving clinical assessment and 
treatment of oedema and ii) aid oedema management intervention studies aimed at 
reducing the overall impact of burn severity.  
The final study of this thesis explores BIS, as an objective measure of monitoring 
burn wound healing. Localised BIS is able to monitor wound healing in traumatic 
and surgical wounds and has been shown to be more sensitive at detecting wound 
infections than regular laboratory tests. It is not known however, if BIS can monitor 
wound healing in acute minor burns. 
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6.1 Introduction  
Wound healing, re-epithelisation, is a complex but well described physiological 
process. Erythema, heat, pain and swelling are classic symptoms of both acute and 
chronic wounds, which are caused by a vascular and cellular inflammatory response 
of the body to injury (1). Timely treatment of the wound and associated symptoms is 
crucial for providing the best possible environment for healing.  Acute burn wounds 
are unique in their degree of swelling. After a burn the body responds with an influx 
of chemical and inflammatory mediators resulting in excess swelling (2).  
Immediate management of a burn wound should include optimum first aid, 
management of swelling and medical attention with appropriate dressings (3, 4). 
Improvements in dressings, surgical intervention and the advent of antibiotics over 
the decades has improved aspects of burn wound care, yet oedema remains an issue. 
It is known that in the first 3-5 days post burn when assessed according to Jackson’s 
three zones of tissue injury (5), the burn wound can progress, thus increasing the 
wound depth and time to healing and increasing the risk of a worse scar and 
functional outcome (6). Time to healing is directly related to severity of scarring (2).  
Oedema is considered a primary impediment to the healing process and burn wound 
conversion (7). The specific mechanism by which oedema interferes with healing is 
unknown but is theorised to be related to compromised vascular and tissue diffusion 
dynamics (8). Peri-wound oedema is thought to impair the clearance of cellular 
debris and waste; to prevent the migration of inflammatory cells impairing defence 
from infection and antigens; and impeding nutrient transport from the capillary bed 
to the cell (9). Other factors affecting healing are an individual’s pre-morbid health 
and age. Systemic factors such as diabetes, peripheral vascular disease and obesity 
are associated with slowed wound healing (10). 
It is essential to monitor wound healing closely to ensure the most appropriate 
intervention to promote healing is carried out. In clinical practice the assessment of a 
burn wound must include the wound size (total body surface area (TBSA)), depth, 
agent and days post burn. Each of these factors helps guide the best and optimal 
medical management of the patient (11). Other signs such as wound oedema volume 
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and chemical changes in the wound surface are essential assessment points and may 
indicate infection (1). 
The most common measures used to assess a burn wound are: visual evaluation; 
photos, TBSA and depth (determined by colour, skin elasticity, hairs left) (12, 13). 
These are influenced by a certain degree of subjectivity and clinician specialisation 
and training. Clinician assessment of a burn wound has been shown to be accurate 
only 60–75% of the time (14). The use of computer software, planimetry, wound 
biopsy, laser Doppler and ultrasound can be used to objectively assess the structure 
of the wound but these can be expensive, require specialist training and don’t 
necessarily provide immediate results (15). In the burns wound environment, 
dressings may remain in place for 2-5 days, limiting wound assessment unless 
dressings are removed. Having the capability to monitor wound healing with a 
dressing in place would limit dressing cost, decrease patient burden and pain and 
potentially detect infection and delayed or poor healing in wounds earlier. 
Kenworthy et al (2017) (the authors of this study) found bioimpedance raw 
resistance measures, can monitor localised changes in acute burn oedema with 
dressings in place (16). In addition, the ability to monitor wound healing in real time, 
non-invasively and without subjectivity would be advantageous and minimise error.  
Bioimpedance spectroscopy (BIS) is an instrument with this potential. It can measure 
the body’s inter-compartmental fluid volumes, indicate metabolic state and cell 
health through passing a small electrical current, over a number of frequencies, via 
electrodes placed on the skin and measuring the voltage drop between them (17). The 
current flows depending on the body’s composition. The body offers two types of 
resistance to an electrical current. They are resistive R (resistance) and capacitive R 
(reactance) (18). Resistance is the opposition to flow of an electric current and 
capacitance is the delay in the passage of current through the cell membranes and 
tissue interfaces. The BIS instrument measures real time raw variables (resistance 
(R), reactance (Xc) and phase angle (PA)) using current frequencies of 4-1000 kHz. 
Mathematical formulas embedded in the BIS instrument then utilise these raw 
variables to estimate the inter-compartmental fluid volumes (19). 
Resistance has an inverse relationship to fluid volume due to alterations in electrolyte 
concentration, so as the fluid volume increases R decreases. Resistance at zero (R0) 
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frequency theoretically indicates extracellular fluid ((ECF) oedema), as the current 
does not traverse the cell membrane. Higher frequency currents pass through the cell 
membrane and ionic extracellular environment, therefore R at infinity frequency 
(Rinf) indicates total body fluid (TBF) (20). Practical limitations prevent the use of 
zero frequency (direct currents) and low high frequency alternating currents, 
therefore values of R0 and Rinf are predicted by the BIS instrument using a Cole-Cole 
plot (21). Resistance of the intracellular fluid (ICF) (Ri) is extrapolated using the 
other raw variable data. Reactance represents cell membrane mass and function. 
Phase angle, calculated as the arc tangent of Xc/R and expressed in degrees (18). The 
capacitance of the cell membrane causes the current to lag behind the voltage as it 
traverses the cell, creating a phase shift of the waveform as measured by BIS (22). If 
the health of the tissue is disturbed in any way (e.g. inflammation, disease) the 
electrical properties of those tissues (cell membranes) are altered. Phase angle is 
therefore promoted as a measure of cell membrane health and a prognostic indicator 
of malnutrition and disease (23). As the health of the cell improves, the transit of the 
BIS current and voltage is delayed, thus resulting in greater PA’s. In experimental 
case studies, BIS R and PA measures have been, shown to be associated with wound 
healing in acute and chronic wounds (24-26). Resistance measures were also 
positively associated with histological measures of healing in surgically induced 
wounds in rats (26). The following study therefore aims to examine whether the BIS 
technique is a valid measure of wound healing.. Based on the evidence from the 
literature it is hypothesised R and PA will increase with burn wound healing. 
6.2 Methods 
6.2.1 Participants  
Participants were recruited from the Western Australian State Burns Service, 
outpatient clinic between December 2014 and December 2016. 
Participants, who were over 18 years of age, had a minor limb burn (less than five 
percent TBSA) which was less than four days old were eligible for inclusion in the 
study. Participants were able to be included if they also had minor burns to other 
non-assessed body locations and, or if they had surgical intervention to the burn 
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wound of interest. They were excluded if they had a body mass index (BMI) < 15 
kg/m2 and were unable to lie supine. Manufacturer’s contradictions also excluded 
pregnant or breast-feeding individuals, participants with surgical implants and 
cardiac pacemakers. 
This was a longitudinal study, with participants having BIS, circumference limb 
measures (CLM) and photos taken on two different days. Patients were initially 
recruited within four days of injury and followed up in a second measurement 
session within 14 days of initial assessment.  
 
6.2.2 Data Collection 
6.2.2.1 Wound Healing 
Digital photos (in colour), were standardised by inclusion of a measurement scale in 
each image, and were taken of the individual’s burn at initial recruitment and follow 
up to visually monitor wound healing area. A Burns Attending Surgeon reviewed the 
scaled photographs and determined whether there was healing of the burn wound 
over time. Indicators such as epithelialisation (assessed by wound hue and wound 
surface moisture), presence of erythema and wound area were used to assess the 
wound. A combination of these factors were utilised to categorise the wound. The 
wound healing categories and relevant descriptors are as follows: 1) worse – 
increased area, worsening erythema, wound hue changes indicating burn wound 
conversion or increased wound ooze, signs of infection; 2) no change – no clear 
difference in the wound, in any stated parameter as per category 1, could be seen on 
visual assessment and 3) healing – re- epithelialisation, decreased wound area, 
wound contraction, increasing red/pink hue of the wound. The parameters of wound 
healing were assessed at follow up to provide a category of wound healing in 
comparison to the initial assessment. 
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6.2.2.2 Bioimpedance Spectroscopy  
The subject’s height, body mass, age and gender were recorded and entered into the 
BIS instrument (SFB7 ImpediMed, Brisbane, Queensland, Australia). Participants 
were positioned in supine with limbs abducted away from the body. Electrodes were 
placed over cleaned, intact skin with the measurement (sense) electrodes placed 3cm 
longitudinally either side of the burn wound (Figure 1). Drive (current applying) 
electrodes were placed in the standardised position, at the head of the third 
metacarpal dorsally and the base of the third metatarsophalangeal joint dorsally. To 
minimise inter- and intra-rater error, bony anatomical landmarks were used as 
measurement reference points for placement of the two sense electrodes, with the 
patient in supine and the distance between the sense electrodes was also measured 
(27). Within each assessment session localised BIS (R0, Ri, Rinf and PA) measures 
were taken in triplicate with an open wound. Phase angle measured at 50 kHz (PA50) 
was utilised as it has been suggested to be the most appropriate frequency to monitor 
changes in bioimpedance variables in humans (28).  
 
Figure 6.1: Burn of volar forearm two days after surgery. Sense 
electrodes in place either side of wound 
6.2.2.3 Localised limb segment volume (oedema) 
The localised limb segment volume was calculated using the truncated cone method, 
as a method of oedema assessment. In minor burns, oedema peaks on day one (1) 
post injury and then reduces to clinically insignificant levels by day four (4). Wound 
healing clinically manifests itself as reduced oedema (29). Therefore limb segment 
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oedema volume was determined to support and strengthen the statistical analysis and 
primary aim .Limb circumference measures were taken at the site of the sense 
electrodes (distal edge) and at their mid point with the patient in the anatomical 
position. These CLM were then utilised to calculate limb segment volume using the 
truncated cone method (27). Reliability of our CLM has been determined in a 
previous study (16). The tape measure was cleaned with medi-wipes to adhere to 
infection control protocols. 
Truncated volume measures of the localised segment were determined using the 
below formula.  
V = [h (CP2 + CPCM + CM2)]/ 12 𝜋 + [h (CD2 + CDCM + CM2)]/ 12 𝜋 
Where: 
C P,M,D = circumference limb measures (P = proximal, M = mid, D = distal) 
h = height of each segment = inter electrode distance /2 
Researchers were blinded to the CLM and BIS measures between recruitment and 
follow up. The Burns Attending Surgeon was also blinded to both the BIS and CLM 
results. 
6.2.3 Equipment 
Localised BIS measures were collected using the ImpediMed SFB7 instrument 
(ImpediMed, Brisbane, Queensland, Australia) (Figure 6.2). 
The portable BIS instrument applies a small AC current across 256 discrete current 
frequencies (4-1000 kHz) via electrodes placed on intact skin. Electrical leads 
connect the electrodes (via alligator clips) and the BIS instrument together. Patient’s 
details are entered via a touch screen. BIS measures raw R and Xc values and then 
computes PA (at the varying BIS frequencies) as the arc tangent of Xc/R.  
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Figure 6.2: ImpediMed SFB7 instrument (ImpediMed, Brisbane, 
Queensland, Australia) 
Kendall CA610 diagnostic tab electrodes (reference code 31447793, Covidien, 
Mansfield, MA, USA) were utilised. 
A tape measure was used for circumference limb measures (CLM) to calculate 
truncated limb volume and Fiona Stanley Hospital (FSH) medical illustrations 
department photographed the wounds with a standardised technique. 
6.2.4 Ethics 
Approval for the study was granted by the Royal Perth Hospital (RPH) Human 
Research Ethics Committee (EC 2011/028), and subsequently Fiona Stanley Hospital 
(FSH) Governance Committee (2014-106) (upon transfer of the Burn Service to the 
new hospital during the study period) and The University of Notre Dame Australia 
Human Research Ethics Committee (014139F). 
6.2.5 Data Analysis  
Statistical analysis of the results was completed using Stata statistical software, 
release 14 (StataCorp LP 2014, College Station, TX). Normality of the data was 
assessed using skewness – kurtosis tests.  Descriptive statistics (mean ± standard 
deviation) were utilised to portray normally distributed patient characteristics and 
appropriate predictor variables.  
Non-parametric statistics were performed where the data was not normally 
distributed. A Spearman’s rank-order correlation was performed to determine the 
relationship between a healing wound and the mean limb segmental volume. The 
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results are presented as the correlation co-efficient (rho) (weak, 0-0.39; moderate, 
0.40-0.59; strong, > 0.6) (30). Kruskal-Wallis equality of populations test was 
applied to determine if limb segment volume was different for the three groups of 
wound healing (worse, no change, healing). The results of the Kruskal-Wallis test 
were reported as χ2. A p value of less than 0.05 was considered statistically 
significant for all analysis. 
A series of proportional-odds ordered logistic regression (POLR) analyses, were used 
to determine the effect of BIS variables R0, Ri, Rinf, PA50 and limb segmental 
volume on the dependent categorical variable, wound healing. Wound healing as 
confirmed by epithelialisation and area. The odds ratios, with 95% confidence 
intervals were reported. Statistical significance was determined if the p value was 
less than 0.05. Prior to interpreting the results of the OLR models; 1) several 
assumptions were evaluated, confirming the response variable healing is ordinal and, 
healing is linearly related to each BIS variable and 2) Step-wise, backward 
elimination of the variables was completed, to produce the final model. 
6.3 Results 
A total of 30 patients with minor limbs burns <5% TBSA were recruited and a final 
28 (20 male, 10 female) were included in the analysis. Two patients were excluded, 
one due to equipment malfunction and one lost to follow up (did not return for 
second assessment). Patient injury details are presented in Table 6.1.  
Table 6.1: Patient injury details (n=28). Values presented as means 
and (standard deviations) or number, where appropriate. 
TBSA of  
Ax 
wound 
Days post burn Burn Location Wound Healing 
Categories 
Surgery 
Initial Ax Follow 
up Ax 
Upper 
limb 
Lower 
limb 
Worse No 
Change 
Better Yes 
1.39% 
(0.96) 
2.35 
(1.18) 
7.05 
(3.98) 
16 14 5 2 21 6 
Ax = assessed 
Within this patient sample, burn wound depths included superficial partial thickness 
(n=9), mid dermal (n= 11), deep partial thickness (n=6) and full thickness (n=2). The 
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surgical intervention included dermabrasion and ReCell® (Visiomed group ltd) 
(n=3) and split skin graft and ReCell® (n=3). The median limb localised segment 
volume was 1861.94 ml (inter quartile range (IQR) 850.63 ml – 3010.36 ml). The 
median limb localised segment volumes by wound category were ‘worse’ 3010.48 
ml (IQR 1587.64 – 3231.84 ml), ‘no change’ 1221.15 ml (IQR 1081.52 – 1360.78 
ml) and ‘healing’ 969.57 ml (IQR 509.86 – 1810.44 ml). 
Spearman’s correlation determined there was a significant but weak negative 
association between a healing wound and limb segment volume (ml), rho -0.30, p 
<0.01. 
Kruskal-Wallis tests determined that there was a statistically significant difference in 
limb segment volume between the three wound healing groups, χ2 = 9.62, p = 0.008. 
However, the non-healing wound response category sample sizes were small (worse, 
n = 5; no change, n = 2) and the results should be interpreted with caution. An 
analysis of variables with sample size less than five (5) per category cannot be 
considered a robust result (31).  
Proportional-odds ordered logistic regression analysis determined surgery was a 
significant predictor variable of healing. Once surgery was adjusted for, R0 and Rinf 
were significantly associated with healing. A one ohm increase in R0 and Rinf will 
increase the odds of wound healing by 6% and 5% respectively (Table 6.2). Phase 
angle and Ri were not significantly associated with healing of the wound. Whilst 
limb segment volume was correlated with wound healing (spearman’s analysis), 
when added to the POLR analysis it was not significantly associated with the wound 
healing categories i.e.it did not enhance prediction of wound healing outcome 
compared to BIS variables, and thus was not warranted in the final POLR model. 
Burn wound depth was not significantly associated with wound healing category (p = 
0.85). 
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Table 6.2: Relationship of wound healing with localised BIS variables      
Wound Covariate Odds Ratio 
95% Confidence Interval 
p-value 
Lower Upper 
Healed R0 (ohms) 1.05 1.02 1.08 <0.01* 
 Ri (ohms) 1.01 1.00 1.03 0.07 
 Rinf (ohms) 1.06 1.02 1.11 <0.01* 
 PA50 (degrees) 0.94 0.67 1.32 0.74 
R0 = resistance at zero frequency, Ri = intracellular resistance, Rinf = resistance at infinite 
frequency; PA50 = phase at 50Hz; *p= <0.05. BIS = bioimpedance spectroscopy 
6.4 Discussion  
In patients with minor limb burns, localised BIS resistance measures, at zero and 
infinite frequencies, are able to monitor wound healing. BIS demonstrated a 
significant association with a healing wound and the subsequent decrease in oedema 
volume which supports this result. 
The POLR analysis allowed us to confirm part of the hypothesis that bioimpedance 
resistance variables (R0, Ri, Rinf) will increase as the wound heals. The results 
determined R0 and Rinf significantly increased with wound healing, but Ri and PA did 
not. These results are supported by rodent and human studies where epithelialisation 
of a wound was associated with an increase in resistance measured at a variety of 
frequencies (24, 26, 32). Lukaski and Moore (2012) suggest R is a specific 
biomarker of cell growth where increases reflect healing and decreases is suggestive 
of a lack of healing.  
Resistance at zero frequency increasing with wound healing may also be explained 
by the reduction in limb oedema with healing. At low frequencies the BIS current 
cannot penetrate the cell membrane and is therefore a measure of ECF. In the acute 
phase, one element of burn wound healing is a reduction in oedema (7, 33). This is 
further supported by the significant negative spearman’s correlation between a 
healing wound and limb segment volume (ml), and the difference in limb volumes in 
each of the three wound healing categories (worse, no change and healing) as 
determined by Kruskal-Wallis analysis. The spearman’s correlation and Kruskal-
Wallis analysis results also indicate that reduction of edema volume is a measureable 
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symptom of progression of acute wound healing. The Kruskal-Wallis analysis result 
though, needs to be interpreted as a preliminary finding due to the low sample 
numbers in two of the wound healing categories. Segmental limb volume however, 
was not a significant independent predictor of wound healing in the multivariable 
POLR analysis. Measurement of resistance at high frequencies, Rinf, is reflective of 
molecules inside and outside the cells (TBF). Resistance at infinite frequency would 
therefore increase as a result of decreased oedema and cell proliferation (34). 
Changes in Ri are not reflective of wound healing and may be due to the intracellular 
fluid compartment remaining stable in an acute minor burn wound.  
In this study, the PA measured by BIS at a frequency of 50 kHz was not significantly 
associated with healing of a minor limb burn for this cohort. Therefore, using the 
markers of wound healing defined for this study, there is no evidence in this sample 
that PA50 measurements are related to wound healing. Phase angle indicates the 
distribution of water between intracellular and extracellular space and reflects the 
electrical integrity of vital cell membranes (35). Wagner et al (1996) found localised 
PA measures taken at two different sites were significantly different between those at 
high risk of pressure ulcers compared to a control group. There was however no 
difference in PA within the high risk or control groups between the two sites (36). It 
is therefore possible, in minor limb burn injuries, that the relationship between Xc 
and R is consistent independent of the extent of tissue injury. In contrast however, 
localised PA50 has been demonstrated in a series of case studies using serial 
measures of wounds with varying aetiologies, to reflect wound healing and 
breakdown (23). An alternative explanation for the inconclusive findings regarding 
phase angle as an indicator of wound healing from this analysis may be due to the 
lack of sensitivity of the wound healing markers used in this study i.e. visual 
assessment and, or the limitation of a small sample size in the wound healing 
categories, worse (n = 5) and no change (n = 2). A second explanation of the PA 
results measured at 50 kHz may not be the optimum frequency that is sensitive 
enough to measure cellular proliferation in acute burn wounds. Tornuev et al (2014) 
demonstrated that a PA at higher frequencies (100 or 200 kHz) is best to distinguish 
a change in the level of cellular healing and thus is more sensitive in detecting wound 
healing and inflammatory diseases in mammary glands after surgery (37). In 
contrast, Kekonen et al (2012) found healing of a single superficial acute wound 
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could be first detected with BIS at frequencies between 1 - 100 kHz within the first 
four days of injury. Frequencies lower than 1 kHz did not indicate any significant 
change in the wound. It appears optimal PA frequency for measuring healing may 
differ for different wound aetiologies.  
This study demonstrates the capability of BIS as a quantitative non-invasive index of 
wound healing. The BIS measures are sensitive which allows some confidence in the 
generalisation of our results. A limitation of the study however is the small overall 
sample size, which is not a representative sample of the burns population and does 
not allow conclusive results to be drawn with respect to PA as a wound healing 
measure. 
To further enhance the clinical applicability of BIS in burns, studies investigating the 
association of PA at various frequencies with burn wound healing using enhanced 
wound healing markers and larger sample sizes are warranted. In addition assessment 
of bioimpedance until wound healing would provide a greater understanding of the 
relationship between BIS variables and the wound healing process. 
6.5 Conclusion 
Bioimpedance spectroscopy resistance variables, R0 and Rinf, can be used to monitor 
wound healing in minor limb burns as an adjunct to standard practice. Further 
research is required however to investigate if phase angle is of value as an indicator 
of the wound healing process. 
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Chapter 7 Synthesis Of Results And Conclusions 
7.1 Introduction  
The oedema that occurs after an acute burn has a significant negative impact on 
wound healing and in severe cases, patient survival (1). The rate of wound healing is 
directly related to the severity of the scar, which consequentially can significantly 
affect the functional and psychological well-being of the patient (2-4). There is 
therefore an urgency to reduce acute burn oedema. Whilst considerable gains have 
been made in many areas of burn care, few advances have been made in the 
treatment and measurement of acute burn oedema in both minor and major burns. 
Advancements in acute burn oedema management have been stunted by the ability to 
measure the efficacy of interventions (5, 6).  
Following a burn injury, significant oedema is present in measurable amounts for up 
to 5 days, as fluid leaks (fluid shift) into the tissue from the inflamed blood vessels 
(6). The management of this fluid shift in major burns involves formal fluid 
resuscitation. Adjustment of the patient’s fluid requirements is a dynamic process 
and close monitoring is recommended, in order to prevent under or over resuscitation 
in the first 24 - 48 hours after burn the burn injury. When treating a burn this way, 
the clinician treads a fine line between excess tissue oedema, which slows wound 
healing and increases the risk of scar; and the prevention of hypovolaemic shock, 
renal failure and possibly death. The current most widely utilised measures of 
oedema and fluid shift include CLM, urine output monitoring and WDV. However 
they either lack precision, are invasive and/or lack utility in the acute burn unit. 
Urine output is a ‘quasi’ measure of fluid shifts and whole body perfusion and is 
suggested to lag behind actual hypoperfusion events (7). These limitations and the 
challenges of oedema volume change assessment in burns was the driving force 
behind this series of studies. A rapid, real time, reliable method of oedema 
assessment is required to help reduce the negative sequelae of acute burn oedema. 
Bioimpedance spectroscopy, is emergent in the literature as a method to evaluate 
oedema change in burns. It has advantages of other competing technologies of 
oedema change assessment such as near-infrared spectroscopy (NIR), perometry and 
  
162 
ultrasound as it has demonstrated reliability, sensitivity in detecting fluid volume 
change, is practical and user friendly (1, 8, 9). Also, after initial purchase BIS is low 
cost and likely a sustainable method of oedema monitoring in comparison to other 
technologies.  
Bioimpedance spectroscopy is a non-invasive tool, which is based on the principle 
that the resistance to the flow of an electric current through the body is directly 
related to the composition of the body. By measuring the resistance of the whole 
body and the limbs it is possible to calculate the inter-compartmental fluid volumes 
of the body (and other tissues) and hence obtain an index measure of oedema. The 
utility of BIS, as a non-invasive measure of fluid shifts in burn patients has been 
previously demonstrated, however the studies lacked power to determine BIS as a 
valid measure of fluid shift (1, 10, 11). The use of the BIS method in acute burns is 
also hindered by the presence of open wounds at the sites of standard electrode 
placement, i.e. the hands and the feet and by the presence of dressings. The dressings 
routinely used in the first 24-48 hours of injury, in the BSWA, incorporate silver 
compounds and dressings after this period are commonly hydrocolloid or similar. 
Since bioimpedance is based on the flow of an electrical current through the body, it 
raises the question as to whether the accuracy of the BIS measures is altered in the 
presence of various dressings. 
This research therefore aimed to investigate an alternative method, which is easy and 
rapid to use, for monitoring fluid shifts in the acute burn environment. Hence, the 
primary aim was establishing whether BIS was a reliable and valid instrument for 
measuring fluid shifts in acute burns, across the spectrum of burn severity. Secondly, 
to address the potential barriers to the clinical application of the BIS instrument in 
this environment and thirdly to examine whether BIS could monitor minor burn 
wound healing. 
The outlined research problems were addressed using four integrated studies. This 
chapter: 1) summarises the outcomes of each of the studies, 2) discusses the clinical 
limitations of BIS, 3) considers the future path of research and 4) concludes with the 
significance, recommendations and clinical implications of the research. 
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7.1.1 Study 1: Addressing The Barriers To Bioimpedance 
Spectroscopy In Major Burns: Alternate Electrode 
Placements  
The first study in the study series addressed potential barriers to the use of BIS in 
burns receiving fluid resuscitation to enable greater clinical utility by investigating 
alternate electrode placements when wounds hinder the use of standardised 
placement. The literature reports movement of electrodes circumferentially around 
the limb, theoretically, will not affect BIS measures (12). However Grisbrook et al 
(2015) found BIS measures were significantly different when electrodes were moved 
circumferentially on the lower limb in healthy populations. In contrast, movement of 
electrodes proximally 1cm and 2 cm has been reported to result in a change of mean 
BIS resistance values by 2% and 4% respectively (13). The use of alternate electrode 
placements in the burns patient population has not been described in the literature. 
The single service study therefore specifically aimed to contribute to the body of 
knowledge and determine whether alternate electrode configurations for whole body 
and limb segmental BIS outputs were comparable to standardised electrode 
configurations in moderate to large size burns across different dressing conditions 
(an open wound and Acticoat
TM
 dressing). 
The first study demonstrated that whole body bioimpedance spectroscopy resistance 
variables (R0, Ri, Rinf indicative of extracellular, intracellular and total body fluid 
respectively) and extracellular fluid (ECF) volumes were interchangeable in an open 
wound and the Acticoat
TM
 dressing condition. All upper limb segmental measures 
were interchangeable in an open wound only but not in an Acticoat
TM
 dressing. The 
differences between measurements of other BIS variables (namely intracellular fluid 
(ICF) and total body fluid (TBF) whole body measures and all lower limb measures) 
across the dressing conditions were not clinically acceptable. It was also evident that 
the Acticoat
TM
 dressing condition amplified the differences between the standard and 
alternate electrode positions but also between the open wound and Acticoat
TM 
dressing condition for each BIS variable. The study however was not designed to 
explore this effect further. Additionally, it was shown that the standardised whole 
body BIS fluid volumes measured in the open wound environment were comparable 
to those expected when fluid resuscitation volumes were taken into consideration 
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(14) i.e. the ECF, ICF and TBF volumes were within 4 L (maximum resuscitation 
volumes) of normal values. This further supports the establishment of BIS as a valid 
measure of fluid volume change in the burns environment. Also, the fact that 
resistance variables were more stable than fluid volumes between the two electrode 
configurations (standard and alternate) may suggest that resistance measures are 
more clinically useful as it removes the need for predictive equations (15).  
The results of the study therefore demonstrates whole body alternate electrode 
placements are a feasible alternative when wounds preclude the use of standardised 
placement for monitoring R0, Ri, Rinf and ECF within dressing conditions in burns 
>12% TBSA. This result hence partly ameliorates the potential difficulties to the use 
of BIS in the burn population, improving its practical application in this clinical 
environment. Further research is required to establish the best alternate electrode 
placements to measure all BIS variables in moderate to large burns and to therefore 
enhance its clinical utility. 
7.1.2 Study 2: An Objective Measure For The Assessment And 
Management Of Fluid Shifts In Acute Major Burns 
The second study, in the study series, expands on addressing the barriers to BIS 
application in burns and explores its reliability and validity as a measure of fluid shift 
(using both raw resistance variables and calculated fluid volumes). The reliability 
and applicability of BIS in the measurement of fluid volumes in the burns 
environment has been demonstrated yet it has not been validated as a method of fluid 
shift assessment (10, 12). The second observational longitudinal study therefore 
aimed to contribute to the understanding of a) the reliability of BIS with respect to 
dressing condition and electrode position, b) the influence of Acticoat
TM
 on BIS 
variable outputs and c) the validity of whole body BIS to assess net fluid shift in the 
presence of moderate to major burns. 
This study demonstrated the reliability of BIS under any dressing conditions and 
electrode position. All BIS measures were reliable within any electrode position 
(standard and alternate whole body and limb segmental), across dressing conditions 
(open wound and Acticoat
TM
) and over time. We therefore propose that 
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bioimpedance spectroscopy is a reliable method for monitoring fluid change in 
moderate to large burns patients. 
Further, this study supported the hypothesis that “Acticoat dressing used in the first 
48 hours of burn injury in the BSWA reduced BIS variable outputs”. ActicoatTM, an 
antimicrobial silver impregnated dressing significantly reduced BIS resistance 
variables as expected, and led to increased calculated fluid volumes. There was also 
a significant Acticoat
TM
 TBSA interaction where the Acticoat
TM
 effect on BIS 
measures was magnified with increasing TBSA. These results concur with those 
found by Grisbrook et al (2015). Therefore, in order to maximise clinical utility of 
BIS in the measurement of oedema at the bedside, this PhD project has included the 
production of algorithms embedded in a calculator to adjust for the effect of 
Acticoat
TM
 on BIS fluid volume measures. 
The final hypothesis that ‘BIS raw resistance variables will decrease and predicted 
fluid volumes will increase with increasing fluid shift’ was also accepted. 
Bioimpedance variables and net fluid shift were found to have a negative inverse 
linear relationship for resistance and calculated fluid volumes a positive linear 
relationship providing the net fluid shift, between consecutive measures, was greater 
than -100 ml. Other factors influencing BIS measures were: initial TBF volumes, 
with increasing initial TBF increasing measured fluid volumes and decreasing 
measured resistance and; time, where increasing time decreased resistance variables 
and increased fluid volumes measured. 
This study confirmed that BIS is a reliable and valid indicator of fluid volume 
change in moderate to large burns, if BIS measures are corrected for using the 
provided calculator and the fluid shift is not larger than -100 ml i.e. the patient can’t 
have a loss of fluid >100ml within the consecutive time periods. The calculator is 
able to adjust for the effect of Acticoat
TM
 and can provide an estimated change in 
BIS fluid volumes between consecutive BIS measurements (e.g. half hourly or 
hourly intervals), hence providing the potential for fluids to be titrated accordingly. 
This finding is important as BIS provides immediate, non-invasive assessment of 
fluid volume, thus having the potential to reduce the risk of over or under 
resuscitation and associated adverse outcomes. Other methods of fluid shift 
monitoring in the acute burn resuscitation period involve invasive monitoring or 
  
166 
delayed results from laboratories (16, 17). And the most widely used outcome 
measure, urine output has been suggested to lag behind the actual events of 
hypoperfusion by up to two hours questioning its accuracy (18, 19). Further work is 
required though, to increase confidence and allow greater reliance on this sensitive 
measure in fluid resuscitation management, over standard haemodynamic 
monitoring. Figure 7.1 shows a summary flow chart for the use of BIS in major 
burns.
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Figure 7.1: Summary flow chart for the use of BIS in major acute burns
  
168 
7.1.3 Study 3: Bioimpedance Spectroscopy: A Technique 
To Monitor Interventions For Swelling In Minor 
Burns 
The first two studies in the series demonstrated BIS is a reliable and valid measure of 
whole body fluid volume change if measures are corrected for the presence of 
dressings by using the using the developed calculator. These studies attempted to 
address barriers to the use of BIS in the acute burns resuscitation environment by 
investigating alternative electrode placements and the effect of routinely used 
dressings in the BSWA. The third study continues in the same vein, exploring BIS as 
a reliable and valid measure of oedema change in minor burns with respect to 
dressing condition and electrode placement. Limb segmental and localised BIS has 
been shown to be a reliable and sensitive measure of lymphoedema and oedema 
change in muscle injuries (9, 20) but whole body BIS has not (21). Yet, it is 
unknown if this is true in minor burns less than five percent TBSA. Therefore, the 
third study examined the reliability and validity of the BIS technique for the 
measurement of localised burn wound oedema with respect to electrode position and 
dressing condition.  
This study supported the hypothesis that BIS variables R0 (resistance of extracellular 
fluid), Ri (resistance of intracellular fluid), Rinf (resistance of total body fluid) 
increased as limb volume decreased. This finding is supported by Ward et al (2006) 
who reported raw resistance values could be used as a surrogate index of volume due 
to the inverse relationship between the two. It was also determined that localised BIS 
was the most sensitive electrode positioning to detect oedema change (R0), was 
reliable and the BIS raw resistance measures provided a valid index of oedema 
change in minor burns. Additionally, BIS was found to be more sensitive to fluid 
volume change than calculated truncated cone volume measures from CLM. 
As with the major burn study (second study) dressings were found to influence the 
BIS measures and they had a significant interaction with TBSA. It was found 
hydrocolloid dressings increased and silver impregnated dressings decreased the 
measured BIS resistance. An algorithm was therefore developed to adjust resistance 
values when dressings are in use. This improves the clinical utility of BIS to monitor 
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localised changes in burn wound oedema. These findings expand the usefulness of 
BIS in the burns population. There is now a rapid, reliable and valid objective 
measure of peripheral oedema that can be utilised in the presence of dressings and 
wounds. Unlike CLM and WDV, the most widely accepted methods of peripheral 
oedema assessment, where their use is limited to open wounds, and they pose an 
infection risk if cleaning procedures are not thorough. Bioimpedance spectroscopy’s 
utility in the monitoring of peripheral oedema change is valuable as being able to 
determine the effectiveness of oedema management interventions easily, can guide 
best patient care and help improve functional and scar outcomes post burn.  
7.1.4 Study 4: Monitoring Wound Healing In Minor Burns – A 
Novel Approach  
The final study explores BIS as a method of monitoring wound healing. As with 
assessing oedema changes, usual assessment of wound healing involves an undressed 
wound. The most common current assessment tools are computer software packages, 
which assess the area and depth of wound, and subjective assessment by specialised 
clinicians (22). Bioimpedance spectroscopy is emerging as a tool for wound healing 
assessment both in rodent and human studies (23, 24). It has been investigated in 
chronic non-healing wounds of differing aetiologies (e.g. traumatic, surgical) and in 
surgical mammary gland wounds (25, 26). All BIS variables appear to be associated 
with healing, however the totality of studies performed in this area seem to primarily 
investigate resistance and phase angle as indicators of wound status. 
The fourth and final study determined the BIS technique is a valid measure of wound 
healing and examined whether a healing wound is associated with oedema volume 
change. 
The hypothesis that ‘BIS resistance increased with burn wound healing’ was partly 
confirmed. It was determined that the resistance of the extracellular and total body 
fluid (R0 and Rinf respectively) were associated with a healing wound, each 
increasing as the burn wound heals. An increase in both of these resistance values is 
related to a reduction in oedema with a healing wound. This was further supported 
by the significant negative correlation between a healing wound and limb segment 
volume (ml). Kekonen et al (2015) found resistance, measured at varying 
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frequencies, increased with epithelialisation of an acute wound (27). The results 
however found phase angle (PA and promoted as a measure of cell membrane 
health) at 50 kHz was not significantly associated with healing of a minor burn for 
this cohort. Therefore, using the markers of wound healing as per this study, there is 
no evidence in this sample that measurements of PA at 50 kHz are related to wound 
healing. Further research is warranted to explore the capability of BIS as a non-
invasive tool for quantitative evaluation of wound health with PA’s at different 
frequencies. It has been demonstrated that BIS frequencies of 100-200 Hz are more 
sensitive to early changes in indicating wound healing and is worth investigation in 
burn patients (26).  
It can be concluded that BIS resistance values at zero (indicative of oedema) and 
infinite frequencies can be used, in conjunction with standard practice, to monitor the 
status of minor burn wounds. Figure 7.2 provides a summary of how localised BIS is 
utilised in minor burns.
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Localised BIS 
in  
Minor limb Burns 
<5% TBSA 
Monitoring wound 
healing 
Place electrodes 3cm 
longitudinally from 
wound edge 
Monitoring oedema  
 
Measure inter-electrode 
distance + electrode distance 
from anatomical landmarks 
 
Dressing insitu 
Measure BIS 
resistance variables 
Open wound (no 
dressing) 
 
Measured resistance at zero frequency 
(R0) = index  oedema change 
R0 =      oedema 
 
BIS can monitor oedema 
change where R0 = index 
of oedema volume change 
Measured R0 , if corrected using 
appropriate algorithm (for the 
dressing type), is a valid index 
of oedema change 
Measure BIS 
resistance variables 
Resistance at zero (R0) and 
infinite  (Rinf) frequency are 
associated with healing 
Localised BIS may be used in 
conjunction with standard practice to 
monitor the status of a minor burn 
wound 
Figure 7.2: Summary flow chart for the use of BIS in minor acute burns  
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7.2 Limitations 
Even though the individual studies presented in Chapters three to six discuss their 
limitations, these were guided by the journal requirements. Further limitations 
relevant to the individual studies are detailed below. 
7.2.1 General Limitations 
This study was limited in terms of the population involved. It was a single service 
study including adults only and results may not able applicable to paediatrics. This is 
due to the different developmental stages of children and varying body composition 
throughout these stages, which significantly influence BIS measures (28). 
Furthermore, being a single service study allowed only dressings routinely used in 
the BSWA within the specified timeframes to be investigated. This may limit the 
generalizability of the results to other services, which use different dressings, 
especially silver impregnated ones, in the acute period. The population was also 
limited to acute burns, potentially decreasing the application and generalisation of 
results to subacute and chronic burn oedematous states. 
7.2.2 Study 1: Addressing The Barriers To Bioimpedance 
Spectroscopy In Major Burns: Alternate Electrode 
Placements  
A limitation of this study was the use of the same alternate lower limb electrode 
positions utilised in the healthy population by Grisbrook et al (2015). Due to the time 
constraints of the research and schedule of the researchers we were unable to await 
the results of their study. We had to move forward with the proposed alternate 
electrode placements, based on the theory of equi-potentials from the literature (12). 
Grisbrook et al (2015) demonstrated the lower limb alternate electrode placements 
did not provide interchangeable BIS measures with the standardised positions. 
Knowing this, we could have investigated other alternate electrode placements but 
were unable to. This is therefore considered in the future research. The standard and 
alternate electrode positions were only measured in a new Acticoat
TM
 dressing 
condition so results may not be generalizable to measures in older dressings. 
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Acticoat
TM
 works by depositing silver ions into the wound over time thus likely 
increasing the conductivity of the BIS electrical current, in turn affecting BIS 
measures. 
7.2.3 Study 2: An Objective Measure For The Assessment And 
Management Of Fluid Shifts In Acute Major Burns 
The results from this study are not generalizable to major burns with dressings other 
than an open wound or Acticoat
TM
. Study Three demonstrated that non-silver 
impregnated dressings alter BIS measures. Due to other research projects being 
conducted at the BSWA site, time constraints were put on the research and the 
project was limited to collection of data within the first 48 hours of injury only. 
Hence other dressing conditions were unable to be included in this study, as 
Acticoat
TM
 is the dressing used in this timeframe in the BSWA. Investigating the 
relationship between BIS measures and total body weight changes (a gross measure 
of oedema change) was also limited. Burn dressings and retention of fluid from 
formal resuscitation in large burns pose a barrier to regular reliable weights in the 
acute period. 
7.2.4 Study 3: Bioimpedance Spectroscopy: A Technique To 
Monitor Interventions For Swelling In Minor Burns 
Confirmation of localised BIS as a measure of localised wound oedema ideally 
should have been compared to WDV rather than CLM, however in collusion with the 
supervisors of this candidature it was not considered viable during this project. 
Firstly, to be able to include limb burns at any location (upper or lower limb) large 
containers of water would be required which are cumbersome, heavy and pose a risk 
to the researcher. Secondly, it is another burden to the patient as they potentially 
have to undress and must be functionally able to get a limb in and out of the water 
container (especially if it is on the upper thigh). In contrast, we could have tightened 
the inclusion criteria to burns on the forearm or lower leg but this was not considered 
feasible due to the timeframe of the research.  
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7.2.5 Study 4: Monitoring Wound Healing In Minor Burns – A 
Novel Approach 
The comparative measure for wound healing over time was visual assessment via 
photographs by a Specialist Burns Consultant. Ideally a wound area measurement 
would have been included as another objective outcome measure. Wound area was 
calculated for each series of photographs using Image J, a free software package able 
to calculate wound area but it was not used in the final analysis (29). The wound area 
measure was excluded because frequently, at early follow ups, the wound margins 
had extended. Therefore wound area increased even though the wound was clearly 
healing on visual assessment. This is the nature of burn wounds and may have been 
due to further debridement of dead tissue with a healing wound presenting itself 
underneath the removed tissue. Patients who had surgery were also included in the 
patient cohort. If surgery was completed after recruitment the wound area had 
increased, due to debridement, but the wound was healing or healed. This inherently 
goes against a healing wound where the area decreases as it heals (30). The image J 
area measurement was therefore not appropriate for inclusion in the analysis. 
Additionally, it was difficult to account for the curve of the limb in the bigger minor 
limb burns, which led to large discrepancies between the two photo areas calculated. 
It was therefore decided to omit the image J area calculations from the analysis. 
Further, we were unable to examine whether there is a quantifiable volume of 
oedema that impacts significantly on wound healing. A degree of oedema is essential 
in an acute wound injury and is a normal part of the healing process (31). However, 
it is not certain how much oedema is detrimental to healing. It was not possible to 
investigate the rate of, or time to healing associated with a quantifiable volume of 
oedema due to the available instrumentation and equipment and the time constraints 
of the study. 
7.3 Conclusions 
The novel findings of this study demonstrate a single instrument, BIS, is capable of 
monitoring fluid shifts easily, in real time and in the presence of dressings in the 
burns population. The first study of this study series determined whole body BIS 
alternate electrode placement measures can be utilised in burns > 12% TBSA, 
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without adjustment, for the assessment of i) all resistance variables and extracellular 
fluid (ECF) volumes in an open wound and Acticoat
TM
 dressing, ii) total body fluid 
(TBF) in an open wound only. Total body fluid volumes in an Acticoat
TM
 dressing 
and intracellular fluid volumes in an open wound and Acticoat
TM
 dressing need to be 
used with caution as there is the potential for them to be over or underestimated. 
The second and third studies showed BIS is a reliable method for monitoring fluid 
volume change across the spectrum of burns severity in any dressing condition and 
electrode position. Both whole body and localised BIS are accurate in the assessment 
of fluid shifts in major and minor burns, respectively. Silver and non-silver 
impregnated dressings alter BIS measures. Therefore, in the presence of dressings, 
BIS measures have to be corrected using the appropriate algorithms or calculator. 
The final study established BIS resistance values, (R0 ECF equivalent and Rinf, TBF 
equivalent) are able to monitor the status of minor limb burn wounds and are a useful 
adjunct to standard practice. However, further research is required to investigate 
phase angle as an indicator of the wound healing process. 
7.4 Future Research 
There is a plethora of opportunity to extend the use of BIS in burns as mentioned in 
the literature review, but in keeping with the overarching theme of this research the 
future recommendations will concentrate its application in the assessment of fluid 
volume change. 
This research has demonstrated that BIS is able to monitor fluid volume change 
across the spectrum of burn severity with use of the developed algorithms or 
calculator. To make further progress and to enhance the clinical utility of BIS in the 
burns population, development of one workable calculator for burns greater than 5% 
TBSA would help achieve this. It is recommended the results of this research (Study 
Two) and Grisbrook et al’s (2016) be pooled together to accomplish this. As touched 
on in Study Two, additional work is required to improve confidence in the use of BIS 
over standard haemodynamic monitoring in major burns for titration of resuscitation 
fluids. A greater understanding of the effect of large negative fluid shifts (> 100 ml) 
on BIS measures is also required as negative volumes of such amplitude clinically 
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exist. Future research design should therefore include repeated BIS measures (e.g. 
hourly, over seven-eight hours) over the initial 48-72 hours of burn injury, in order to 
capture the ebbs and flows of fluid shift in major acute burns. Study Two in this 
series only included five consecutive half hourly BIS measures (with dressings 
intact), over a two-three hour period. Ideally multi centred trials would be conducted 
to increase major burn patient numbers, thus providing the best representative burn 
population sample and generalisability of results. This would also allow for 
comparison of burn centre’s fluid resuscitation regimes and the effects on acute burn 
fluid shifts. To extend BIS’s ability to measure oedema change, studies need to be 
conducted in subacute and chronic burns to explore its reliability and validity in 
these sub groups. 
With respect to wounds posing a potential barrier to BIS utility, further exploration 
into optimal alternate electrode placements is required (as discussed in Study One). 
A greater understanding of limb segmental measures in measuring whole body fluid 
volumes is also warranted. It has been suggested whole body impedance and 
composition may be predicted by the measurement of one extremity’s (or segment of 
extremity) impedance (32). Bioimpedance measurement of a calf segment in dialysis 
patients has been shown to reflect whole body fluid shifts (33). Therefore if upper 
limb burns prevent the placement of hand electrodes then is it possible lower limb 
segmental BIS measures alone provide an option of whole body fluid volume 
assessment? Segmental upper and lower limb BIS measurements, in healthy 
individuals, were collected as a part of Grisbrook et al’s study thus providing 
normative data (34). Limb segmental BIS measurements were also measured in study 
one of this series (major burns) but investigation of the results in monitoring fluid 
shifts were considered out of scope of the study. This data may therefore be utilised 
in a pilot study exploring limb segmental BIS measures in monitoring whole body 
fluid volume change. 
An option to combine a BIS instrument with intravenous fluid pumps would enhance 
the utility of this non-invasive tool in not only burns, but other clinical areas where 
fluid resuscitation is required e.g. major trauma, severe sepsis. Combining BIS with 
intravenous fluid pumps would allow continuous monitoring of fluid shifts and 
automatic, real time titration of fluid volumes to set targets. In burns receiving fluid 
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resuscitation, fluid volumes delivered could be automatically titrated to maintain ICF 
fluid volumes within a normal average range (for given height, weight and gender) 
and ECF volumes within five percent of average.  
Another possibility to address open wounds hindering oedema assessment by BIS is 
putting electrodes directly on the wound. Kekonen et al (2012) demonstrated a two 
electrode configuration, where one electrode was placed on the wound, was able to 
evaluate the status of a superficial acute wound (35). Investigation of within wound 
electrode configurations is worth pursuing. It eliminates the impedance of the skin 
and would reduce the barriers to BIS use in the burns population. Handheld 
microelectric, direct current generators with electrodes embedded in wound dressings 
have been developed to facilitate wound healing (36). These could be considered as 
another alternative to increase the clinical utility of BIS in populations where wounds 
preclude the placement of electrodes.  
Furthermore, it may be more advantageous to use the change in BIS resistance values 
(between consecutive measures) rather than calculated volumes as it removes the 
need for specific predictive equations and may eliminate the need for height and 
weight measures (15). There are a growing number of studies, which suggest raw 
variables may be more useful than calculated measures in predicting clinical 
outcomes (15, 37). Additionally, removing the use of predictive equations has been 
proposed to increase the sensitivity of BIS measures to detect change (38). However, 
further investigation in the burns population is needed to clarify this. Future studies 
are also required to determine what resistance change equates to a real volume 
change i.e. 1 ohm = x ml, so an absolute volume measure can be determined without 
the need for predictive equations.  
Following on from Study Three, research quantifying absolute volumes of oedema 
change over time with BIS in minor burns is also indicated. This is pertinent in 
oedema management interventional studies to help determine best practice. To 
achieve an absolute volume measure in minor burns a comparative objective measure 
of oedema volume change with greater sensitivity than circumference limb measures 
(CLM) is recommended. If funding and time allowed MRI should be considered. 
Water displacement volumetry (WDV) may be an option if patients with burns above 
the elbow and knee are excluded from the studies. If this was established the 
  
178 
applications of BIS wound expand considerably. With an valid technique to quantify 
oedema further examination of the association between oedema volume (through BIS 
variables) and wound healing is warranted. Improving knowledge of the effects of 
oedema would allow for advances in the development of treatment options to 
decrease and, or control oedema, of both large resuscitation and minor burns 
Thus  further enhancing clinical decision making in the management of the patient 
and the burn. 
Further study investigating the effect of the age of dressings on BIS measures in both 
localised and whole body burn wound oedema is also warranted. Dressings in acute 
major burns are changed every 24 - 48 hours and in minor burns they can be left in 
place for up to four to five days. Over time, wound exudate is absorbed by the 
dressing, which may potentially alter BIS measures. Therefore longitudinal studies 
should be conducted with BIS measures taken prior to removal of the intact dressing. 
A portable, mini size BIS instrument (strapped to the limb) which could monitor 
limb segment oedema change continuously, would allow patients to independently 
monitor and respond appropriately to changes in resistance measures (an index of 
oedema change). If resistance values significantly decreased, the patient could then 
instigate oedema management principles (e.g. elevation and/or movement) to reduce 
the oedema. A portable, real time oedema management device such as this would 
guide Specialist Consultant decision making and reduce the negative impact of 
oedema on wound healing and patient function.  
The final study has demonstrated BIS as an auspicious tool in the assessment of 
minor burn wound healing. Additional research is indicated to examine whether PA 
measured at other frequencies, other than 50 KHz, are associated with minor burn 
wound healing. It is recommended future studies continue wound healing assessment 
and BIS measures until complete epithelialisation of the burn wound, rather than just 
an initial and follow up assessment (as per Study Four). For the purposes of research 
improved markers of wound healing, such as tissue sample collection for histological 
assessment and laser Doppler imaging, are also indicated for exploration of BIS as a 
wound monitoring tool. However, taking tissue samples introduce ethical issues and 
increase the risk of adverse outcomes for the patients (39). Another question is 
whether BIS variables, in major burns, are associated with the status of the wound. 
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Confidence in the application of BIS as method of monitoring fluid volume change 
in the burns environment will increase as further research is conducted and questions 
answered. As a result it will guide best practice in oedema management strategies 
and reduce the burden of burn wound injury on the individual and society. 
7.5 Significance of This Research 
The results of this research have demonstrated the clinical and research utility of 
BIS, across the spectrum of burn severity. The novel findings show BIS possesses 
advantages over the widely accepted and current methods of oedema measurement 
and wound assessment, as it is user friendly, safe, rapid and non invasive. The 
current findings demonstrate that bioimpedance spectroscopy can provide an 
immediate measure of oedema volume change, estimate resuscitation requirements 
and monitor wound status. It can be utilised with dressings intact, a capability WDV, 
CLM and wound monitoring methods do not possess. Development of algorithms 
(from the results of studies two and three), to adjust for the presence of dressings, 
further enhances the application of the instrument in this arena. The new findings 
from the study series may also be useful and translational to other clinical 
populations, such as the critically ill, traumatic limb injuries and chronic ulcers 
where large or minor oedema changes pose a barrier to optimal recovery and patient 
treatment. 
Progress in optimising acute burn oedema removal has been limited by the ability to 
measure the efficacies of interventions. Oedema may contribute to burn wound 
conversion and other negative sequelae of the burn injury if urgent treatment to 
reduce oedema is not implemented. The results of the study series show BIS, a single 
instrument, has the potential to positively impact patient outcome and recovery 
following a burn. This will be achieved through implementation of its use 
immediately in patient care as tool for monitoring oedema change and through 
guiding future interventional studies to improve proactive oedema management and 
assessment of wound healing status.  
“Every intervention from the point of injury influences the outcome after burn” (6). 
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